HEADER RECORD*******LIBRARY HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SAS SASLIB 6.06 MAC1. 14NOV23:08:03:1614NOV23:08:03:16 HEADER RECORD*******MEMBER HEADER RECORD!!!!!!!000000000000000001600000000140 HEADER RECORD*******DSCRPTR HEADER RECORD!!!!!!!000000000000000000000000000000 SAS DM_2 SASDATA 6.06 14NOV23:08:03:1614NOV23:08:03:16 Demographics HEADER RECORD*******NAMESTR HEADER RECORD!!!!!!!000000002600000000000000000000 STUDYID Study Identifier DOMAIN Domain Abbreviation USUBJID Unique Subject Identifier SUBJID Subject Identifier for the Study RFSTDTC Subject Reference Start Date/Time ( RFENDTC Subject Reference End Date/Time ;RFXSTDTCDate/Time of First Study Treatment ERFXENDTCDate/Time of Last Study Treatment X RFICDTC Date/Time of Informed Consent k RFPENDTCDate/Time of End of Participation u DTHDTC Date/Time of Death  DTHFL Subject Death Flag € SITEID Study Site Identifier INVID Investigator Identifier …INVNAM Investigator Name ŒBRTHDTC Date/Time of Birth ¥AGE Age BEST  «AGEU Age Units ³SEX Sex ¸)RACE Race ¹ETHNIC Ethnicity â ARMCD Planned Arm Code øARM Description of Planned Arm  ACTARMCDActual Arm Code ACTARM Description of Actual Arm 'COUNTRY Country B HEADER RECORD*******OBS HEADER RECORD!!!!!!!000000000000000000000000000000 C4591001DMC4591001 1005 10051317100513172020-10-20T09:35:002021-05-132020-10-20T09:35:002020-11-12T09:06:002020-10-202021-05-13 100579828 Davis, Matthew Gilruth (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051328100513282020-10-20T12:31:002021-05-132020-10-20T12:31:002020-11-11T11:04:002020-10-202021-05-13 100579828 Davis, Matthew Gilruth (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051339100513392020-10-21T11:41:002021-07-072020-10-21T11:41:002021-06-09T02:05:002020-10-212021-07-07 100579828 Davis, Matthew Gilruth (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051410100514102020-12-09T16:46:002021-07-072020-12-09T16:46:002021-06-09T15:18:002020-12-092021-07-07 100579828 Davis, Matthew Gilruth (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051412100514122020-12-14T09:49:002021-06-302020-12-14T09:49:002021-01-05T09:17:002020-12-142021-06-30 100579828 Davis, Matthew Gilruth (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051413100514132020-12-14T09:32:002021-07-262020-12-14T09:32:002021-01-04T09:45:002020-12-142021-07-26 100579828 Davis, Matthew Gilruth (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051414100514142020-12-14T11:36:002021-07-232020-12-14T11:36:002021-06-25T11:17:002020-12-142021-07-23 100579828 Davis, Matthew Gilruth (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051415100514152020-12-14T16:26:002021-07-082020-12-14T16:26:002021-06-10T15:33:002020-12-142021-07-08 100579828 Davis, Matthew Gilruth (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051417100514172020-12-16T12:25:002021-08-142020-12-16T12:25:002021-08-13T10:53:002020-12-16 100579828 Davis, Matthew Gilruth (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051418100514182020-12-16T12:30:002021-07-162020-12-16T12:30:002021-01-06T10:19:002020-12-162021-07-16 100579828 Davis, Matthew Gilruth (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051419100514192020-12-16T15:57:002021-06-022020-12-16T15:57:002021-03-17T15:18:002020-12-16 100579828 Davis, Matthew Gilruth (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051420100514202020-12-16T15:50:002021-07-192020-12-16T15:50:002021-01-04T12:13:002020-12-162021-07-19 100579828 Davis, Matthew Gilruth (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051421100514212020-12-17T15:48:002021-07-192020-12-17T15:48:002021-06-09T15:03:002020-12-172021-07-19 100579828 Davis, Matthew Gilruth (b)(6)AĞYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051422100514222020-12-17T15:56:002021-07-192020-12-17T15:56:002021-06-09T15:02:002020-12-172021-07-19 100579828 Davis, Matthew Gilruth (b)(6)AÀYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051424100514242020-12-18T09:36:002021-07-122020-12-18T09:36:002021-01-08T09:03:002020-12-182021-07-12 100579828 Davis, Matthew Gilruth (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051425100514252020-12-18T12:13:002021-07-082020-12-18T12:13:002021-01-08T12:13:002020-12-182021-07-08 100579828 Davis, Matthew Gilruth (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051427100514272020-12-21T11:11:002021-07-082020-12-21T11:11:002021-06-07T12:18:002020-12-212021-07-08 100579828 Davis, Matthew Gilruth (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051428100514282020-12-21T14:37:002021-07-142020-12-21T14:37:002021-01-13T09:21:002020-12-212021-07-14 100579828 Davis, Matthew Gilruth (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051429100514292020-12-21T15:09:002021-07-162020-12-21T15:09:002021-01-11T16:16:002020-12-212021-07-16 100579828 Davis, Matthew Gilruth (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051430100514302020-12-22T08:48:002021-07-192020-12-22T08:48:002021-05-13T10:36:002020-12-222021-07-19 100579828 Davis, Matthew Gilruth (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051431100514312020-12-22T09:40:002021-07-202020-12-22T09:40:002021-01-12T11:52:002020-12-222021-07-20 100579828 Davis, Matthew Gilruth (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051436100514362020-12-22T12:26:002021-07-082020-12-22T12:26:002021-01-12T14:25:002020-12-222021-07-08 100579828 Davis, Matthew Gilruth (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051437100514372020-12-22T12:20:002021-07-192020-12-22T12:20:002021-06-17T10:57:002020-12-222021-07-19 100579828 Davis, Matthew Gilruth (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051438100514382020-12-22T12:13:002021-07-262020-12-22T12:13:002021-06-17T10:55:002020-12-222021-07-26 100579828 Davis, Matthew Gilruth (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051439100514392020-12-22T15:07:002021-07-122020-12-22T15:07:002021-01-11T15:13:002020-12-222021-07-12 100579828 Davis, Matthew Gilruth (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051440100514402020-12-22T15:10:002021-07-072020-12-22T15:10:002021-06-09T13:58:002020-12-222021-07-07 100579828 Davis, Matthew Gilruth (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051441100514412020-12-22T15:00:002021-08-052020-12-22T15:00:002021-01-12T14:14:002020-12-222021-08-05 100579828 Davis, Matthew Gilruth (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051444100514442020-12-22T16:23:002021-07-262020-12-22T16:23:002021-06-10T03:28:002020-12-22 100579828 Davis, Matthew Gilruth (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051445100514452020-12-22T16:50:002021-07-152020-12-22T16:50:002021-06-16T09:01:002020-12-222021-07-15 100579828 Davis, Matthew Gilruth (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051447100514472021-01-11T10:48:002021-07-262021-01-11T10:48:002021-02-01T10:07:002021-01-112021-07-26 100579828 Davis, Matthew Gilruth (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051448100514482021-01-11T12:59:002021-07-192021-01-11T12:59:002021-06-16T13:48:002021-01-112021-07-19 100579828 Davis, Matthew Gilruth (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051449100514492021-01-11T12:48:002021-08-022021-01-11T12:48:002021-02-01T11:21:002021-01-112021-08-02 100579828 Davis, Matthew Gilruth (b)(6)AàYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1005 10051450100514502021-01-11T14:54:002021-07-192021-01-11T14:54:002021-06-14T15:30:002021-01-112021-07-19 100579828 Davis, Matthew Gilruth (b)(6)AàYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1005 10051451100514512021-01-12T14:32:002021-08-092021-01-12T14:32:002021-02-03T12:57:002021-01-122021-08-09 100579828 Davis, Matthew Gilruth (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061183100611832020-11-30T09:24:002021-07-122020-11-30T09:24:002021-06-08T09:15:002020-11-302021-07-12 100682785 Peterson, James Todd (b)(6)AàYEARSMMULTIPLE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061184100611842020-11-30T12:03:002021-06-142020-11-30T12:03:002020-12-21T11:05:002020-11-302021-06-14 100682785 Peterson, James Todd (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061188100611882020-12-01T17:24:002021-07-122020-12-01T17:24:002021-06-07T17:03:002020-12-012021-07-12 100682785 Peterson, James Todd (b)(6)AÀYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061189100611892020-12-01T17:24:002021-06-152020-12-01T17:24:002020-12-22T16:59:002020-12-012021-06-15 100682785 Peterson, James Todd (b)(6)AğYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061190100611902020-12-02T08:52:002021-06-172020-12-02T08:52:002020-12-22T10:26:002020-12-022021-06-17 100682785 Peterson, James Todd (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061191100611912020-12-02T11:09:002021-06-182020-12-02T11:09:002020-12-22T10:47:002020-12-022021-06-18 100682785 Peterson, James Todd (b)(6)AğYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061196100611962020-12-02T18:00:002021-07-062020-12-02T18:00:002021-06-08T12:03:002020-12-022021-07-06 100682785 Peterson, James Todd (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061200100612002020-12-03T14:59:002021-08-262020-12-03T14:59:002021-04-07T10:44:002020-12-032021-08-26 100682785 Peterson, James Todd (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061201100612012020-12-03T14:58:002021-07-072020-12-03T14:58:002020-12-24T10:12:002020-12-032021-07-07 100682785 Peterson, James Todd (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061203100612032020-12-03T17:14:002021-06-172020-12-03T17:14:002020-12-22T12:02:002020-12-032021-06-17 100682785 Peterson, James Todd (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061206100612062020-12-04T09:16:002021-05-182020-12-04T09:16:002020-12-23T09:03:002020-12-042021-05-18 100682785 Peterson, James Todd (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061207100612072020-12-04T09:17:002021-05-182020-12-04T09:17:002020-12-23T09:02:002020-12-042021-05-18 100682785 Peterson, James Todd (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061209100612092020-12-04T12:09:002021-06-222020-12-04T12:09:002020-12-23T11:18:002020-12-042021-06-22 100682785 Peterson, James Todd (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061212100612122020-12-04T14:24:002021-07-082020-12-04T14:24:002021-06-08T13:53:002020-12-042021-07-08 100682785 Peterson, James Todd (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061213100612132020-12-04T14:23:002021-06-162020-12-04T14:23:002020-12-23T09:52:002020-12-042021-06-16 100682785 Peterson, James Todd (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061214100612142020-12-04T15:54:002021-07-192020-12-04T15:54:002021-06-21T15:11:002020-12-042021-07-19 100682785 Peterson, James Todd (b)(6)AàYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061219100612192020-12-07T09:55:002021-09-012020-12-07T09:55:002021-07-30T15:35:002020-12-072021-09-01 100682785 Peterson, James Todd (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061220100612202020-12-07T10:58:002021-06-232020-12-07T10:58:002020-12-28T10:02:002020-12-07 100682785 Peterson, James Todd (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061221100612212020-12-07T12:09:002021-08-022020-12-07T12:09:002020-12-28T11:47:002020-12-072021-08-02 100682785 Peterson, James Todd (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061223100612232020-12-07T13:48:002021-07-082020-12-07T13:48:002021-06-08T11:11:002020-12-072021-07-08 100682785 Peterson, James Todd (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061224100612242020-12-07T15:10:002021-07-082020-12-07T15:10:002020-12-28T09:50:002020-12-072021-07-08 100682785 Peterson, James Todd (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061226100612262020-12-07T16:29:002021-07-082020-12-07T16:29:002021-06-04T10:56:002020-12-072021-07-08 100682785 Peterson, James Todd (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061227100612272020-12-07T16:30:002021-06-212020-12-07T16:30:002020-12-28T17:30:002020-12-072021-06-21 100682785 Peterson, James Todd (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061228100612282020-12-08T10:56:002021-07-082020-12-08T10:56:002021-06-04T14:27:002020-12-082021-07-08 100682785 Peterson, James Todd (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061229100612292020-12-08T13:00:002021-06-232020-12-08T13:00:002021-03-11T16:32:002020-12-082021-06-23 100682785 Peterson, James Todd (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061230100612302020-12-08T17:08:002021-08-102020-12-08T17:08:002020-12-31T12:36:002020-12-082021-08-10 100682785 Peterson, James Todd (b)(6)AàYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061231100612312020-12-08T17:33:002021-08-162020-12-08T17:33:002020-12-28T10:09:002020-12-082021-08-16 100682785 Peterson, James Todd (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061232100612322020-12-08T17:56:002021-07-082020-12-08T17:56:002021-06-08T17:37:002020-12-082021-07-08 100682785 Peterson, James Todd (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061233100612332020-12-08T17:51:002021-07-082020-12-08T17:51:002021-06-08T17:38:002020-12-082021-07-08 100682785 Peterson, James Todd (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061234100612342020-12-09T08:59:002021-06-232020-12-09T08:59:002020-12-30T08:54:002020-12-092021-06-23 100682785 Peterson, James Todd (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061235100612352020-12-09T09:00:002021-07-142020-12-09T09:00:002021-06-08T09:00:002020-12-092021-07-14 100682785 Peterson, James Todd (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061236100612362020-12-09T11:20:002021-06-212020-12-09T11:20:002020-12-28T14:16:002020-12-092021-06-21 100682785 Peterson, James Todd (b)(6)AğYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061237100612372020-12-09T11:39:002021-06-302020-12-09T11:39:002021-06-02T13:45:002020-12-09 100682785 Peterson, James Todd (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061239100612392020-12-09T12:26:002021-07-092020-12-09T12:26:002021-06-09T17:42:002020-12-092021-07-09 100682785 Peterson, James Todd (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061241100612412020-12-09T14:21:002021-06-222020-12-09T14:21:002020-12-28T14:56:002020-12-09 100682785 Peterson, James Todd (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061242100612422020-12-09T16:24:002021-07-062020-12-09T16:24:002020-12-28T08:59:002020-12-092021-07-06 100682785 Peterson, James Todd (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061243100612432020-12-10T10:07:002021-06-292020-12-10T10:07:002020-12-29T08:59:002020-12-10 100682785 Peterson, James Todd (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061244100612442020-12-10T12:10:002021-06-222020-12-10T12:10:002020-12-29T11:36:002020-12-102021-06-22 100682785 Peterson, James Todd (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061245100612452020-12-10T12:11:002021-07-082020-12-10T12:11:002021-06-09T15:02:002020-12-102021-07-08 100682785 Peterson, James Todd (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061247100612472020-12-10T18:19:002021-07-122020-12-10T18:19:002021-06-04T17:01:002020-12-102021-07-12 100682785 Peterson, James Todd (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061248100612482020-12-11T09:11:002021-07-092020-12-11T09:11:002021-06-09T09:56:002020-12-112021-07-09 100682785 Peterson, James Todd (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061249100612492020-12-11T11:00:002021-06-252020-12-11T11:00:002020-12-31T11:04:002020-12-112021-06-25 100682785 Peterson, James Todd (b)(6)AğYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061250100612502020-12-11T11:03:002021-07-272020-12-11T11:03:002021-06-28T17:28:002020-12-112021-07-27 100682785 Peterson, James Todd (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061252100612522020-12-11T12:42:002021-07-122020-12-11T12:42:002020-12-31T12:15:002020-12-112021-07-12 100682785 Peterson, James Todd (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061253100612532020-12-11T14:15:002021-07-082020-12-11T14:15:002021-06-08T10:52:002020-12-112021-07-08 100682785 Peterson, James Todd (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061254100612542020-12-11T14:00:002021-07-062020-12-11T14:00:002020-12-30T14:11:002020-12-112021-07-06 100682785 Peterson, James Todd (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061256100612562020-12-11T17:55:002021-07-072020-12-11T17:55:002020-12-30T16:57:002020-12-112021-07-07 100682785 Peterson, James Todd (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061257100612572020-12-11T17:50:002021-04-092020-12-11T17:50:002021-03-12T14:03:002020-12-11 100682785 Peterson, James Todd (b)(6)AğYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061258100612582020-12-14T09:15:002021-07-092020-12-14T09:15:002021-01-05T08:57:002020-12-142021-07-09 100682785 Peterson, James Todd (b)(6)AàYEARSMNATIVE HAWAIIAN OR OTHER PACIFIC ISLANDERNOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061259100612592020-12-14T10:42:002021-05-112020-12-14T10:42:002021-04-13T09:25:002020-12-142021-05-11 100682785 Peterson, James Todd (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061260100612602020-12-14T10:44:002021-07-092020-12-14T10:44:002021-06-07T10:58:002020-12-142021-07-09 100682785 Peterson, James Todd (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061261100612612020-12-14T15:52:002021-06-302020-12-14T15:52:002021-01-05T10:15:002020-12-142021-06-30 100682785 Peterson, James Todd (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061262100612622020-12-14T17:40:002021-09-012020-12-14T17:40:002021-07-07T10:33:002020-12-142021-09-01 100682785 Peterson, James Todd (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061263100612632020-12-14T17:30:002021-07-072020-12-14T17:30:002021-01-04T16:57:002020-12-142021-07-07 100682785 Peterson, James Todd (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061264100612642020-12-14T18:00:002021-07-062020-12-14T18:00:002021-01-04T17:30:002020-12-142021-07-06 100682785 Peterson, James Todd (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061265100612652020-12-18T10:00:002021-05-142020-12-18T10:00:002021-01-06T08:45:002020-12-152021-05-14 100682785 Peterson, James Todd (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061266100612662020-12-15T11:15:002021-04-142020-12-15T11:15:002021-03-17T10:59:002020-12-15 100682785 Peterson, James Todd (b)(6)AğYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061267100612672020-12-15T13:25:002021-08-132020-12-15T13:25:002021-08-13T15:46:002020-12-15 100682785 Peterson, James Todd (b)(6)AğYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061269100612692020-12-15T17:36:002021-06-292020-12-15T17:36:002021-01-06T16:21:002020-12-152021-06-29 100682785 Peterson, James Todd (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061270100612702020-12-16T10:56:002021-04-092020-12-16T10:56:002021-03-11T16:30:002020-12-16 100682785 Peterson, James Todd (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061271100612712020-12-16T11:47:002021-07-072020-12-16T11:47:002021-01-05T14:26:002020-12-162021-07-07 100682785 Peterson, James Todd (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061272100612722020-12-16T12:07:002021-08-122020-12-16T12:07:002021-05-17T16:41:002020-12-162021-08-12 100682785 Peterson, James Todd (b)(6)AĞYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061273100612732020-12-16T16:05:002021-07-082020-12-16T16:05:002021-06-10T17:01:002020-12-162021-07-08 100682785 Peterson, James Todd (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061274100612742020-12-16T17:48:002021-07-072020-12-16T17:48:002021-01-08T10:56:002020-12-162021-07-07 100682785 Peterson, James Todd (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061276100612762020-12-17T12:52:002021-07-202020-12-17T12:52:002021-06-22T10:30:002020-12-172021-07-20 100682785 Peterson, James Todd (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061277100612772020-12-17T15:30:002021-08-232020-12-17T15:30:002021-06-07T15:52:002020-12-172021-08-23 100682785 Peterson, James Todd (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061278100612782020-12-17T17:11:002021-07-022020-12-17T17:11:002021-01-05T12:12:002020-12-172021-07-02 100682785 Peterson, James Todd (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061279100612792020-12-17T17:31:002021-08-112020-12-17T17:31:002021-06-07T17:12:002020-12-172021-08-11 100682785 Peterson, James Todd (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061280100612802020-12-17T17:41:002021-08-022020-12-17T17:41:002021-01-07T17:03:002020-12-172021-08-02 100682785 Peterson, James Todd (b)(6)AğYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061282100612822020-12-18T11:37:002021-07-022020-12-18T11:37:002021-01-08T10:59:002020-12-182021-07-02 100682785 Peterson, James Todd (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061283100612832020-12-18T12:28:002021-07-082020-12-18T12:28:002021-06-10T14:03:002020-12-182021-07-08 100682785 Peterson, James Todd (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061284100612842020-12-18T17:36:002021-08-312020-12-18T17:36:002021-06-15T15:57:002020-12-182021-08-31 100682785 Peterson, James Todd (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061285100612852020-12-21T11:59:002021-07-272020-12-21T11:59:002021-06-22T13:55:002020-12-21 100682785 Peterson, James Todd (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061286100612862020-12-21T14:26:002021-07-122020-12-21T14:26:002021-01-11T16:51:002020-12-212021-07-12 100682785 Peterson, James Todd (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061287100612872020-12-21T16:08:002021-05-252020-12-21T16:08:002021-01-11T17:38:002020-12-212021-05-25 100682785 Peterson, James Todd (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061288100612882020-12-21T16:09:002021-08-022020-12-21T16:09:002021-01-11T17:37:002020-12-212021-08-02 100682785 Peterson, James Todd (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061289100612892020-12-22T09:18:002021-08-192020-12-22T09:18:002021-01-13T16:49:002020-12-222021-08-19 100682785 Peterson, James Todd (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061290100612902020-12-22T09:19:002021-08-242020-12-22T09:19:002021-01-13T16:50:002020-12-222021-08-24 100682785 Peterson, James Todd (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061291100612912020-12-22T09:20:002021-07-132020-12-22T09:20:002021-06-14T16:42:002020-12-222021-07-13 100682785 Peterson, James Todd (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061292100612922020-12-22T13:53:002021-06-302020-12-22T13:53:002021-06-02T09:06:002020-12-222021-06-30 100682785 Peterson, James Todd (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061293100612932020-12-22T13:52:002021-07-142020-12-22T13:52:002021-01-12T09:18:002020-12-22 100682785 Peterson, James Todd (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061294100612942020-12-22T16:43:002021-07-082020-12-22T16:43:002021-06-08T16:28:002020-12-222021-07-08 100682785 Peterson, James Todd (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061295100612952020-12-24T10:21:002021-06-302020-12-24T10:21:002021-06-02T09:07:002020-12-242021-06-30 100682785 Peterson, James Todd (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061296100612962020-12-29T09:54:002021-05-272020-12-29T09:54:002021-01-19T16:04:002020-12-292021-05-27 100682785 Peterson, James Todd (b)(6)AàYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061297100612972020-12-29T09:55:002021-05-272020-12-29T09:55:002021-01-19T16:03:002020-12-292021-05-27 100682785 Peterson, James Todd (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061298100612982020-12-29T14:51:002021-07-092020-12-29T14:51:002021-06-09T09:48:002020-12-29 100682785 Peterson, James Todd (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1006 10061299100612992020-12-31T11:41:002021-07-262020-12-31T11:41:002021-01-22T17:07:002020-12-312021-07-26 100682785 Peterson, James Todd (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1006 10061300100613002021-01-07T16:41:002021-07-222021-01-07T16:41:002021-01-28T16:33:002021-01-072021-07-22 100682785 Peterson, James Todd (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071409100714092020-10-22T11:29:002021-07-012020-10-22T11:29:002021-05-27T10:40:002020-10-222021-07-01 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071414100714142020-10-22T12:17:002021-07-122020-10-22T12:17:002021-06-14T14:38:002020-10-222021-07-12 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071415100714152020-10-22T12:57:002021-06-072020-10-22T12:57:002020-12-10T09:13:002020-10-222021-06-07 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071417100714172020-10-22T13:32:002021-05-062020-10-22T13:32:002020-11-12T12:35:002020-10-222021-05-06 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071428100714282020-10-22T16:20:002021-05-132020-10-22T16:20:002020-11-12T16:26:002020-10-222021-05-13 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071429100714292020-10-22T16:34:002021-07-242020-10-22T16:34:002020-11-12T16:40:002020-10-222021-07-24 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071467100714672020-11-30T10:26:002021-06-142020-11-30T10:26:002020-12-21T09:59:002020-11-30 100713351 Frenck, Robert Wilson (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071469100714692020-11-30T11:22:002021-06-212020-11-30T11:22:002020-12-21T11:22:002020-11-30 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071471100714712020-11-30T12:25:002021-06-142020-11-30T12:25:002020-12-21T11:32:002020-11-302021-06-14 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071472100714722020-11-30T13:57:002021-07-122020-11-30T13:57:002021-06-07T15:02:002020-11-302021-07-12 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071475100714752020-11-30T15:02:002021-06-142020-11-30T15:02:002020-12-21T14:39:002020-11-302021-06-14 100713351 Frenck, Robert Wilson (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071476100714762020-11-30T17:18:002021-06-142020-11-30T17:18:002020-12-21T11:47:002020-11-302021-06-14 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071478100714782020-11-30T17:02:002021-07-132020-11-30T17:02:002021-06-09T14:01:002020-11-302021-07-13 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071480100714802020-11-30T17:21:002021-07-132020-11-30T17:21:002021-06-08T11:19:002020-11-302021-07-13 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071481100714812020-12-01T09:43:002021-08-012020-12-01T09:43:002021-06-28T09:46:002020-12-01 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071482100714822020-12-01T10:05:002021-07-152020-12-01T10:05:002020-12-22T10:32:002020-12-012021-07-15 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071483100714832020-12-01T11:20:002021-05-182020-12-01T11:20:002021-04-20T15:35:002020-12-012021-05-18 100713351 Frenck, Robert Wilson (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071484100714842020-12-01T11:16:002021-07-072020-12-01T11:16:002021-06-09T15:52:002020-12-012021-07-07 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071485100714852020-12-01T14:04:002021-06-152020-12-01T14:04:002020-12-21T15:01:002020-12-012021-06-15 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071488100714882020-12-01T15:56:002021-06-152020-12-01T15:56:002020-12-22T12:00:002020-12-012021-06-15 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071490100714902020-12-01T16:54:002021-06-162020-12-01T16:54:002020-12-22T11:58:002020-12-012021-06-16 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071492100714922020-12-01T17:22:002021-06-242020-12-01T17:22:002020-12-21T15:45:002020-12-01 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071494100714942020-12-02T11:29:002021-06-212020-12-02T11:29:002020-12-21T15:09:002020-12-022021-06-21 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071495100714952020-12-02T15:13:002021-07-132020-12-02T15:13:002021-06-14T12:03:002020-12-022021-07-13 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071496100714962020-12-02T17:12:002021-07-122020-12-02T17:12:002021-06-14T13:30:002020-12-022021-07-12 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071497100714972020-12-02T17:22:002021-06-162020-12-02T17:22:002020-12-22T09:50:002020-12-022021-06-16 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071499100714992020-12-03T16:21:002021-06-282020-12-03T16:21:002020-12-22T15:18:002020-12-032021-06-28 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071500100715002020-12-03T16:54:002021-06-222020-12-03T16:54:002020-12-22T10:26:002020-12-032021-06-22 100713351 Frenck, Robert Wilson (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071504100715042020-12-07T09:41:002021-06-232020-12-07T09:41:002020-12-30T10:35:002020-12-072021-06-23 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071505100715052020-12-07T10:16:002021-07-222020-12-07T10:16:002021-06-23T13:50:002020-12-072021-07-22 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071506100715062020-12-07T10:42:002021-06-212020-12-07T10:42:002020-12-28T16:05:002020-12-072021-06-21 100713351 Frenck, Robert Wilson (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071507100715072020-12-07T12:07:002021-07-092020-12-07T12:07:002021-06-10T14:10:002020-12-072021-07-09 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071508100715082020-12-07T13:47:002021-06-212020-12-07T13:47:002020-12-28T13:46:002020-12-072021-06-21 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071509100715092020-12-07T14:42:002021-07-072020-12-07T14:42:002021-06-09T12:16:002020-12-072021-07-07 100713351 Frenck, Robert Wilson (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071511100715112020-12-07T16:50:002021-07-132020-12-07T16:50:002021-06-08T10:01:002020-12-072021-07-13 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071512100715122020-12-07T17:14:002021-08-102020-12-07T17:14:002020-12-28T16:46:002020-12-072021-08-10 100713351 Frenck, Robert Wilson (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071514100715142020-12-07T17:11:002021-06-212020-12-07T17:11:002020-12-28T14:39:002020-12-072021-06-21 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071515100715152020-12-08T09:50:002021-06-242020-12-08T09:50:002020-12-29T10:14:002020-12-082021-06-24 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071516100715162020-12-08T09:43:002021-07-132020-12-08T09:43:002021-06-08T10:37:002020-12-082021-07-13 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071517100715172020-12-08T10:45:002021-06-222020-12-08T10:45:002020-12-29T15:55:002020-12-082021-06-22 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071518100715182020-12-08T11:20:002021-07-012020-12-08T11:20:002020-12-29T09:38:002020-12-082021-07-01 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071519100715192020-12-08T11:58:002021-06-092020-12-08T11:58:002021-04-21T14:11:002020-12-082021-06-09 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071520100715202020-12-08T12:03:002021-08-012020-12-08T12:03:002021-07-01T09:58:002020-12-082021-08-01 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071521100715212020-12-08T13:50:002021-07-192020-12-08T13:50:002020-12-29T14:53:002020-12-082021-07-19 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071522100715222020-12-08T15:38:002021-07-162020-12-08T15:38:002021-06-16T15:04:002020-12-082021-07-16 100713351 Frenck, Robert Wilson (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071523100715232020-12-08T15:30:002021-08-252020-12-08T15:30:002020-12-29T11:40:002020-12-082021-08-25 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071524100715242020-12-08T16:55:002021-04-202020-12-08T16:55:002021-03-18T16:09:002020-12-08 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071525100715252020-12-08T16:48:002021-06-242020-12-08T16:48:002020-12-29T11:28:002020-12-082021-06-24 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071526100715262020-12-08T17:18:002021-07-262020-12-08T17:18:002020-12-29T13:58:002020-12-082021-07-26 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071527100715272020-12-08T17:09:002021-07-212020-12-08T17:09:002021-06-22T14:12:002020-12-082021-07-21 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071528100715282020-12-09T09:40:002021-06-232020-12-09T09:40:002020-12-30T13:36:002020-12-092021-06-23 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071529100715292020-12-09T10:28:002021-06-292020-12-09T10:28:002020-12-30T10:22:002020-12-092021-06-29 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071530100715302020-12-09T10:40:002021-07-132020-12-09T10:40:002020-12-29T16:26:002020-12-092021-07-13 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071531100715312020-12-09T10:46:002021-07-282020-12-09T10:46:002021-06-22T09:29:002020-12-092021-07-28 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071533100715332020-12-09T11:46:002021-07-192020-12-09T11:46:002021-06-16T11:03:002020-12-092021-07-19 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071535100715352020-12-09T11:57:002021-08-272020-12-09T11:57:002020-12-30T12:49:002020-12-092021-08-27 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071536100715362020-12-09T12:48:002021-06-172020-12-09T12:48:002020-12-29T15:54:002020-12-092021-06-17 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071537100715372020-12-09T14:12:002021-06-232020-12-09T14:12:002020-12-30T16:25:002020-12-092021-06-23 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071539100715392020-12-09T15:23:002021-08-302020-12-09T15:23:002021-06-23T14:29:002020-12-092021-08-30 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071540100715402020-12-09T15:30:002021-08-302020-12-09T15:30:002021-06-23T14:14:002020-12-092021-08-30 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071541100715412020-12-09T16:50:002021-08-242020-12-09T16:50:002021-03-02T15:14:002020-12-092021-08-24 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071542100715422020-12-09T17:04:002021-06-232020-12-09T17:04:002020-12-30T16:28:002020-12-092021-06-23 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071543100715432020-12-09T17:05:002021-08-162020-12-09T17:05:002020-12-30T14:06:002020-12-092021-08-16 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071544100715442020-12-09T17:09:002021-08-162020-12-09T17:09:002020-12-30T14:13:002020-12-092021-08-16 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071546100715462020-12-10T09:54:002021-06-232020-12-10T09:54:002020-12-30T10:40:002020-12-102021-06-23 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071547100715472020-12-10T10:59:002021-07-132020-12-10T10:59:002021-06-10T11:04:002020-12-102021-07-13 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071550100715502020-12-10T15:20:002021-06-242020-12-10T15:20:002020-12-30T15:13:002020-12-10 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071551100715512020-12-10T15:08:002021-08-302020-12-10T15:08:002021-06-14T14:49:002020-12-102021-08-30 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071552100715522020-12-10T16:40:002021-07-162020-12-10T16:40:002021-06-16T14:54:002020-12-102021-07-16 100713351 Frenck, Robert Wilson (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071554100715542020-12-10T16:55:002021-08-042020-12-10T16:55:002020-12-30T15:29:002020-12-102021-08-04 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071555100715552020-12-10T16:36:002021-06-222020-12-10T16:36:002020-12-29T15:48:002020-12-10 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071557100715572020-12-14T09:42:002021-08-102020-12-14T09:42:002021-01-04T11:06:002020-12-14 100713351 Frenck, Robert Wilson (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071558100715582020-12-14T09:53:002021-06-282020-12-14T09:53:002021-01-04T09:33:002020-12-142021-06-28 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071559100715592020-12-14T11:52:002021-08-302020-12-14T11:52:002021-06-17T11:48:002020-12-142021-08-30 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071560100715602020-12-14T14:21:002021-07-062020-12-14T14:21:002021-06-07T14:56:002020-12-142021-07-06 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071561100715612020-12-14T15:08:002021-08-192020-12-14T15:08:002021-01-04T15:04:002020-12-142021-08-19 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071562100715622020-12-14T16:30:002021-07-062020-12-14T16:30:002021-06-07T12:26:002020-12-142021-07-06 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071563100715632020-12-14T16:21:002021-07-062020-12-14T16:21:002021-06-07T12:31:002020-12-142021-07-06 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071564100715642020-12-14T17:10:002021-06-302020-12-14T17:10:002021-01-06T15:38:002020-12-142021-06-30 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071565100715652020-12-14T17:22:002021-06-302020-12-14T17:22:002021-01-06T15:44:002020-12-142021-06-30 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071566100715662020-12-14T17:14:002021-07-072020-12-14T17:14:002021-01-04T16:35:002020-12-142021-07-07 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071567100715672020-12-15T10:06:002021-06-292020-12-15T10:06:002021-01-05T09:14:002020-12-152021-06-29 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071568100715682020-12-15T10:16:002021-07-222020-12-15T10:16:002021-06-22T09:29:002020-12-152021-07-22 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071569100715692020-12-15T11:10:002021-07-222020-12-15T11:10:002021-06-23T10:21:002020-12-152021-07-22 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071570100715702020-12-15T11:24:002021-07-222020-12-15T11:24:002021-06-23T10:28:002020-12-152021-07-22 100713351 Frenck, Robert Wilson (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071571100715712020-12-15T13:46:002021-06-302020-12-15T13:46:002021-01-06T16:32:002020-12-152021-06-30 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071572100715722020-12-15T17:05:002021-07-062020-12-15T17:05:002021-01-05T16:03:002020-12-152021-07-06 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071573100715732020-12-15T17:14:002021-06-302020-12-15T17:14:002021-01-04T15:13:002020-12-152021-06-30 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071574100715742020-12-16T10:00:002021-08-242020-12-16T10:00:002021-01-06T13:30:002020-12-162021-08-24 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071575100715752020-12-16T15:11:002021-06-302020-12-16T15:11:002021-01-06T14:56:002020-12-162021-06-30 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071576100715762020-12-16T15:31:002021-07-012020-12-16T15:31:002021-06-03T16:26:002020-12-162021-07-01 100713351 Frenck, Robert Wilson (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071577100715772020-12-16T17:32:002021-06-082020-12-16T17:32:002021-05-11T10:09:002020-12-162021-06-08 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071578100715782020-12-16T17:26:002021-07-122020-12-16T17:26:002021-06-14T13:56:002020-12-162021-07-12 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071579100715792020-12-16T17:36:002021-07-072020-12-16T17:36:002021-01-06T14:56:002020-12-162021-07-07 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071580100715802020-12-16T17:44:002021-06-302020-12-16T17:44:002021-01-06T16:45:002020-12-162021-06-30 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071581100715812020-12-17T15:49:002021-07-132020-12-17T15:49:002021-06-14T11:23:002020-12-172021-07-13 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071582100715822020-12-17T15:59:002021-07-082020-12-17T15:59:002021-01-07T15:43:002020-12-172021-07-08 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071583100715832020-12-17T16:41:002021-07-092020-12-17T16:41:002021-06-09T13:54:002020-12-172021-07-09 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071584100715842020-12-17T16:25:002021-08-272020-12-17T16:25:002021-01-07T16:12:002020-12-172021-08-27 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071585100715852020-12-17T16:27:002021-07-062020-12-17T16:27:002021-06-08T13:48:002020-12-172021-07-06 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071586100715862020-12-17T16:34:002021-07-212020-12-17T16:34:002021-06-22T09:49:002020-12-172021-07-21 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071587100715872020-12-17T16:47:002021-07-012020-12-17T16:47:002021-01-07T16:16:002020-12-172021-07-01 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071588100715882020-12-28T10:19:002021-07-272020-12-28T10:19:002021-01-20T09:20:002020-12-282021-07-27 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071589100715892020-12-28T11:25:002021-07-072020-12-28T11:25:002021-06-09T14:12:002020-12-282021-07-07 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071590100715902020-12-28T12:21:002021-07-142020-12-28T12:21:002021-01-20T15:49:002020-12-282021-07-14 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071591100715912020-12-28T12:56:002021-07-222020-12-28T12:56:002021-06-23T09:23:002020-12-282021-07-22 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071592100715922020-12-28T12:50:002021-07-132020-12-28T12:50:002021-01-19T09:29:002020-12-282021-07-13 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071593100715932020-12-28T12:57:002021-02-122020-12-28T12:57:002020-12-28T12:57:002020-12-282021-02-12 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071594100715942020-12-28T14:21:002021-07-192020-12-28T14:21:002021-01-19T16:55:002020-12-282021-07-19 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071595100715952020-12-28T14:50:002021-08-042020-12-28T14:50:002021-06-10T10:57:002020-12-282021-08-04 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071596100715962020-12-28T15:26:002021-07-122020-12-28T15:26:002021-06-14T11:31:002020-12-282021-07-12 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071597100715972020-12-28T15:35:002021-07-152020-12-28T15:35:002021-01-19T16:10:002020-12-282021-07-15 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071599100715992020-12-28T16:40:002021-07-132020-12-28T16:40:002021-01-19T12:06:002020-12-282021-07-13 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071600100716002020-12-28T16:44:002021-08-122020-12-28T16:44:002021-07-14T11:34:002020-12-28 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071601100716012020-12-28T16:54:002021-07-292020-12-28T16:54:002021-01-19T15:31:002020-12-282021-07-29 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071602100716022020-12-28T17:02:002021-07-202020-12-28T17:02:002021-01-19T16:56:002020-12-282021-07-20 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071603100716032020-12-29T10:08:002021-07-202020-12-29T10:08:002021-01-19T16:45:002020-12-292021-07-20 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071604100716042020-12-29T09:40:002021-07-142020-12-29T09:40:002021-01-19T16:37:002020-12-292021-07-14 100713351 Frenck, Robert Wilson (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071605100716052020-12-29T10:33:002021-07-132020-12-29T10:33:002021-01-19T10:01:002020-12-292021-07-13 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071606100716062020-12-29T12:15:002021-07-192020-12-29T12:15:002021-01-19T16:36:002020-12-292021-07-19 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071607100716072020-12-29T14:27:002021-08-312020-12-29T14:27:002021-06-10T14:10:002020-12-292021-08-31 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071608100716082020-12-29T14:21:002021-07-132020-12-29T14:21:002021-06-10T14:05:002020-12-29 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071609100716092020-12-29T14:49:002021-07-192020-12-29T14:49:002021-01-19T16:46:002020-12-29 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071610100716102020-12-29T15:05:002021-07-222020-12-29T15:05:002021-01-21T16:00:002020-12-292021-07-22 100713351 Frenck, Robert Wilson (b)(6)AğYEARSFAMERICAN INDIAN OR ALASKA NATIVE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071612100716122020-12-29T15:00:002021-07-132020-12-29T15:00:002021-01-19T16:12:002020-12-292021-07-13 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071613100716132020-12-29T16:13:002021-07-132020-12-29T16:13:002021-06-15T09:36:002020-12-292021-07-13 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071614100716142020-12-29T16:40:002021-08-262020-12-29T16:40:002021-06-28T14:09:002020-12-292021-08-26 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071615100716152020-12-29T16:12:002021-08-302020-12-29T16:12:002021-01-19T16:34:002020-12-292021-08-30 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071616100716162020-12-29T16:31:002021-07-282020-12-29T16:31:002021-01-19T13:55:002020-12-292021-07-28 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071617100716172020-12-29T17:14:002021-06-092020-12-29T17:14:002021-05-10T17:03:002020-12-292021-06-09 100713351 Frenck, Robert Wilson (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071618100716182020-12-29T17:13:002021-07-262020-12-29T17:13:002021-01-19T09:24:002020-12-292021-07-26 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071619100716192020-12-30T09:45:002021-07-142020-12-30T09:45:002021-01-20T09:09:002020-12-302021-07-14 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071620100716202020-12-30T10:26:002021-07-142020-12-30T10:26:002021-01-20T16:30:002020-12-302021-07-14 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071621100716212020-12-30T10:45:002021-07-142020-12-30T10:45:002021-01-20T16:33:002020-12-302021-07-14 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071622100716222020-12-30T10:39:002021-07-142020-12-30T10:39:002020-12-30T10:39:002020-12-302021-07-14 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071623100716232020-12-30T10:59:002021-07-202020-12-30T10:59:002021-06-22T14:13:002020-12-302021-07-20 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071624100716242020-12-30T12:08:002021-07-072020-12-30T12:08:002021-06-07T14:27:002020-12-302021-07-07 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071625100716252020-12-30T12:17:002021-07-072020-12-30T12:17:002021-06-07T14:21:002020-12-302021-07-07 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071626100716262020-12-30T14:05:002021-07-142020-12-30T14:05:002021-01-20T09:30:002020-12-302021-07-14 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071627100716272020-12-30T14:33:002021-07-212020-12-30T14:33:002021-01-20T09:00:002020-12-302021-07-21 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071628100716282020-12-30T16:10:002021-08-022020-12-30T16:10:002021-01-20T14:07:002020-12-302021-08-02 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071629100716292020-12-30T15:45:002021-07-202020-12-30T15:45:002021-06-22T12:31:002020-12-302021-07-20 100713351 Frenck, Robert Wilson (b)(6)AğYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071630100716302020-12-30T15:39:002021-07-202020-12-30T15:39:002021-06-22T12:38:002020-12-302021-07-20 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071631100716312020-12-30T16:26:002021-07-152020-12-30T16:26:002021-01-21T16:04:002020-12-302021-07-15 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071632100716322020-12-30T16:45:002021-07-072020-12-30T16:45:002021-06-08T10:08:002020-12-302021-07-07 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071633100716332020-12-30T16:41:002021-07-152020-12-30T16:41:002021-01-21T16:17:002020-12-302021-07-15 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071634100716342021-01-04T10:34:002021-07-192021-01-04T10:34:002021-01-25T11:01:002021-01-042021-07-19 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071635100716352021-01-04T10:09:002021-05-122021-01-04T10:09:002021-01-25T14:04:002021-01-042021-05-12 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071636100716362021-01-04T11:21:002021-07-192021-01-04T11:21:002021-01-25T10:00:002021-01-042021-07-19 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071638100716382021-01-04T11:45:002021-08-022021-01-04T11:45:002021-01-25T09:32:002021-01-042021-08-02 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071639100716392021-01-04T12:10:002021-06-012021-01-04T12:10:002021-01-25T09:07:002021-01-042021-06-01 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071640100716402021-01-04T13:30:002021-07-212021-01-04T13:30:002021-06-22T13:58:002021-01-042021-07-21 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071641100716412021-01-04T14:14:002021-08-092021-01-04T14:14:002021-01-26T15:34:002021-01-042021-08-09 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071642100716422021-01-04T15:01:002021-08-092021-01-04T15:01:002021-05-27T14:42:002021-01-042021-08-09 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071643100716432021-01-04T14:55:002021-08-292021-01-04T14:55:002021-06-24T11:12:002021-01-042021-08-29 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071644100716442021-01-04T16:36:002021-07-192021-01-04T16:36:002021-01-25T15:34:002021-01-04 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071645100716452021-01-04T16:22:002021-07-142021-01-04T16:22:002021-06-16T10:23:002021-01-042021-07-14 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071646100716462021-01-04T17:09:002021-07-202021-01-04T17:09:002021-06-22T15:23:002021-01-042021-07-20 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071647100716472021-01-04T17:19:002021-07-192021-01-04T17:19:002021-01-25T15:17:002021-01-042021-07-19 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071648100716482021-01-05T09:27:002021-06-082021-01-05T09:27:002021-05-11T12:00:002021-01-052021-06-08 100713351 Frenck, Robert Wilson (b)(6)AğYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071649100716492021-01-05T09:55:002021-07-202021-01-05T09:55:002021-01-26T15:17:002021-01-052021-07-20 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071650100716502021-01-05T11:09:002021-08-162021-01-05T11:09:002021-06-15T14:35:002021-01-05 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071651100716512021-01-05T10:55:002021-07-222021-01-05T10:55:002021-01-26T10:48:002021-01-052021-07-22 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071652100716522021-01-05T11:17:002021-07-192021-01-05T11:17:002021-06-21T11:17:002021-01-052021-07-19 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071653100716532021-01-05T14:25:002021-07-202021-01-05T14:25:002021-01-26T14:42:002021-01-052021-07-20 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071654100716542021-01-05T14:14:002021-07-222021-01-05T14:14:002021-01-26T14:47:002021-01-052021-07-22 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071655100716552021-01-06T09:35:002021-07-062021-01-06T09:35:002021-06-07T16:06:002021-01-062021-07-06 100713351 Frenck, Robert Wilson (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071656100716562021-01-06T10:14:002021-07-272021-01-06T10:14:002021-01-27T14:56:002021-01-062021-07-27 100713351 Frenck, Robert Wilson (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071658100716582021-01-06T17:12:002021-07-122021-01-06T17:12:002021-06-07T15:08:002021-01-062021-07-12 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071659100716592021-01-06T16:57:002021-07-212021-01-06T16:57:002021-01-27T15:56:002021-01-06 100713351 Frenck, Robert Wilson (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071660100716602021-01-06T16:53:002021-07-222021-01-06T16:53:002021-06-24T14:31:002021-01-06 100713351 Frenck, Robert Wilson (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1007 10071661100716612021-01-07T15:30:002021-08-172021-01-07T15:30:002021-01-28T16:06:002021-01-072021-08-17 100713351 Frenck, Robert Wilson (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1007 10071662100716622021-01-07T16:07:002021-08-122021-01-07T16:07:002021-01-28T09:33:002021-01-072021-08-12 100713351 Frenck, Robert Wilson (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081751100817512020-12-01T11:04:002021-07-022020-12-01T11:04:002021-06-04T10:07:002020-12-012021-07-02 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081752100817522020-12-01T15:26:002021-07-022020-12-01T15:26:002021-06-04T13:50:002020-12-012021-07-02 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081753100817532020-12-01T15:27:002021-06-172020-12-01T15:27:002020-12-22T15:05:002020-12-012021-06-17 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081754100817542020-12-02T13:50:002021-06-162020-12-02T13:50:002020-12-22T08:50:002020-12-022021-06-16 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081755100817552020-12-02T13:57:002021-06-172020-12-02T13:57:002020-12-23T11:00:002020-12-022021-06-17 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081756100817562020-12-02T14:25:002021-06-142020-12-02T14:25:002021-05-12T15:08:002020-12-022021-06-14 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081757100817572020-12-02T14:22:002021-07-072020-12-02T14:22:002021-06-07T11:27:002020-12-022021-07-07 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081758100817582020-12-02T15:05:002021-08-022020-12-02T15:05:002020-12-23T10:35:002020-12-022021-08-02 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081760100817602020-12-07T15:53:002021-07-062020-12-07T15:53:002020-12-28T11:11:002020-12-072021-07-06 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081761100817612020-12-07T15:00:002021-05-252020-12-07T15:00:002021-04-27T14:56:002020-12-072021-05-25 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081763100817632020-12-07T16:28:002021-07-082020-12-07T16:28:002021-06-09T13:43:002020-12-072021-07-08 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081764100817642020-12-07T16:23:002021-06-252020-12-07T16:23:002020-12-30T11:26:002020-12-072021-06-25 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081767100817672020-12-08T14:35:002021-07-012020-12-08T14:35:002021-06-03T13:25:002020-12-082021-07-01 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081768100817682020-12-08T14:52:002021-06-292020-12-08T14:52:002020-12-29T13:29:002020-12-082021-06-29 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081769100817692020-12-08T15:08:002021-08-092020-12-08T15:08:002020-12-29T10:39:002020-12-082021-08-09 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081770100817702020-12-09T10:57:002021-06-232020-12-09T10:57:002020-12-30T11:35:002020-12-092021-06-23 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081771100817712020-12-09T10:50:002021-06-232020-12-09T10:50:002020-12-30T11:38:002020-12-092021-06-23 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081773100817732020-12-09T14:14:002021-07-022020-12-09T14:14:002021-06-04T11:18:002020-12-09 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081774100817742020-12-09T15:00:002021-06-302020-12-09T15:00:002020-12-28T12:06:002020-12-092021-06-30 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081775100817752020-12-09T14:57:002021-07-162020-12-09T14:57:002021-06-18T14:38:002020-12-092021-07-16 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081777100817772020-12-10T11:22:002021-06-282020-12-10T11:22:002020-12-31T09:27:002020-12-102021-06-28 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081780100817802020-12-10T14:55:002021-07-072020-12-10T14:55:002021-06-07T09:42:002020-12-102021-07-07 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081781100817812020-12-10T15:02:002021-07-072020-12-10T15:02:002021-06-09T10:06:002020-12-102021-07-07 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081785100817852020-12-11T14:37:002021-06-252020-12-11T14:37:002020-12-30T10:33:002020-12-112021-06-25 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081788100817882020-12-14T10:17:002021-07-012020-12-14T10:17:002021-06-03T14:53:002020-12-142021-07-01 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081789100817892020-12-14T10:23:002021-07-082020-12-14T10:23:002021-01-04T13:06:002020-12-142021-07-08 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081790100817902020-12-14T14:22:002021-08-102020-12-14T14:22:002021-06-03T13:16:002020-12-142021-08-10 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081791100817912020-12-14T15:11:002021-07-022020-12-14T15:11:002021-01-04T12:46:002020-12-142021-07-02 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081792100817922020-12-14T15:15:002021-07-022020-12-14T15:15:002021-01-04T12:44:002020-12-142021-07-02 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081793100817932020-12-14T15:21:002021-07-012020-12-14T15:21:002021-06-03T14:08:002020-12-142021-07-01 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081794100817942020-12-14T15:26:002021-07-012020-12-14T15:26:002021-06-03T14:09:002020-12-142021-07-01 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081795100817952020-12-15T11:41:002021-07-062020-12-15T11:41:002021-01-07T12:27:002020-12-152021-07-06 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081796100817962020-12-15T14:07:002021-07-062020-12-15T14:07:002021-06-03T11:23:002020-12-152021-07-06 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081797100817972020-12-15T15:08:002021-07-062020-12-15T15:08:002021-01-05T15:36:002020-12-152021-07-06 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFAMERICAN INDIAN OR ALASKA NATIVE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081798100817982020-12-15T15:16:002021-07-122020-12-15T15:16:002021-06-04T14:02:002020-12-152021-07-12 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081799100817992020-12-15T15:21:002021-07-122020-12-15T15:21:002021-01-05T10:22:002020-12-152021-07-12 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081800100818002020-12-16T11:20:002021-07-072020-12-16T11:20:002021-01-06T13:19:002020-12-162021-07-07 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081801100818012020-12-17T11:02:002021-07-062020-12-17T11:02:002021-06-07T13:41:002020-12-172021-07-06 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081802100818022020-12-17T14:04:002021-08-132020-12-17T14:04:002021-01-07T09:42:002020-12-172021-08-13 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081803100818032020-12-17T14:13:002021-05-112020-12-17T14:13:002021-04-09T13:54:002020-12-172021-05-11 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081804100818042020-12-17T14:42:002021-07-012020-12-17T14:42:002021-06-03T14:17:002020-12-172021-07-01 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081805100818052020-12-17T15:33:002021-07-022020-12-17T15:33:002021-01-07T15:32:002020-12-172021-07-02 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081806100818062020-12-17T15:45:002021-07-092020-12-17T15:45:002021-01-07T15:05:002020-12-17 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081807100818072020-12-18T10:25:002021-07-062020-12-18T10:25:002021-06-04T09:39:002020-12-182021-07-06 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081808100818082020-12-18T10:40:002021-07-062020-12-18T10:40:002021-06-07T09:48:002020-12-182021-07-06 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081809100818092020-12-18T11:36:002021-07-142020-12-18T11:36:002021-06-03T12:09:002020-12-182021-07-14 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081810100818102020-12-18T11:56:002021-07-022020-12-18T11:56:002021-01-08T11:19:002020-12-182021-07-02 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081811100818112020-12-18T11:49:002021-07-022020-12-18T11:49:002021-01-08T11:16:002020-12-182021-07-02 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081812100818122020-12-18T14:20:002021-07-022020-12-18T14:20:002021-06-04T09:43:002020-12-182021-07-02 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081813100818132020-12-18T14:42:002021-07-122020-12-18T14:42:002021-01-08T11:45:002020-12-182021-07-12 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081814100818142020-12-18T15:12:002021-07-022020-12-18T15:12:002021-01-08T15:12:002020-12-182021-07-02 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081815100818152020-12-18T15:22:002021-07-082020-12-18T15:22:002021-06-10T09:27:002020-12-182021-07-08 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081816100818162020-12-18T15:19:002021-07-022020-12-18T15:19:002021-01-08T14:52:002020-12-182021-07-02 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081817100818172020-12-18T15:42:002021-07-022020-12-18T15:42:002021-06-04T11:58:002020-12-182021-07-02 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081818100818182020-12-18T15:50:002021-07-082020-12-18T15:50:002021-01-08T14:28:002020-12-182021-07-08 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081819100818192020-12-21T10:12:002021-07-062020-12-21T10:12:002021-06-08T09:28:002020-12-212021-07-06 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081820100818202020-12-21T10:18:002021-07-132020-12-21T10:18:002021-06-15T13:17:002020-12-212021-07-13 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081821100818212020-12-21T10:49:002021-07-092020-12-21T10:49:002021-01-12T15:03:002020-12-212021-07-09 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081822100818222020-12-21T11:05:002021-07-062020-12-21T11:05:002021-06-04T10:11:002020-12-212021-07-06 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081823100818232020-12-21T11:10:002021-08-242020-12-21T11:10:002021-01-11T08:55:002020-12-212021-08-24 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081824100818242020-12-21T11:45:002021-07-162020-12-21T11:45:002021-01-11T09:36:002020-12-212021-07-16 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081825100818252020-12-21T14:07:002021-07-012020-12-21T14:07:002021-06-03T11:15:002020-12-212021-07-01 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081826100818262020-12-21T14:13:002021-07-282020-12-21T14:13:002021-01-12T13:37:002020-12-212021-07-28 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081827100818272020-12-21T15:07:002021-07-072020-12-21T15:07:002021-01-11T14:52:002020-12-212021-07-07 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081828100818282020-12-21T14:56:002021-07-072020-12-21T14:56:002021-06-08T13:57:002020-12-212021-07-07 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081829100818292020-12-22T09:56:002021-05-132020-12-22T09:56:002021-01-12T15:09:002020-12-222021-05-13 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081830100818302020-12-22T10:02:002021-07-072020-12-22T10:02:002021-06-09T11:27:002020-12-222021-07-07 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081831100818312020-12-22T10:46:002021-07-062020-12-22T10:46:002021-01-12T08:48:002020-12-222021-07-06 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081832100818322020-12-22T11:06:002021-08-202020-12-22T11:06:002021-01-12T09:17:002020-12-222021-08-20 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081833100818332020-12-22T11:01:002021-07-022020-12-22T11:01:002021-06-04T10:15:002020-12-222021-07-02 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081834100818342020-12-22T12:50:002021-05-132020-12-22T12:50:002021-01-13T14:52:002020-12-222021-05-13 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081835100818352020-12-22T14:18:002021-07-062020-12-22T14:18:002021-01-12T14:58:002020-12-222021-07-06 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081836100818362020-12-22T14:59:002021-07-022020-12-22T14:59:002021-06-04T10:42:002020-12-222021-07-02 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081837100818372020-12-22T15:40:002021-09-012020-12-22T15:40:002021-06-09T13:47:002020-12-222021-09-01 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081838100818382020-12-22T15:44:002021-07-082020-12-22T15:44:002021-01-12T15:23:002020-12-222021-07-08 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081839100818392020-12-22T15:50:002021-07-192020-12-22T15:50:002021-01-12T14:28:002020-12-222021-07-19 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081840100818402020-12-23T09:40:002021-07-022020-12-23T09:40:002021-06-04T13:52:002020-12-232021-07-02 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081841100818412020-12-23T09:44:002021-07-132020-12-23T09:44:002021-01-13T14:26:002020-12-232021-07-13 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081842100818422020-12-23T09:48:002021-07-082020-12-23T09:48:002021-06-09T13:39:002020-12-232021-07-08 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081843100818432020-12-23T10:09:002021-07-072020-12-23T10:09:002021-01-13T15:03:002020-12-232021-07-07 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081844100818442020-12-23T10:13:002021-07-082020-12-23T10:13:002021-06-09T15:18:002020-12-232021-07-08 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081845100818452020-12-23T11:15:002021-08-112020-12-23T11:15:002021-06-08T09:45:002020-12-232021-08-11 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081846100818462020-12-23T11:24:002021-07-082020-12-23T11:24:002021-01-11T09:18:002020-12-232021-07-08 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081847100818472020-12-23T11:09:002021-07-082020-12-23T11:09:002021-01-13T13:51:002020-12-232021-07-08 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081848100818482020-12-23T11:31:002021-09-012020-12-23T11:31:002021-01-14T15:08:002020-12-232021-09-01 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081849100818492020-12-23T11:37:002021-07-022020-12-23T11:37:002021-06-04T11:57:002020-12-232021-07-02 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081850100818502020-12-23T11:58:002021-07-122020-12-23T11:58:002021-01-14T14:17:002020-12-232021-07-12 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081851100818512020-12-23T12:43:002021-07-062020-12-23T12:43:002021-06-08T09:18:002020-12-232021-07-06 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081852100818522020-12-23T12:47:002021-07-062020-12-23T12:47:002021-06-08T09:20:002020-12-232021-07-06 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081853100818532020-12-28T10:18:002021-07-062020-12-28T10:18:002021-06-07T13:44:002020-12-282021-07-06 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081854100818542020-12-28T11:05:002021-07-092020-12-28T11:05:002021-01-18T09:55:002020-12-282021-07-09 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081855100818552020-12-28T11:26:002021-07-262020-12-28T11:26:002021-01-18T14:56:002020-12-282021-07-26 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081856100818562020-12-28T11:39:002021-08-032020-12-28T11:39:002021-06-09T10:09:002020-12-282021-08-03 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081857100818572020-12-28T15:03:002021-07-132020-12-28T15:03:002021-01-19T15:21:002020-12-282021-07-13 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081858100818582020-12-28T15:00:002021-09-012020-12-28T15:00:002021-03-08T14:50:002020-12-282021-09-01 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081859100818592020-12-28T15:10:002021-07-122020-12-28T15:10:002021-01-18T11:47:002020-12-282021-07-12 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081860100818602020-12-28T15:16:002021-07-192020-12-28T15:16:002021-01-18T14:05:002020-12-28 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081861100818612020-12-29T10:25:002021-06-302020-12-29T10:25:002021-06-02T14:02:002020-12-292021-06-30 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081862100818622020-12-29T11:15:002021-08-062020-12-29T11:15:002021-01-20T10:12:002020-12-292021-08-06 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081863100818632020-12-29T11:24:002021-07-062020-12-29T11:24:002021-06-07T09:46:002020-12-292021-07-06 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081864100818642020-12-29T11:29:002021-07-262020-12-29T11:29:002021-01-18T11:12:002020-12-292021-07-26 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081865100818652020-12-29T11:35:002021-08-092020-12-29T11:35:002021-01-19T14:50:002020-12-292021-08-09 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081866100818662020-12-29T14:47:002021-07-022020-12-29T14:47:002021-06-04T09:48:002020-12-292021-07-02 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081867100818672020-12-29T14:51:002021-07-222020-12-29T14:51:002021-06-04T09:49:002020-12-292021-07-22 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081868100818682020-12-29T14:56:002021-07-142020-12-29T14:56:002021-01-19T13:47:002020-12-292021-07-14 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081869100818692020-12-29T15:13:002021-06-302020-12-29T15:13:002021-06-02T11:30:002020-12-292021-06-30 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081870100818702020-12-29T15:33:002021-07-092020-12-29T15:33:002021-01-18T12:16:002020-12-292021-07-09 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081871100818712020-12-30T10:40:002021-07-022020-12-30T10:40:002021-06-03T13:19:002020-12-302021-07-02 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081872100818722020-12-30T11:12:002021-06-012020-12-30T11:12:002021-04-28T14:51:002020-12-302021-06-01 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081873100818732020-12-30T11:16:002021-07-302020-12-30T11:16:002021-01-18T09:19:002020-12-302021-07-30 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081874100818742020-12-30T11:45:002021-07-142020-12-30T11:45:002021-01-20T10:18:002020-12-302021-07-14 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081875100818752020-12-30T11:49:002021-07-012020-12-30T11:49:002021-06-03T09:11:002020-12-302021-07-01 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081876100818762020-12-30T14:22:002021-07-212020-12-30T14:22:002021-01-20T13:19:002020-12-30 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081877100818772020-12-30T14:36:002021-07-072020-12-30T14:36:002021-06-07T13:27:002020-12-302021-07-07 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081878100818782020-12-30T14:42:002021-07-162020-12-30T14:42:002021-01-20T14:31:002020-12-302021-07-16 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081879100818792020-12-30T14:47:002021-07-162020-12-30T14:47:002021-01-20T10:48:002020-12-302021-07-16 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081880100818802020-12-30T15:08:002021-07-062020-12-30T15:08:002021-06-08T14:27:002020-12-302021-07-06 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081881100818812020-12-30T15:12:002021-07-062020-12-30T15:12:002021-06-08T14:28:002020-12-302021-07-06 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081882100818822020-12-31T10:50:002021-08-162020-12-31T10:50:002021-01-21T15:00:002020-12-312021-08-16 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081883100818832020-12-31T10:55:002021-07-162020-12-31T10:55:002021-01-21T14:57:002020-12-312021-07-16 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081884100818842020-12-31T11:30:002021-07-092020-12-31T11:30:002021-06-03T13:13:002020-12-312021-07-09 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081885100818852020-12-31T11:51:002021-07-292020-12-31T11:51:002021-01-21T09:45:002020-12-312021-07-29 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081886100818862020-12-31T11:54:002021-07-212020-12-31T11:54:002021-01-21T09:48:002020-12-312021-07-21 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081887100818872021-01-04T10:31:002021-07-012021-01-04T10:31:002021-06-03T09:07:002021-01-042021-07-01 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081888100818882021-01-04T10:40:002021-07-012021-01-04T10:40:002021-06-03T14:05:002021-01-042021-07-01 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081889100818892021-01-04T11:24:002021-07-262021-01-04T11:24:002021-01-25T09:08:002021-01-042021-07-26 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081890100818902021-01-04T11:21:002021-07-262021-01-04T11:21:002021-01-25T08:56:002021-01-042021-07-26 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081891100818912021-01-04T11:31:002021-07-062021-01-04T11:31:002021-06-08T08:50:002021-01-042021-07-06 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081892100818922021-01-04T14:32:002021-07-132021-01-04T14:32:002021-06-15T08:50:002021-01-042021-07-13 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMAMERICAN INDIAN OR ALASKA NATIVE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081893100818932021-01-04T14:37:002021-07-262021-01-04T14:37:002021-01-25T14:15:002021-01-042021-07-26 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081894100818942021-01-04T15:21:002021-07-212021-01-04T15:21:002021-01-27T10:06:002021-01-042021-07-21 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081895100818952021-01-04T15:28:002021-07-192021-01-04T15:28:002021-01-25T14:45:002021-01-042021-07-19 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081896100818962021-01-04T15:26:002021-07-062021-01-04T15:26:002021-06-04T12:58:002021-01-042021-07-06 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081897100818972021-01-05T10:54:002021-08-302021-01-05T10:54:002021-01-26T10:00:002021-01-052021-08-30 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081898100818982021-01-05T11:05:002021-07-012021-01-05T11:05:002021-06-02T13:36:002021-01-052021-07-01 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081899100818992021-01-05T11:07:002021-07-012021-01-05T11:07:002021-06-02T13:35:002021-01-052021-07-01 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081900100819002021-01-05T14:44:002021-08-112021-01-05T14:44:002021-01-26T14:48:002021-01-052021-08-11 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081901100819012021-01-05T14:50:002021-08-312021-01-05T14:50:002021-03-08T14:02:002021-01-052021-08-31 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081902100819022021-01-05T15:02:002021-07-012021-01-05T15:02:002021-06-03T14:57:002021-01-052021-07-01 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081903100819032021-01-05T15:07:002021-07-162021-01-05T15:07:002021-01-26T09:50:002021-01-052021-07-16 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081904100819042021-01-05T15:25:002021-07-012021-01-05T15:25:002021-06-03T14:13:002021-01-052021-07-01 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081905100819052021-01-06T10:28:002021-07-292021-01-06T10:28:002021-01-29T14:33:002021-01-062021-07-29 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081906100819062021-01-06T10:58:002021-07-212021-01-06T10:58:002021-01-27T10:37:002021-01-062021-07-21 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081907100819072021-01-06T11:22:002021-07-022021-01-06T11:22:002021-06-04T14:05:002021-01-062021-07-02 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081908100819082021-01-06T11:18:002021-07-212021-01-06T11:18:002021-01-27T10:20:002021-01-062021-07-21 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081909100819092021-01-06T11:28:002021-07-072021-01-06T11:28:002021-06-07T12:05:002021-01-062021-07-07 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081910100819102021-01-06T14:46:002021-07-282021-01-06T14:46:002021-01-27T13:21:002021-01-062021-07-28 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081911100819112021-01-06T14:52:002021-07-022021-01-06T14:52:002021-06-04T09:45:002021-01-062021-07-02 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081912100819122021-01-06T15:31:002021-08-022021-01-06T15:31:002021-01-28T15:01:002021-01-062021-08-02 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081913100819132021-01-06T15:20:002021-07-062021-01-06T15:20:002021-06-07T13:37:002021-01-062021-07-06 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081914100819142021-01-06T15:15:002021-06-302021-01-06T15:15:002021-06-02T13:31:002021-01-062021-06-30 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081915100819152021-01-07T10:57:002021-07-222021-01-07T10:57:002021-01-28T10:25:002021-01-072021-07-22 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081916100819162021-01-07T11:13:002021-07-222021-01-07T11:13:002021-01-28T14:35:002021-01-072021-07-22 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081917100819172021-01-07T11:06:002021-07-092021-01-07T11:06:002021-06-10T08:47:002021-01-072021-07-09 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081918100819182021-01-07T14:45:002021-07-222021-01-07T14:45:002021-01-28T14:07:002021-01-072021-07-22 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081919100819192021-01-07T14:57:002021-07-082021-01-07T14:57:002021-06-10T13:21:002021-01-072021-07-08 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081920100819202021-01-07T15:17:002021-07-262021-01-07T15:17:002021-01-28T14:00:002021-01-072021-07-26 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081921100819212021-01-07T15:42:002021-07-122021-01-07T15:42:002021-05-17T14:37:002021-01-072021-07-12 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081922100819222021-01-08T10:28:002021-07-232021-01-08T10:28:002021-01-29T14:42:002021-01-082021-07-23 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081923100819232021-01-08T10:36:002021-07-012021-01-08T10:36:002021-06-03T11:43:002021-01-082021-07-01 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081924100819242021-01-08T10:49:002021-07-062021-01-08T10:49:002021-06-04T11:54:002021-01-082021-07-06 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081925100819252021-01-08T11:27:002021-07-282021-01-08T11:27:002021-01-29T14:57:002021-01-082021-07-28 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081926100819262021-01-08T15:13:002021-07-072021-01-08T15:13:002021-06-04T13:47:002021-01-082021-07-07 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081927100819272021-01-08T14:44:002021-08-022021-01-08T14:44:002021-01-29T13:18:002021-01-082021-08-02 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081928100819282021-01-08T15:23:002021-07-302021-01-08T15:23:002021-01-29T14:26:002021-01-082021-07-30 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081929100819292021-01-08T15:37:002021-07-272021-01-08T15:37:002021-01-29T14:37:002021-01-082021-07-27 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081930100819302021-01-11T10:41:002021-07-062021-01-11T10:41:002021-06-04T11:56:002021-01-112021-07-06 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081931100819312021-01-11T10:48:002021-07-122021-01-11T10:48:002021-06-09T10:01:002021-01-112021-07-12 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081932100819322021-01-11T10:52:002021-07-072021-01-11T10:52:002021-06-09T10:03:002021-01-112021-07-07 1008424439 Jennings, Timothy W. (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081933100819332021-01-11T13:49:002021-07-062021-01-11T13:49:002021-06-07T14:07:002021-01-112021-07-06 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081934100819342021-01-11T14:27:002021-07-272021-01-11T14:27:002021-02-01T14:54:002021-01-112021-07-27 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081935100819352021-01-11T14:57:002021-08-132021-01-11T14:57:002021-02-03T14:14:002021-01-112021-08-13 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081936100819362021-01-11T15:06:002021-06-302021-01-11T15:06:002021-06-02T10:04:002021-01-112021-06-30 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081937100819372021-01-11T15:27:002021-07-262021-01-11T15:27:002021-02-01T14:49:002021-01-112021-07-26 1008424439 Jennings, Timothy W. (b)(6)AĞYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081938100819382021-01-11T15:36:002021-07-062021-01-11T15:36:002021-06-07T11:23:002021-01-112021-07-06 1008424439 Jennings, Timothy W. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081940100819402021-01-12T11:49:002021-07-272021-01-12T11:49:002021-02-02T09:30:002021-01-122021-07-27 1008424439 Jennings, Timothy W. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1008 10081941100819412021-01-12T14:34:002021-07-022021-01-12T14:34:002021-06-04T13:56:002021-01-122021-07-02 1008424439 Jennings, Timothy W. (b)(6)AÀYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081942100819422021-01-12T14:35:002021-07-022021-01-12T14:35:002021-06-04T13:54:002021-01-122021-07-02 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1008 10081943100819432021-01-12T14:40:002021-08-042021-01-12T14:40:002021-02-02T14:59:002021-01-122021-08-04 1008424439 Jennings, Timothy W. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091204100912042020-10-15T10:10:002021-08-232020-10-15T10:10:002021-08-23T15:54:002020-10-15 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091205100912052020-10-15T12:58:002021-06-102020-10-15T12:58:002020-11-06T16:45:002020-10-152021-06-10 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091208100912082020-10-15T13:24:002021-04-232020-10-15T13:24:002021-03-25T16:02:002020-10-15 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091209100912092020-10-15T16:52:002021-05-212020-10-15T16:52:002020-11-04T16:25:002020-10-152021-05-21 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091212100912122020-10-16T09:45:002021-07-082020-10-16T09:45:002021-06-10T15:29:002020-10-162021-07-08 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091213100912132020-10-16T10:21:002021-04-162020-10-16T10:21:002021-03-16T09:05:002020-10-16 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091216100912162020-10-16T11:58:002021-05-142020-10-16T11:58:002020-11-06T11:38:002020-10-162021-05-14 100933285 Christensen, Shane Glade (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091218100912182020-10-16T12:03:002021-05-142020-10-16T12:03:002020-11-06T11:44:002020-10-162021-05-14 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091220100912202020-10-19T13:53:002021-08-182020-10-19T13:53:002020-11-07T11:12:002020-10-192021-08-18 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091221100912212020-10-19T13:58:002021-05-142020-10-19T13:58:002020-11-07T11:10:002020-10-192021-05-14 100933285 Christensen, Shane Glade (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091223100912232020-10-19T14:11:002021-05-142020-10-19T14:11:002020-11-10T14:11:002020-10-192021-05-14 100933285 Christensen, Shane Glade (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091226100912262020-10-20T13:13:002021-07-142020-10-20T13:13:002021-06-11T11:06:002020-10-202021-07-14 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091227100912272020-10-20T16:49:002021-07-262020-10-20T16:49:002020-11-10T16:16:002020-10-202021-07-26 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091229100912292020-10-20T17:21:002021-07-132020-10-20T17:21:002021-06-11T15:48:002020-10-202021-07-13 100933285 Christensen, Shane Glade (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091231100912312020-10-20T18:16:002021-05-192020-10-20T18:16:002020-11-09T15:56:002020-10-202021-05-19 100933285 Christensen, Shane Glade (b)(6)AğYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091233100912332020-10-21T10:46:002021-07-222020-10-21T10:46:002021-06-23T11:54:002020-10-212021-07-22 100933285 Christensen, Shane Glade (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091234100912342020-10-21T14:40:002021-09-012020-10-21T14:40:002020-11-11T14:00:002020-10-212021-09-01 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091237100912372020-10-21T15:47:002021-08-302020-10-21T15:47:002020-11-12T14:11:002020-10-21 100933285 Christensen, Shane Glade (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091238100912382020-10-21T17:23:002021-06-212020-10-21T17:23:002021-05-17T13:07:002020-10-212021-06-21 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091240100912402020-10-21T17:42:002021-05-172020-10-21T17:42:002020-11-09T17:40:002020-10-212021-05-17 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091246100912462020-10-22T16:02:002021-07-082020-10-22T16:02:002021-06-08T15:48:002020-10-222021-07-08 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091247100912472020-10-22T16:31:002021-05-192020-10-22T16:31:002020-11-11T17:05:002020-10-222021-05-19 100933285 Christensen, Shane Glade (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091249100912492020-10-22T19:44:002021-07-132020-10-22T19:44:002021-06-09T15:30:002020-10-222021-07-13 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091250100912502020-10-22T19:46:002021-05-182020-10-22T19:46:002020-11-13T12:47:002020-10-222021-05-18 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091265100912652020-12-01T14:57:002021-06-292020-12-01T14:57:002020-12-22T09:16:002020-12-012021-06-29 100933285 Christensen, Shane Glade (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091266100912662020-12-01T11:28:002021-04-202020-12-01T11:28:002021-03-23T12:02:002020-12-01 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091267100912672020-12-01T13:17:002021-07-122020-12-01T13:17:002021-06-07T11:08:002020-12-012021-07-12 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091269100912692020-12-01T18:04:002021-06-172020-12-01T18:04:002020-12-23T18:02:002020-12-012021-06-17 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091270100912702020-12-01T18:06:002021-06-172020-12-01T18:06:002020-12-23T18:07:002020-12-012021-06-17 100933285 Christensen, Shane Glade (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091272100912722020-12-02T13:33:002021-08-102020-12-02T13:33:002020-12-22T12:47:002020-12-022021-08-10 100933285 Christensen, Shane Glade (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091273100912732020-12-02T13:35:002021-07-152020-12-02T13:35:002021-06-11T15:00:002020-12-022021-07-15 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091274100912742020-12-02T17:52:002021-08-232020-12-02T17:52:002021-07-21T08:37:002020-12-022021-08-23 100933285 Christensen, Shane Glade (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091275100912752020-12-02T17:50:002021-08-232020-12-02T17:50:002021-07-21T08:38:002020-12-022021-08-23 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091277100912772020-12-03T15:24:002021-07-302020-12-03T15:24:002021-06-28T14:16:002020-12-032021-07-30 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091280100912802020-12-03T19:31:002021-06-232020-12-03T19:31:002020-12-22T10:27:002020-12-032021-06-23 100933285 Christensen, Shane Glade (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091281100912812020-12-03T17:20:002021-06-182020-12-03T17:20:002020-12-22T10:31:002020-12-032021-06-18 100933285 Christensen, Shane Glade (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091282100912822020-12-03T17:13:002021-08-092020-12-03T17:13:002021-07-12T14:01:002020-12-032021-08-09 100933285 Christensen, Shane Glade (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091283100912832020-12-03T17:40:002021-08-132020-12-03T17:40:002021-07-15T10:16:002020-12-03 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091284100912842020-12-03T17:43:002021-06-212020-12-03T17:43:002020-12-23T10:10:002020-12-032021-06-21 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091287100912872020-12-04T13:29:002021-08-042020-12-04T13:29:002020-12-23T13:41:002020-12-042021-08-04 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091288100912882020-12-04T13:31:002021-06-212020-12-04T13:31:002020-12-23T13:40:002020-12-042021-06-21 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091289100912892020-12-04T14:55:002021-06-222020-12-04T14:55:002020-12-23T11:18:002020-12-042021-06-22 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091292100912922020-12-04T15:36:002021-05-282020-12-04T15:36:002021-04-23T16:21:002020-12-042021-05-28 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091293100912932020-12-04T17:49:002021-08-062020-12-04T17:49:002021-06-10T15:20:002020-12-042021-08-06 100933285 Christensen, Shane Glade (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091294100912942020-12-07T11:38:002021-07-272020-12-07T11:38:002021-04-28T09:35:002020-12-072021-07-27 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091295100912952020-12-07T14:43:002021-06-232020-12-07T14:43:002020-12-29T13:58:002020-12-072021-06-23 100933285 Christensen, Shane Glade (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091296100912962020-12-07T14:41:002021-08-192020-12-07T14:41:002021-07-16T08:55:002020-12-07 100933285 Christensen, Shane Glade (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091297100912972020-12-07T15:30:002021-08-112020-12-07T15:30:002020-12-28T12:40:002020-12-072021-08-11 100933285 Christensen, Shane Glade (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091298100912982020-12-07T16:33:002021-08-102020-12-07T16:33:002020-12-28T15:33:002020-12-072021-08-10 100933285 Christensen, Shane Glade (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091300100913002020-12-07T18:07:002021-06-212020-12-07T18:07:002020-12-28T14:36:002020-12-072021-06-21 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091301100913012020-12-07T18:05:002021-08-262020-12-07T18:05:002021-06-21T16:22:002020-12-072021-08-26 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091303100913032020-12-08T12:52:002021-08-132020-12-08T12:52:002021-07-12T12:59:002020-12-082021-08-13 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091304100913042020-12-08T16:51:002021-06-282020-12-08T16:51:002020-12-29T17:00:002020-12-082021-06-28 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091305100913052020-12-08T18:00:002021-09-022020-12-08T18:00:002021-04-09T12:15:002020-12-082021-09-02 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091306100913062020-12-08T17:58:002021-09-022020-12-08T17:58:002021-06-02T09:44:002020-12-082021-09-02 100933285 Christensen, Shane Glade (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091307100913072020-12-09T09:38:002021-08-312020-12-09T09:38:002020-12-30T09:18:002020-12-092021-08-31 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091308100913082020-12-09T09:40:002021-08-312020-12-09T09:40:002020-12-30T09:17:002020-12-092021-08-31 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091309100913092020-12-09T11:42:002021-06-222020-12-09T11:42:002020-12-29T15:04:002020-12-092021-06-22 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091310100913102020-12-09T11:50:002021-06-242020-12-09T11:50:002020-12-29T14:07:002020-12-092021-06-24 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091311100913112020-12-09T13:52:002021-07-132020-12-09T13:52:002021-06-08T12:50:002020-12-092021-07-13 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091312100913122020-12-09T15:37:002021-07-282020-12-09T15:37:002021-06-25T14:02:002020-12-092021-07-28 100933285 Christensen, Shane Glade (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091313100913132020-12-09T15:34:002021-06-302020-12-09T15:34:002020-12-29T12:03:002020-12-09 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091314100913142020-12-09T16:33:002021-08-022020-12-09T16:33:002021-08-02T10:45:002020-12-09 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091315100913152020-12-09T18:30:002021-06-212020-12-09T18:30:002020-12-28T11:13:002020-12-092021-06-21 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091316100913162020-12-09T18:27:002021-05-072020-12-09T18:27:002021-04-08T10:30:002020-12-092021-05-07 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091317100913172020-12-10T11:23:002021-08-132020-12-10T11:23:002021-07-15T11:06:002020-12-102021-08-13 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091318100913182020-12-10T13:07:002021-06-232020-12-10T13:07:002020-12-29T12:40:002020-12-10 100933285 Christensen, Shane Glade (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091319100913192020-12-10T14:27:002021-06-222020-12-10T14:27:002020-12-29T09:02:002020-12-10 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091320100913202020-12-10T14:35:002021-08-252020-12-10T14:35:002021-06-28T11:48:002020-12-102021-08-25 100933285 Christensen, Shane Glade (b)(6)AàYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091321100913212020-12-10T15:32:002021-06-242020-12-10T15:32:002020-12-30T13:59:002020-12-10 100933285 Christensen, Shane Glade (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091322100913222020-12-10T16:25:002021-08-312020-12-10T16:25:002020-12-30T16:32:002020-12-102021-08-31 100933285 Christensen, Shane Glade (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091323100913232020-12-10T16:28:002021-08-232020-12-10T16:28:002021-07-26T09:54:002020-12-102021-08-23 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091324100913242020-12-11T10:44:002021-08-182020-12-11T10:44:002021-08-18T16:48:002020-12-11 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091325100913252020-12-11T10:47:002021-06-302020-12-11T10:47:002020-12-31T09:55:002020-12-112021-06-30 100933285 Christensen, Shane Glade (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091326100913262020-12-11T10:58:002021-07-282020-12-11T10:58:002021-06-25T15:59:002020-12-112021-07-28 100933285 Christensen, Shane Glade (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091328100913282020-12-11T13:47:002021-07-022020-12-11T13:47:002020-12-30T11:24:002020-12-112021-07-02 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091329100913292020-12-11T13:45:002021-07-202020-12-11T13:45:002021-06-17T15:22:002020-12-11 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091330100913302020-12-11T13:43:002021-08-302020-12-11T13:43:002021-07-28T10:42:002020-12-112021-08-30 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091331100913312020-12-11T15:00:002021-07-092020-12-11T15:00:002020-12-30T11:59:002020-12-112021-07-09 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091332100913322020-12-11T15:04:002021-08-022020-12-11T15:04:002020-12-30T12:01:002020-12-112021-08-02 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091333100913332020-12-11T15:30:002021-06-242020-12-11T15:30:002020-12-30T13:15:002020-12-112021-06-24 100933285 Christensen, Shane Glade (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091334100913342020-12-11T19:06:002021-07-122020-12-11T19:06:002021-06-08T16:57:002020-12-112021-07-12 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091335100913352020-12-11T18:08:002021-06-292020-12-11T18:08:002020-12-31T10:48:002020-12-112021-06-29 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091336100913362020-12-11T18:10:002021-08-052020-12-11T18:10:002021-08-05T16:58:002020-12-11 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091337100913372020-12-14T11:11:002021-09-012020-12-14T11:11:002021-06-08T13:09:002020-12-142021-09-01 100933285 Christensen, Shane Glade (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091338100913382020-12-14T13:57:002021-08-102020-12-14T13:57:002021-08-10T10:15:002020-12-14 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091339100913392020-12-14T13:59:002021-07-202020-12-14T13:59:002021-01-18T10:58:002020-12-142021-07-20 100933285 Christensen, Shane Glade (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091340100913402020-12-14T16:37:002021-07-012020-12-14T16:37:002021-01-04T16:15:002020-12-142021-07-01 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091341100913412020-12-14T18:27:002021-08-232020-12-14T18:27:002021-07-21T08:58:002020-12-142021-08-23 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091342100913422020-12-14T18:25:002021-06-302020-12-14T18:25:002021-01-04T17:11:002020-12-142021-06-30 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091343100913432020-12-15T12:50:002021-07-062020-12-15T12:50:002021-01-05T11:21:002020-12-152021-07-06 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091344100913442020-12-15T12:47:002021-07-302020-12-15T12:47:002021-03-23T15:58:002020-12-15 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091345100913452020-12-15T15:16:002021-08-302020-12-15T15:16:002021-01-05T15:00:002020-12-152021-08-30 100933285 Christensen, Shane Glade (b)(6)AÀYEARSMMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091346100913462020-12-15T15:14:002021-05-042020-12-15T15:14:002021-04-06T16:10:002020-12-152021-05-04 100933285 Christensen, Shane Glade (b)(6)AğYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091347100913472020-12-15T15:31:002021-08-052020-12-15T15:31:002021-08-05T16:17:002020-12-15 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091348100913482020-12-15T15:33:002021-07-022020-12-15T15:33:002021-01-06T11:09:002020-12-152021-07-02 100933285 Christensen, Shane Glade (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091349100913492020-12-15T17:50:002021-08-192020-12-15T17:50:002021-06-07T17:03:002020-12-152021-08-19 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091350100913502020-12-16T10:57:002021-08-042020-12-16T10:57:002021-08-04T16:39:002020-12-16 100933285 Christensen, Shane Glade (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091351100913512020-12-16T12:58:002021-07-012020-12-16T12:58:002021-01-06T13:55:002020-12-162021-07-01 100933285 Christensen, Shane Glade (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091353100913532020-12-16T13:19:002021-07-132020-12-16T13:19:002021-01-06T17:22:002020-12-162021-07-13 100933285 Christensen, Shane Glade (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091354100913542020-12-16T14:45:002021-07-082020-12-16T14:45:002021-01-07T10:03:002020-12-162021-07-08 100933285 Christensen, Shane Glade (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091355100913552020-12-16T16:41:002021-08-242020-12-16T16:41:002021-01-08T15:59:002020-12-162021-08-24 100933285 Christensen, Shane Glade (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091356100913562020-12-16T17:29:002021-07-092020-12-16T17:29:002021-06-07T08:31:002020-12-162021-07-09 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091357100913572020-12-17T10:40:002021-05-042020-12-17T10:40:002021-04-05T10:10:002020-12-17 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091358100913582020-12-17T10:37:002021-08-252020-12-17T10:37:002021-01-06T09:14:002020-12-172021-08-25 100933285 Christensen, Shane Glade (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091359100913592020-12-17T13:02:002021-08-022020-12-17T13:02:002021-06-07T13:45:002020-12-172021-08-02 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091360100913602020-12-17T13:05:002021-07-122020-12-17T13:05:002021-01-06T14:33:002020-12-172021-07-12 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091361100913612020-12-17T14:13:002021-07-192020-12-17T14:13:002021-06-07T12:10:002020-12-172021-07-19 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091362100913622020-12-17T16:21:002021-07-192020-12-17T16:21:002021-01-11T15:44:002020-12-172021-07-19 100933285 Christensen, Shane Glade (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091363100913632020-12-17T16:19:002021-08-272020-12-17T16:19:002021-08-27T16:04:002020-12-172021-08-27 100933285 Christensen, Shane Glade (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091364100913642020-12-17T16:47:002021-07-222020-12-17T16:47:002021-01-19T15:20:002020-12-172021-07-22 100933285 Christensen, Shane Glade (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091365100913652020-12-17T16:50:002021-08-192020-12-17T16:50:002021-08-19T15:57:002020-12-17 100933285 Christensen, Shane Glade (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091366100913662020-12-17T17:05:002021-08-302020-12-17T17:05:002021-08-30T08:52:002020-12-172021-08-30 100933285 Christensen, Shane Glade (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091369100913692020-12-18T11:00:002021-07-142020-12-18T11:00:002021-06-09T09:45:002020-12-182021-07-14 100933285 Christensen, Shane Glade (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091370100913702020-12-18T11:25:002021-08-242020-12-18T11:25:002021-01-08T12:58:002020-12-182021-08-24 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091371100913712020-12-18T13:39:002021-07-212020-12-18T13:39:002021-01-08T12:05:002020-12-182021-07-21 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091372100913722020-12-18T15:10:002021-07-022020-12-18T15:10:002021-01-08T14:14:002020-12-182021-07-02 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091373100913732020-12-18T15:57:002021-08-062020-12-18T15:57:002021-08-06T15:40:002020-12-18 100933285 Christensen, Shane Glade (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091374100913742020-12-21T11:58:002021-07-162020-12-21T11:58:002021-06-14T12:35:002020-12-212021-07-16 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091375100913752020-12-21T12:00:002021-07-122020-12-21T12:00:002021-01-11T17:49:002020-12-212021-07-12 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091376100913762020-12-21T14:00:002021-07-082020-12-21T14:00:002021-01-11T15:46:002020-12-21 100933285 Christensen, Shane Glade (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091377100913772020-12-21T15:50:002021-07-122020-12-21T15:50:002021-01-12T10:23:002020-12-212021-07-12 100933285 Christensen, Shane Glade (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091378100913782020-12-21T15:52:002021-08-182020-12-21T15:52:002021-08-18T16:45:002020-12-21 100933285 Christensen, Shane Glade (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091379100913792020-12-22T14:19:002021-07-132020-12-22T14:19:002021-06-09T09:25:002020-12-222021-07-13 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091380100913802020-12-29T16:31:002021-08-182020-12-29T16:31:002021-07-12T12:55:002020-12-292021-08-18 100933285 Christensen, Shane Glade (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091381100913812020-12-31T11:28:002021-07-132020-12-31T11:28:002021-01-19T08:35:002020-12-312021-07-13 100933285 Christensen, Shane Glade (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091382100913822021-01-04T16:30:002021-07-022021-01-04T16:30:002021-06-02T09:54:002021-01-042021-07-02 100933285 Christensen, Shane Glade (b)(6)AàYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091383100913832021-01-05T13:39:002021-08-052021-01-05T13:39:002021-01-25T12:36:002021-01-052021-08-05 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091384100913842021-01-05T13:37:002021-04-202021-01-05T13:37:002021-03-16T10:06:002021-01-05 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091385100913852021-01-05T14:05:002021-07-132021-01-05T14:05:002021-06-15T12:52:002021-01-052021-07-13 100933285 Christensen, Shane Glade (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091386100913862021-01-06T12:40:002021-07-212021-01-06T12:40:002021-01-25T09:54:002021-01-062021-07-21 100933285 Christensen, Shane Glade (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091387100913872021-01-06T14:12:002021-07-302021-01-06T14:12:002021-01-28T17:01:002021-01-062021-07-30 100933285 Christensen, Shane Glade (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091388100913882021-01-06T16:25:002021-07-122021-01-06T16:25:002021-06-07T13:02:002021-01-062021-07-12 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091389100913892021-01-06T16:53:002021-07-282021-01-06T16:53:002021-01-25T17:11:002021-01-062021-07-28 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091390100913902021-01-07T13:02:002021-08-232021-01-07T13:02:002021-08-23T16:55:002021-01-07 100933285 Christensen, Shane Glade (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091391100913912021-01-07T14:34:002021-08-022021-01-07T14:34:002021-01-29T13:10:002021-01-072021-08-02 100933285 Christensen, Shane Glade (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091392100913922021-01-07T14:36:002021-08-192021-01-07T14:36:002021-07-22T13:04:002021-01-072021-08-19 100933285 Christensen, Shane Glade (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091393100913932021-01-07T14:30:002021-07-272021-01-07T14:30:002021-01-27T12:51:002021-01-072021-07-27 100933285 Christensen, Shane Glade (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091394100913942021-01-07T15:46:002021-08-042021-01-07T15:46:002021-01-27T14:01:002021-01-072021-08-04 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091395100913952021-01-07T15:43:002021-07-162021-01-07T15:43:002021-06-14T10:59:002021-01-072021-07-16 100933285 Christensen, Shane Glade (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091396100913962021-01-07T16:30:002021-08-112021-01-07T16:30:002021-01-26T16:00:002021-01-072021-08-11 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091398100913982021-01-07T17:42:002021-08-262021-01-07T17:42:002021-01-28T17:21:002021-01-072021-08-26 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091399100913992021-01-08T12:00:002021-08-202021-01-08T12:00:002021-08-20T16:28:002021-01-08 100933285 Christensen, Shane Glade (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091400100914002021-01-08T13:28:002021-08-302021-01-08T13:28:002021-08-30T16:38:002021-01-082021-08-30 100933285 Christensen, Shane Glade (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091401100914012021-01-08T14:50:002021-08-232021-01-08T14:50:002021-08-23T16:22:002021-01-08 100933285 Christensen, Shane Glade (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091402100914022021-01-08T14:48:002021-07-272021-01-08T14:48:002021-01-29T15:55:002021-01-082021-07-27 100933285 Christensen, Shane Glade (b)(6)AàYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091403100914032021-01-08T15:41:002021-04-192021-01-08T15:41:002021-03-19T13:53:002021-01-08 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091404100914042021-01-08T16:49:002021-07-272021-01-08T16:49:002021-01-29T09:33:002021-01-082021-07-27 100933285 Christensen, Shane Glade (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091405100914052021-01-08T18:16:002021-08-192021-01-08T18:16:002021-08-19T16:13:002021-01-08 100933285 Christensen, Shane Glade (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091406100914062021-01-08T18:14:002021-08-192021-01-08T18:14:002021-08-19T16:12:002021-01-08 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091407100914072021-01-11T12:55:002021-08-042021-01-11T12:55:002021-02-01T12:11:002021-01-112021-08-04 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091408100914082021-01-11T17:38:002021-08-112021-01-11T17:38:002021-02-02T17:31:002021-01-112021-08-11 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091409100914092021-01-11T17:36:002021-08-112021-01-11T17:36:002021-02-02T17:29:002021-01-112021-08-11 100933285 Christensen, Shane Glade (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091410100914102021-01-12T09:48:002021-07-262021-01-12T09:48:002021-02-01T16:42:002021-01-122021-07-26 100933285 Christensen, Shane Glade (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091411100914112021-01-12T10:37:002021-07-132021-01-12T10:37:002021-06-08T11:08:002021-01-122021-07-13 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091412100914122021-01-12T15:29:002021-08-202021-01-12T15:29:002021-08-20T15:05:002021-01-12 100933285 Christensen, Shane Glade (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1009 10091413100914132021-01-12T15:50:002021-08-092021-01-12T15:50:002021-02-03T16:20:002021-01-122021-08-09 100933285 Christensen, Shane Glade (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1009 10091414100914142021-01-12T16:59:002021-08-022021-01-12T16:59:002021-02-04T16:33:002021-01-122021-08-02 100933285 Christensen, Shane Glade (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131821101318212020-11-30T13:28:002021-06-212020-11-30T13:28:002020-12-21T15:45:002020-11-302021-06-21 1013347220 Dever, Michael Edward (b)(6)AàYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131822101318222020-11-30T13:25:002021-08-262020-11-30T13:25:002020-12-21T15:42:002020-11-302021-08-26 1013347220 Dever, Michael Edward (b)(6)AğYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131823101318232020-12-01T13:05:002021-08-102020-12-01T13:05:002021-07-13T16:10:002020-12-01 1013347220 Dever, Michael Edward (b)(6)AğYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131824101318242020-12-01T13:08:002021-08-032020-12-01T13:08:002020-12-22T14:50:002020-12-01 1013347220 Dever, Michael Edward (b)(6)AàYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131826101318262020-12-01T16:29:002021-07-192020-12-01T16:29:002021-06-21T15:42:002020-12-012021-07-19 1013347220 Dever, Michael Edward (b)(6)AàYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131828101318282020-12-02T10:32:002021-06-092020-12-02T10:32:002020-12-30T15:10:002020-12-022021-06-09 1013347220 Dever, Michael Edward (b)(6)AàYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131830101318302020-12-02T10:42:002021-05-122020-12-02T10:42:002020-12-23T15:20:002020-12-022021-05-12 1013347220 Dever, Michael Edward (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131835101318352020-12-02T12:40:002021-07-192020-12-02T12:40:002021-06-15T14:14:002020-12-022021-07-19 1013347220 Dever, Michael Edward (b)(6)AàYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131836101318362020-12-02T12:42:002021-06-152020-12-02T12:42:002020-12-22T14:17:002020-12-022021-06-15 1013347220 Dever, Michael Edward (b)(6)AÀYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131839101318392020-12-02T13:15:002021-07-142020-12-02T13:15:002020-12-23T14:48:002020-12-022021-07-14 1013347220 Dever, Michael Edward (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131841101318412020-12-02T16:50:002021-06-172020-12-02T16:50:002020-12-22T15:31:002020-12-022021-06-17 1013347220 Dever, Michael Edward (b)(6)AĞYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131842101318422020-12-02T16:52:002021-07-202020-12-02T16:52:002021-07-20T16:00:002020-12-022021-07-20 1013347220 Dever, Michael Edward (b)(6)AğYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131843101318432020-12-02T17:02:002021-08-032020-12-02T17:02:002020-12-22T16:05:002020-12-022021-08-03 1013347220 Dever, Michael Edward (b)(6)AàYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131844101318442020-12-02T17:00:002021-08-162020-12-02T17:00:002021-07-15T16:42:002020-12-022021-08-16 1013347220 Dever, Michael Edward (b)(6)AĞYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131845101318452020-12-03T10:00:002021-06-212020-12-03T10:00:002020-12-23T14:15:002020-12-032021-06-21 1013347220 Dever, Michael Edward (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131846101318462020-12-03T11:48:002021-05-142020-12-03T11:48:002020-12-22T15:55:002020-12-032021-05-14 1013347220 Dever, Michael Edward (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131848101318482020-12-03T11:50:002021-05-142020-12-03T11:50:002020-12-22T15:38:002020-12-032021-05-14 1013347220 Dever, Michael Edward (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131850101318502020-12-03T13:05:002021-06-212020-12-03T13:05:002020-12-23T15:25:002020-12-032021-06-21 1013347220 Dever, Michael Edward (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131851101318512020-12-07T11:15:002021-08-312020-12-07T11:15:002021-07-26T14:22:002020-12-072021-08-31 1013347220 Dever, Michael Edward (b)(6)AğYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131852101318522020-12-07T11:50:002021-07-212020-12-07T11:50:002021-06-22T14:17:002020-12-072021-07-21 1013347220 Dever, Michael Edward (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131855101318552020-12-08T11:25:002021-06-232020-12-08T11:25:002020-12-29T16:22:002020-12-082021-06-23 1013347220 Dever, Michael Edward (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131856101318562020-12-09T12:48:002021-05-112020-12-09T12:48:002020-12-30T15:58:002020-12-092021-05-11 1013347220 Dever, Michael Edward (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131858101318582020-12-09T12:42:002021-08-312020-12-09T12:42:002021-06-15T15:20:002020-12-092021-08-31 1013347220 Dever, Michael Edward (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131859101318592020-12-09T12:36:002021-06-302020-12-09T12:36:002020-12-31T09:30:002020-12-092021-06-30 1013347220 Dever, Michael Edward (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131860101318602020-12-09T14:58:002021-07-152020-12-09T14:58:002021-06-15T15:25:002020-12-092021-07-15 1013347220 Dever, Michael Edward (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131861101318612020-12-10T10:42:002021-08-252020-12-10T10:42:002021-01-04T14:10:002020-12-102021-08-25 1013347220 Dever, Michael Edward (b)(6)AÀYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131862101318622020-12-10T12:27:002021-08-172020-12-10T12:27:002020-12-29T14:50:002020-12-102021-08-17 1013347220 Dever, Michael Edward (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131863101318632020-12-10T16:30:002021-07-132020-12-10T16:30:002021-06-14T14:15:002020-12-102021-07-13 1013347220 Dever, Michael Edward (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131865101318652020-12-14T11:03:002021-07-082020-12-14T11:03:002021-01-06T15:56:002020-12-142021-07-08 1013347220 Dever, Michael Edward (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131866101318662020-12-14T11:00:002021-07-082020-12-14T11:00:002021-01-06T15:54:002020-12-142021-07-08 1013347220 Dever, Michael Edward (b)(6)AğYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131867101318672020-12-17T12:32:002021-08-022020-12-17T12:32:002021-06-30T16:32:002020-12-172021-08-02 1013347220 Dever, Michael Edward (b)(6)AÀYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131868101318682020-12-21T11:04:002021-05-182020-12-21T11:04:002021-01-12T14:55:002020-12-212021-05-18 1013347220 Dever, Michael Edward (b)(6)AĞYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131869101318692020-12-21T12:05:002021-06-022020-12-21T12:05:002021-01-13T15:59:002020-12-212021-06-02 1013347220 Dever, Michael Edward (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131870101318702020-12-21T12:08:002021-04-222020-12-21T12:08:002021-01-13T15:58:002020-12-212021-04-22 1013347220 Dever, Michael Edward (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131871101318712020-12-21T13:28:002021-07-062020-12-21T13:28:002021-01-11T16:00:002020-12-212021-07-06 1013347220 Dever, Michael Edward (b)(6)AĞYEARSMMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131872101318722020-12-21T13:25:002021-08-112020-12-21T13:25:002021-01-11T15:55:002020-12-21 1013347220 Dever, Michael Edward (b)(6)AÀYEARSMMULTIPLE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131873101318732020-12-22T13:02:002021-07-202020-12-22T13:02:002021-01-13T14:07:002020-12-222021-07-20 1013347220 Dever, Michael Edward (b)(6)AĞYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131874101318742020-12-22T12:14:002021-08-112020-12-22T12:14:002021-08-11T13:55:002020-12-22 1013347220 Dever, Michael Edward (b)(6)AÀYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131875101318752020-12-22T12:17:002021-07-192020-12-22T12:17:002021-06-14T14:18:002020-12-222021-07-19 1013347220 Dever, Michael Edward (b)(6)AàYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131876101318762020-12-22T13:06:002021-07-122020-12-22T13:06:002021-01-12T14:08:002020-12-222021-07-12 1013347220 Dever, Michael Edward (b)(6)AğYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131877101318772020-12-23T09:50:002021-07-132020-12-23T09:50:002021-01-13T16:09:002020-12-232021-07-13 1013347220 Dever, Michael Edward (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131878101318782020-12-23T10:20:002021-05-252020-12-23T10:20:002021-01-13T15:50:002020-12-232021-05-25 1013347220 Dever, Michael Edward (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131879101318792020-12-23T10:14:002021-06-162020-12-23T10:14:002021-05-19T15:41:002020-12-232021-06-16 1013347220 Dever, Michael Edward (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131880101318802020-12-23T10:07:002021-07-062020-12-23T10:07:002021-01-11T16:20:002020-12-232021-07-06 1013347220 Dever, Michael Edward (b)(6)AàYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131881101318812020-12-28T11:45:002021-07-152020-12-28T11:45:002021-01-20T15:06:002020-12-282021-07-15 1013347220 Dever, Michael Edward (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131882101318822020-12-30T10:55:002021-07-092020-12-30T10:55:002021-06-07T16:19:002020-12-302021-07-09 1013347220 Dever, Michael Edward (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131883101318832020-12-31T11:00:002021-07-082020-12-31T11:00:002021-06-10T16:07:002020-12-312021-07-08 1013347220 Dever, Michael Edward (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131884101318842021-01-07T10:05:002021-08-182021-01-07T10:05:002021-01-28T16:37:002021-01-072021-08-18 1013347220 Dever, Michael Edward (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1013 10131885101318852021-01-07T10:10:002021-07-132021-01-07T10:10:002021-06-15T14:18:002021-01-072021-07-13 1013347220 Dever, Michael Edward (b)(6)AàYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1013 10131886101318862021-01-07T12:20:002021-07-092021-01-07T12:20:002021-06-10T16:03:002021-01-072021-07-09 1013347220 Dever, Michael Edward (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161307101613072020-10-15T12:18:002021-08-302020-10-15T12:18:002021-06-10T11:00:002020-10-152021-08-30 101680863 Finn, Daniel J. (b)(6)AĞYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161308101613082020-10-15T12:24:002021-07-122020-10-15T12:24:002021-06-14T09:16:002020-10-152021-07-12 101680863 Finn, Daniel J. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161309101613092020-10-15T14:54:002021-08-262020-10-15T14:54:002020-11-12T11:39:002020-10-152021-08-26 101680863 Finn, Daniel J. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161310101613102020-10-15T15:07:002021-05-252020-10-15T15:07:002020-11-04T09:24:002020-10-152021-05-25 101680863 Finn, Daniel J. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161311101613112020-10-15T15:32:002021-05-282020-10-15T15:32:002020-11-03T14:22:002020-10-15 101680863 Finn, Daniel J. (b)(6)AğYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161314101613142020-10-16T11:13:002021-05-262020-10-16T11:13:002020-11-05T09:58:002020-10-162021-05-26 101680863 Finn, Daniel J. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161315101613152020-10-16T15:01:002021-07-072020-10-16T15:01:002021-06-09T15:50:002020-10-162021-07-07 101680863 Finn, Daniel J. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161316101613162020-10-16T15:10:002021-04-132020-10-16T15:10:002021-03-16T14:33:002020-10-16 101680863 Finn, Daniel J. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161318101613182020-10-16T15:39:002021-07-272020-10-16T15:39:002021-06-29T14:51:002020-10-162021-07-27 101680863 Finn, Daniel J. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161319101613192020-10-16T15:53:002021-07-122020-10-16T15:53:002021-06-14T15:13:002020-10-16 101680863 Finn, Daniel J. (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161320101613202020-10-21T11:07:002021-05-172020-10-21T11:07:002020-11-09T10:08:002020-10-192021-05-17 101680863 Finn, Daniel J. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161322101613222020-10-19T11:52:002021-05-132020-10-19T11:52:002020-11-09T10:26:002020-10-192021-05-13 101680863 Finn, Daniel J. (b)(6)AàYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161323101613232020-10-19T14:04:002021-05-132020-10-19T14:04:002020-11-09T11:42:002020-10-192021-05-13 101680863 Finn, Daniel J. (b)(6)AĞYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161324101613242020-10-19T14:02:002021-07-152020-10-19T14:02:002021-06-17T14:21:002020-10-192021-07-15 101680863 Finn, Daniel J. (b)(6)AğYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161325101613252020-10-19T14:58:002021-08-302020-10-19T14:58:002020-11-10T15:54:002020-10-192021-08-30 101680863 Finn, Daniel J. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161326101613262020-10-20T09:46:002021-05-132020-10-20T09:46:002020-11-10T10:48:002020-10-202021-05-13 101680863 Finn, Daniel J. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161327101613272020-10-20T09:46:002021-07-202020-10-20T09:46:002021-06-22T09:22:002020-10-20 101680863 Finn, Daniel J. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161329101613292020-10-20T09:53:002021-07-172020-10-20T09:53:002021-06-09T15:53:002020-10-20 101680863 Finn, Daniel J. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161330101613302020-10-20T14:59:002021-05-132020-10-20T14:59:002020-11-11T16:07:002020-10-202021-05-13 101680863 Finn, Daniel J. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161331101613312020-10-20T14:54:002021-08-092020-10-20T14:54:002021-06-14T11:56:002020-10-202021-08-09 101680863 Finn, Daniel J. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161332101613322020-10-21T14:35:002021-05-132020-10-21T14:35:002020-11-09T11:39:002020-10-212021-05-13 101680863 Finn, Daniel J. (b)(6)AàYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161334101613342020-10-21T14:59:002021-07-142020-10-21T14:59:002021-06-15T09:39:002020-10-212021-07-14 101680863 Finn, Daniel J. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161335101613352020-10-21T16:51:002021-08-202020-10-21T16:51:002020-11-11T10:28:002020-10-21 101680863 Finn, Daniel J. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161336101613362020-10-21T16:53:002021-08-232020-10-21T16:53:002021-07-26T11:54:002020-10-212021-08-23 101680863 Finn, Daniel J. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161337101613372020-10-21T16:31:002021-06-082020-10-21T16:31:002021-05-10T16:25:002020-10-212021-06-08 101680863 Finn, Daniel J. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161338101613382020-10-22T10:10:002021-05-142020-10-22T10:10:002020-11-10T11:06:002020-10-222021-05-14 101680863 Finn, Daniel J. (b)(6)AÀYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161339101613392020-10-22T11:02:002021-05-182020-10-22T11:02:002020-11-10T10:16:002020-10-222021-05-18 101680863 Finn, Daniel J. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161340101613402020-10-22T11:03:002021-07-192020-10-22T11:03:002021-06-15T09:35:002020-10-222021-07-19 101680863 Finn, Daniel J. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161343101613432020-10-22T16:39:002021-05-142020-10-22T16:39:002020-11-13T14:08:002020-10-222021-05-14 101680863 Finn, Daniel J. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161344101613442020-10-22T16:44:002021-07-052020-10-22T16:44:002021-06-07T16:20:002020-10-222021-07-05 101680863 Finn, Daniel J. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161350101613502020-11-30T10:30:002021-08-092020-11-30T10:30:002020-12-21T11:25:002020-11-302021-08-09 101680863 Finn, Daniel J. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161351101613512020-11-30T10:23:002021-08-092020-11-30T10:23:002021-07-12T09:28:002020-11-302021-08-09 101680863 Finn, Daniel J. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161352101613522020-11-30T15:49:002021-07-192020-11-30T15:49:002021-06-21T11:57:002020-11-302021-07-19 101680863 Finn, Daniel J. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161353101613532020-11-30T16:33:002021-07-122020-11-30T16:33:002021-06-14T10:45:002020-11-302021-07-12 101680863 Finn, Daniel J. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161354101613542020-12-02T10:08:002021-06-242020-12-02T10:08:002020-12-23T09:44:002020-12-02 101680863 Finn, Daniel J. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161356101613562020-12-02T11:02:002021-06-172020-12-02T11:02:002020-12-22T10:12:002020-12-022021-06-17 101680863 Finn, Daniel J. (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161357101613572020-12-02T11:32:002021-06-152020-12-02T11:32:002020-12-22T10:37:002020-12-022021-06-15 101680863 Finn, Daniel J. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161358101613582020-12-03T09:45:002021-06-222020-12-03T09:45:002020-12-22T14:24:002020-12-032021-06-22 101680863 Finn, Daniel J. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161361101613612020-12-04T10:29:002021-07-052020-12-04T10:29:002021-06-07T14:48:002020-12-042021-07-05 101680863 Finn, Daniel J. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161362101613622020-12-04T15:38:002021-06-232020-12-04T15:38:002020-12-28T14:38:002020-12-042021-06-23 101680863 Finn, Daniel J. (b)(6)AÀYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161363101613632020-12-08T16:07:002021-06-232020-12-08T16:07:002020-12-28T15:15:002020-12-082021-06-23 101680863 Finn, Daniel J. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161364101613642020-12-09T15:34:002021-06-282020-12-09T15:34:002020-12-31T11:10:002020-12-092021-06-28 101680863 Finn, Daniel J. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161365101613652020-12-10T11:42:002021-07-082020-12-10T11:42:002021-06-10T10:17:002020-12-102021-07-08 101680863 Finn, Daniel J. (b)(6)AĞYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161366101613662020-12-15T15:38:002021-08-102020-12-15T15:38:002021-07-07T15:28:002020-12-15 101680863 Finn, Daniel J. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161367101613672020-12-29T10:57:002021-07-122020-12-29T10:57:002021-06-14T12:10:002020-12-292021-07-12 101680863 Finn, Daniel J. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161368101613682020-12-30T16:02:002021-08-312020-12-30T16:02:002021-06-09T16:33:002020-12-30 101680863 Finn, Daniel J. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161369101613692020-12-30T16:18:002021-08-232020-12-30T16:18:002021-01-27T16:02:002020-12-30 101680863 Finn, Daniel J. (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161370101613702021-01-04T11:37:002021-07-282021-01-04T11:37:002021-01-25T16:34:002021-01-042021-07-28 101680863 Finn, Daniel J. (b)(6)AğYEARSMMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161371101613712021-01-04T15:34:002021-07-122021-01-04T15:34:002021-06-14T16:22:002021-01-042021-07-12 101680863 Finn, Daniel J. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161372101613722021-01-05T15:51:002021-07-012021-01-05T15:51:002021-06-03T15:50:002021-01-052021-07-01 101680863 Finn, Daniel J. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161373101613732021-01-05T16:26:002021-07-212021-01-05T16:26:002021-01-27T10:02:002021-01-052021-07-21 101680863 Finn, Daniel J. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161374101613742021-01-06T12:28:002021-08-042021-01-06T12:28:002021-01-28T11:45:002021-01-06 101680863 Finn, Daniel J. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161375101613752021-01-06T16:08:002021-07-062021-01-06T16:08:002021-06-07T11:00:002021-01-062021-07-06 101680863 Finn, Daniel J. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161376101613762021-01-07T12:04:002021-07-262021-01-07T12:04:002021-01-26T11:30:002021-01-072021-07-26 101680863 Finn, Daniel J. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161377101613772021-01-07T12:05:002021-07-262021-01-07T12:05:002021-01-26T11:32:002021-01-072021-07-26 101680863 Finn, Daniel J. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161378101613782021-01-07T16:06:002021-08-252021-01-07T16:06:002021-08-25T16:25:002021-01-07 101680863 Finn, Daniel J. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161379101613792021-01-07T16:49:002021-07-282021-01-07T16:49:002021-06-28T10:30:002021-01-072021-07-28 101680863 Finn, Daniel J. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161381101613812021-01-08T10:40:002021-09-012021-01-08T10:40:002021-01-28T11:21:002021-01-082021-09-01 101680863 Finn, Daniel J. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161382101613822021-01-08T10:59:002021-07-262021-01-08T10:59:002021-01-28T15:35:002021-01-082021-07-26 101680863 Finn, Daniel J. (b)(6)AÀYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161383101613832021-01-08T10:56:002021-06-302021-01-08T10:56:002021-06-01T11:00:002021-01-082021-06-30 101680863 Finn, Daniel J. (b)(6)AÀYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161384101613842021-01-08T11:23:002021-07-262021-01-08T11:23:002021-01-27T16:32:002021-01-082021-07-26 101680863 Finn, Daniel J. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161385101613852021-01-08T15:00:002021-08-022021-01-08T15:00:002021-01-29T09:26:002021-01-082021-08-02 101680863 Finn, Daniel J. (b)(6)AàYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161386101613862021-01-08T15:25:002021-07-232021-01-08T15:25:002021-06-01T14:20:002021-01-082021-07-23 101680863 Finn, Daniel J. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1016 10161387101613872021-01-08T16:06:002021-07-212021-01-08T16:06:002021-01-27T15:08:002021-01-082021-07-21 101680863 Finn, Daniel J. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1016 10161388101613882021-01-11T16:14:002021-06-212021-01-11T16:14:002021-05-24T10:05:002021-01-112021-06-21 101680863 Finn, Daniel J. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391246103912462020-12-01T08:59:002021-04-152020-12-01T08:59:002021-03-18T11:00:002020-12-01 1039406048 Crook, Gretchen (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391247103912472020-12-01T09:09:002021-06-142020-12-01T09:09:002020-12-21T09:17:002020-12-012021-06-14 1039406048 Crook, Gretchen (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391250103912502020-12-04T09:34:002021-07-062020-12-04T09:34:002020-12-28T08:28:002020-12-042021-07-06 1039406048 Crook, Gretchen (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391251103912512020-12-07T08:11:002021-08-202020-12-07T08:11:002021-02-25T07:44:002020-12-072021-08-20 1039406048 Crook, Gretchen (b)(6)AğYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391252103912522020-12-07T08:32:002021-05-142020-12-07T08:32:002021-04-15T13:53:002020-12-072021-05-14 1039406048 Crook, Gretchen (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391253103912532020-12-07T09:11:002021-08-092020-12-07T09:11:002020-12-28T11:15:002020-12-072021-08-09 1039406048 Crook, Gretchen (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391255103912552020-12-07T12:04:002021-07-212020-12-07T12:04:002020-12-29T11:27:002020-12-072021-07-21 1039406048 Crook, Gretchen (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391256103912562020-12-07T12:49:002021-07-212020-12-07T12:49:002021-06-03T12:30:002020-12-072021-07-21 1039406048 Crook, Gretchen (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391258103912582020-12-07T12:40:002021-07-062020-12-07T12:40:002021-06-01T12:02:002020-12-072021-07-06 1039406048 Crook, Gretchen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391259103912592020-12-07T13:39:002021-07-022020-12-07T13:39:002021-06-04T13:11:002020-12-072021-07-02 1039406048 Crook, Gretchen (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391260103912602020-12-07T14:21:002021-07-282020-12-07T14:21:002020-12-28T14:02:002020-12-072021-07-28 1039406048 Crook, Gretchen (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391262103912622020-12-08T08:19:002021-06-222020-12-08T08:19:002020-12-29T08:03:002020-12-082021-06-22 1039406048 Crook, Gretchen (b)(6)AàYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391263103912632020-12-08T08:36:002021-08-042020-12-08T08:36:002020-12-29T07:58:002020-12-082021-08-04 1039406048 Crook, Gretchen (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391264103912642020-12-08T11:55:002021-06-082020-12-08T11:55:002021-05-24T13:58:002020-12-082021-06-08 1039406048 Crook, Gretchen (b)(6)AÀYEARSFASIAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391265103912652020-12-08T12:10:002021-06-292020-12-08T12:10:002020-12-29T12:26:002020-12-082021-06-29 1039406048 Crook, Gretchen (b)(6)AÀYEARSMASIAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391266103912662020-12-08T13:16:002021-07-082020-12-08T13:16:002021-06-03T14:04:002020-12-082021-07-08 1039406048 Crook, Gretchen (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391267103912672020-12-08T13:54:002021-07-022020-12-08T13:54:002020-12-28T08:48:002020-12-082021-07-02 1039406048 Crook, Gretchen (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391268103912682020-12-08T13:30:002021-07-022020-12-08T13:30:002021-06-04T13:09:002020-12-082021-07-02 1039406048 Crook, Gretchen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391269103912692020-12-08T13:42:002021-07-022020-12-08T13:42:002020-12-28T08:02:002020-12-082021-07-02 1039406048 Crook, Gretchen (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391270103912702020-12-09T11:31:002021-07-012020-12-09T11:31:002021-06-03T08:47:002020-12-092021-07-01 1039406048 Crook, Gretchen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391271103912712020-12-09T13:56:002021-07-012020-12-09T13:56:002021-06-03T12:14:002020-12-092021-07-01 1039406048 Crook, Gretchen (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391272103912722020-12-09T12:57:002021-06-302020-12-09T12:57:002020-12-28T12:46:002020-12-092021-06-30 1039406048 Crook, Gretchen (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391273103912732020-12-09T13:58:002021-07-012020-12-09T13:58:002021-06-03T12:14:002020-12-092021-07-01 1039406048 Crook, Gretchen (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391274103912742020-12-16T08:47:002021-07-062020-12-16T08:47:002021-06-04T08:06:002020-12-162021-07-06 1039406048 Crook, Gretchen (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391275103912752020-12-16T08:35:002021-06-282020-12-16T08:35:002021-01-04T13:08:002020-12-162021-06-28 1039406048 Crook, Gretchen (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391276103912762020-12-16T10:35:002021-06-292020-12-16T10:35:002021-01-05T09:56:002020-12-162021-06-29 1039406048 Crook, Gretchen (b)(6)AĞYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391277103912772020-12-16T10:49:002021-07-062020-12-16T10:49:002021-06-04T11:26:002020-12-162021-07-06 1039406048 Crook, Gretchen (b)(6)AàYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391278103912782020-12-16T11:58:002021-07-022020-12-16T11:58:002021-01-05T09:48:002020-12-162021-07-02 1039406048 Crook, Gretchen (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391279103912792020-12-16T12:28:002021-07-062020-12-16T12:28:002021-06-07T10:41:002020-12-162021-07-06 1039406048 Crook, Gretchen (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391280103912802020-12-17T09:27:002021-08-132020-12-17T09:27:002021-06-04T14:15:002020-12-172021-08-13 1039406048 Crook, Gretchen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391281103912812020-12-17T13:54:002021-07-232020-12-17T13:54:002021-01-05T14:30:002020-12-172021-07-23 1039406048 Crook, Gretchen (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391282103912822020-12-18T08:44:002021-07-142020-12-18T08:44:002021-01-08T13:25:002020-12-182021-07-14 1039406048 Crook, Gretchen (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391283103912832020-12-18T09:17:002021-07-012020-12-18T09:17:002021-06-03T13:23:002020-12-182021-07-01 1039406048 Crook, Gretchen (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391284103912842020-12-18T09:27:002021-09-022020-12-18T09:27:002021-01-07T07:50:002020-12-182021-09-02 1039406048 Crook, Gretchen (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391285103912852020-12-18T09:59:002021-07-262020-12-18T09:59:002021-06-04T08:16:002020-12-182021-07-26 1039406048 Crook, Gretchen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391286103912862020-12-18T10:11:002021-07-162020-12-18T10:11:002021-01-08T08:50:002020-12-182021-07-16 1039406048 Crook, Gretchen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391287103912872020-12-18T10:54:002021-07-062020-12-18T10:54:002021-06-03T09:34:002020-12-182021-07-06 1039406048 Crook, Gretchen (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391289103912892020-12-18T11:42:002021-08-292020-12-18T11:42:002021-01-08T12:41:002020-12-182021-08-29 1039406048 Crook, Gretchen (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391290103912902020-12-18T12:58:002021-07-132020-12-18T12:58:002021-01-08T09:43:002020-12-182021-07-13 1039406048 Crook, Gretchen (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391291103912912020-12-18T14:04:002021-05-142020-12-18T14:04:002021-04-16T08:37:002020-12-182021-05-14 1039406048 Crook, Gretchen (b)(6)AğYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391292103912922020-12-18T13:42:002021-07-062020-12-18T13:42:002021-06-04T08:27:002020-12-182021-07-06 1039406048 Crook, Gretchen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391293103912932020-12-21T12:33:002021-07-152020-12-21T12:33:002021-01-11T12:29:002020-12-21 1039406048 Crook, Gretchen (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391294103912942020-12-21T12:43:002021-07-072020-12-21T12:43:002021-06-04T10:02:002020-12-212021-07-07 1039406048 Crook, Gretchen (b)(6)AĞYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391295103912952020-12-29T08:32:002021-09-012020-12-29T08:32:002021-01-19T11:56:002020-12-292021-09-01 1039406048 Crook, Gretchen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391296103912962020-12-29T09:16:002021-08-182020-12-29T09:16:002021-06-04T09:52:002020-12-29 1039406048 Crook, Gretchen (b)(6)AĞYEARSMWHITE NOT REPORTED PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391297103912972020-12-29T09:38:002021-07-202020-12-29T09:38:002021-01-19T07:37:002020-12-292021-07-20 1039406048 Crook, Gretchen (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391298103912982020-12-29T09:50:002021-07-132020-12-29T09:50:002021-01-19T09:44:002020-12-29 1039406048 Crook, Gretchen (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391299103912992020-12-29T10:05:002021-07-022020-12-29T10:05:002021-06-04T10:12:002020-12-292021-07-02 1039406048 Crook, Gretchen (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391300103913002020-12-29T12:06:002021-07-222020-12-29T12:06:002021-01-21T08:12:002020-12-292021-07-22 1039406048 Crook, Gretchen (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391301103913012020-12-29T12:03:002021-07-142020-12-29T12:03:002021-06-04T13:29:002020-12-292021-07-14 1039406048 Crook, Gretchen (b)(6)AàYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391302103913022020-12-29T12:36:002021-08-192020-12-29T12:36:002021-01-18T12:41:002020-12-292021-08-19 1039406048 Crook, Gretchen (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391303103913032020-12-29T13:39:002021-07-062020-12-29T13:39:002021-06-04T08:08:002020-12-292021-07-06 1039406048 Crook, Gretchen (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391304103913042020-12-29T13:51:002021-07-132020-12-29T13:51:002021-01-19T11:58:002020-12-292021-07-13 1039406048 Crook, Gretchen (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391305103913052021-01-06T13:27:002021-07-122021-01-06T13:27:002021-06-04T13:13:002021-01-062021-07-12 1039406048 Crook, Gretchen (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391306103913062021-01-06T13:29:002021-07-282021-01-06T13:29:002021-01-25T08:14:002021-01-062021-07-28 1039406048 Crook, Gretchen (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391307103913072021-01-06T14:08:002021-07-022021-01-06T14:08:002021-06-04T10:43:002021-01-062021-07-02 1039406048 Crook, Gretchen (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391308103913082021-01-06T14:09:002021-07-222021-01-06T14:09:002021-01-27T12:52:002021-01-062021-07-22 1039406048 Crook, Gretchen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391309103913092021-01-07T08:10:002021-07-202021-01-07T08:10:002021-06-08T13:08:002021-01-072021-07-20 1039406048 Crook, Gretchen (b)(6)AàYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391310103913102021-01-07T08:45:002021-07-062021-01-07T08:45:002021-06-07T10:50:002021-01-072021-07-06 1039406048 Crook, Gretchen (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391311103913112021-01-07T10:22:002021-07-212021-01-07T10:22:002021-01-29T09:27:002021-01-072021-07-21 1039406048 Crook, Gretchen (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391312103913122021-01-07T10:10:002021-08-102021-01-07T10:10:002021-01-28T09:05:002021-01-072021-08-10 1039406048 Crook, Gretchen (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391313103913132021-01-07T11:29:002021-07-062021-01-07T11:29:002021-06-03T10:35:002021-01-07 1039406048 Crook, Gretchen (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391314103913142021-01-07T11:57:002021-07-062021-01-07T11:57:002021-06-07T08:06:002021-01-072021-07-06 1039406048 Crook, Gretchen (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391315103913152021-01-07T13:55:002021-07-222021-01-07T13:55:002021-01-27T13:58:002021-01-072021-07-22 1039406048 Crook, Gretchen (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391316103913162021-01-07T13:57:002021-07-222021-01-07T13:57:002021-01-27T13:57:002021-01-072021-07-22 1039406048 Crook, Gretchen (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391317103913172021-01-07T13:59:002021-07-012021-01-07T13:59:002021-06-03T08:09:002021-01-072021-07-01 1039406048 Crook, Gretchen (b)(6)AÀYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391318103913182021-01-07T15:07:002021-08-232021-01-07T15:07:002021-01-29T13:58:002021-01-072021-08-23 1039406048 Crook, Gretchen (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391319103913192021-01-08T08:20:002021-07-092021-01-08T08:20:002021-06-11T14:08:002021-01-082021-07-09 1039406048 Crook, Gretchen (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391320103913202021-01-08T10:19:002021-08-232021-01-08T10:19:002021-01-29T10:23:002021-01-082021-08-23 1039406048 Crook, Gretchen (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391321103913212021-01-08T10:00:002021-07-132021-01-08T10:00:002021-06-08T13:50:002021-01-082021-07-13 1039406048 Crook, Gretchen (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391322103913222021-01-08T12:59:002021-07-232021-01-08T12:59:002021-01-29T11:31:002021-01-082021-07-23 1039406048 Crook, Gretchen (b)(6)AğYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391323103913232021-01-08T13:17:002021-07-232021-01-08T13:17:002021-01-29T13:20:002021-01-082021-07-23 1039406048 Crook, Gretchen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391324103913242021-01-08T15:42:002021-08-292021-01-08T15:42:002021-01-29T13:28:002021-01-082021-08-29 1039406048 Crook, Gretchen (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391325103913252021-01-11T12:51:002021-07-062021-01-11T12:51:002021-06-03T08:34:002021-01-112021-07-06 1039406048 Crook, Gretchen (b)(6)AĞYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391326103913262021-01-11T12:50:002021-08-092021-01-11T12:50:002021-02-01T08:31:002021-01-112021-08-09 1039406048 Crook, Gretchen (b)(6)AğYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391327103913272021-01-11T13:08:002021-07-282021-01-11T13:08:002021-02-01T08:44:002021-01-11 1039406048 Crook, Gretchen (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391328103913282021-01-11T13:15:002021-07-082021-01-11T13:15:002021-06-04T13:05:002021-01-112021-07-08 1039406048 Crook, Gretchen (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391329103913292021-01-11T15:06:002021-07-092021-01-11T15:06:002021-06-10T13:29:002021-01-112021-07-09 1039406048 Crook, Gretchen (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391330103913302021-01-11T14:59:002021-08-102021-01-11T14:59:002021-02-02T13:34:002021-01-112021-08-10 1039406048 Crook, Gretchen (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391331103913312021-01-12T08:08:002021-07-262021-01-12T08:08:002021-02-01T08:33:002021-01-122021-07-26 1039406048 Crook, Gretchen (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391332103913322021-01-12T08:52:002021-06-102021-01-12T08:52:002021-02-02T08:00:002021-01-122021-06-10 1039406048 Crook, Gretchen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391333103913332021-01-12T09:36:002021-07-092021-01-12T09:36:002021-06-11T14:11:002021-01-122021-07-09 1039406048 Crook, Gretchen (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391334103913342021-01-12T09:40:002021-07-092021-01-12T09:40:002021-06-11T14:10:002021-01-122021-07-09 1039406048 Crook, Gretchen (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391335103913352021-01-12T11:36:002021-08-102021-01-12T11:36:002021-02-02T08:52:002021-01-122021-08-10 1039406048 Crook, Gretchen (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391336103913362021-01-12T11:34:002021-08-102021-01-12T11:34:002021-02-02T08:51:002021-01-12 1039406048 Crook, Gretchen (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391337103913372021-01-12T12:09:002021-07-022021-01-12T12:09:002021-06-04T11:21:002021-01-12 1039406048 Crook, Gretchen (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1039 10391338103913382021-01-12T14:50:002021-08-032021-01-12T14:50:002021-02-03T08:30:002021-01-12 1039406048 Crook, Gretchen (b)(6)AğYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1039 10391339103913392021-01-12T14:52:002021-08-022021-01-12T14:52:002021-06-07T08:09:002021-01-122021-08-02 1039406048 Crook, Gretchen (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441251104412512020-11-30T14:59:002021-06-232020-11-30T14:59:002020-12-22T11:53:002020-11-302021-06-23 1044374169 Hartman, Aaron N. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441252104412522020-11-30T16:14:002021-07-062020-11-30T16:14:002021-06-07T11:12:002020-11-302021-07-06 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441253104412532020-11-30T17:42:002021-06-292020-11-30T17:42:002020-12-21T11:54:002020-11-302021-06-29 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441255104412552020-12-01T11:34:002021-06-252020-12-01T11:34:002020-12-21T13:55:002020-12-012021-06-25 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441256104412562020-12-01T11:35:002021-07-072020-12-01T11:35:002021-06-09T10:45:002020-12-012021-07-07 1044374169 Hartman, Aaron N. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441257104412572020-12-01T15:23:002021-06-302020-12-01T15:23:002020-12-23T16:03:002020-12-012021-06-30 1044374169 Hartman, Aaron N. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441259104412592020-12-01T16:49:002021-06-172020-12-01T16:49:002020-12-22T11:45:002020-12-012021-06-17 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441260104412602020-12-01T17:43:002021-07-012020-12-01T17:43:002021-06-03T16:03:002020-12-012021-07-01 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441261104412612020-12-01T17:46:002021-07-022020-12-01T17:46:002021-06-04T16:17:002020-12-012021-07-02 1044374169 Hartman, Aaron N. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441263104412632020-12-07T15:04:002021-06-222020-12-07T15:04:002020-12-28T14:06:002020-12-072021-06-22 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441264104412642020-12-07T16:55:002021-08-232020-12-07T16:55:002021-08-23T10:39:002020-12-07 1044374169 Hartman, Aaron N. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441265104412652020-12-07T17:32:002021-07-082020-12-07T17:32:002021-06-09T14:12:002020-12-072021-07-08 1044374169 Hartman, Aaron N. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441266104412662020-12-08T11:34:002021-06-282020-12-08T11:34:002020-12-28T13:19:002020-12-082021-06-28 1044374169 Hartman, Aaron N. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441267104412672020-12-08T12:04:002021-07-122020-12-08T12:04:002021-06-09T12:22:002020-12-082021-07-12 1044374169 Hartman, Aaron N. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441268104412682020-12-08T12:52:002021-07-022020-12-08T12:52:002020-12-28T15:50:002020-12-082021-07-02 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441270104412702020-12-08T15:26:002021-07-012020-12-08T15:26:002020-12-31T11:25:002020-12-082021-07-01 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSFNOT REPORTED HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441271104412712020-12-08T18:10:002021-06-262020-12-08T18:10:002020-12-28T15:25:002020-12-08 1044374169 Hartman, Aaron N. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441273104412732020-12-08T19:15:002021-07-062020-12-08T19:15:002020-12-28T14:35:002020-12-082021-07-06 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441274104412742020-12-08T19:14:002021-04-092020-12-08T19:14:002021-03-12T14:39:002020-12-08 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441275104412752020-12-09T10:43:002021-07-072020-12-09T10:43:002021-06-09T10:12:002020-12-092021-07-07 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441276104412762020-12-09T12:07:002021-06-282020-12-09T12:07:002020-12-29T11:20:002020-12-092021-06-28 1044374169 Hartman, Aaron N. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441277104412772020-12-09T14:09:002021-07-062020-12-09T14:09:002021-06-08T09:30:002020-12-092021-07-06 1044374169 Hartman, Aaron N. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441278104412782020-12-09T14:06:002021-06-302020-12-09T14:06:002020-12-29T15:52:002020-12-092021-06-30 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441279104412792020-12-09T17:59:002021-07-062020-12-09T17:59:002020-12-29T10:34:002020-12-092021-07-06 1044374169 Hartman, Aaron N. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441280104412802020-12-09T17:58:002021-08-112020-12-09T17:58:002021-02-17T14:35:002020-12-09 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441281104412812020-12-09T18:38:002021-07-012020-12-09T18:38:002020-12-29T12:20:002020-12-092021-07-01 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441282104412822020-12-09T18:31:002021-04-212020-12-09T18:31:002021-03-24T13:43:002020-12-09 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441283104412832020-12-10T10:49:002021-06-302020-12-10T10:49:002020-12-29T12:22:002020-12-102021-06-30 1044374169 Hartman, Aaron N. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441284104412842020-12-10T15:17:002021-07-012020-12-10T15:17:002021-06-03T14:53:002020-12-102021-07-01 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441285104412852020-12-10T16:14:002021-07-022020-12-10T16:14:002020-12-30T10:25:002020-12-102021-07-02 1044374169 Hartman, Aaron N. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441286104412862020-12-11T11:01:002021-07-072020-12-11T11:01:002021-06-07T11:52:002020-12-112021-07-07 1044374169 Hartman, Aaron N. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441288104412882020-12-16T11:29:002021-06-172020-12-16T11:29:002021-01-06T13:56:002020-12-162021-06-17 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441289104412892020-12-16T15:34:002021-08-182020-12-16T15:34:002021-01-11T14:56:002020-12-162021-08-18 100682785 Peterson, James Todd (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441290104412902021-01-08T13:51:002021-07-292021-01-08T13:51:002021-01-29T13:56:002020-12-162021-07-29 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441291104412912020-12-17T14:00:002021-07-022020-12-17T14:00:002021-01-06T16:40:002020-12-172021-07-02 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441292104412922020-12-17T14:39:002021-05-032020-12-17T14:39:002021-04-01T13:03:002020-12-17 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441293104412932020-12-17T18:27:002021-06-212020-12-17T18:27:002021-05-14T16:28:002020-12-172021-06-21 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441294104412942020-12-17T18:28:002021-07-022020-12-17T18:28:002021-05-14T16:27:002020-12-172021-07-02 1044374169 Hartman, Aaron N. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441295104412952020-12-18T09:44:002021-07-262020-12-18T09:44:002021-01-08T10:13:002020-12-182021-07-26 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441296104412962020-12-22T14:05:002021-07-122020-12-22T14:05:002021-01-11T10:50:002020-12-222021-07-12 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441297104412972020-12-23T09:44:002021-07-152020-12-23T09:44:002021-01-13T15:25:002020-12-232021-07-15 1044374169 Hartman, Aaron N. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441298104412982020-12-23T11:53:002021-07-302020-12-23T11:53:002021-06-18T13:47:002020-12-232021-07-30 1044374169 Hartman, Aaron N. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441299104412992020-12-28T16:24:002021-07-062020-12-28T16:24:002021-06-04T14:57:002020-12-282021-07-06 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441300104413002020-12-28T17:48:002021-09-012020-12-28T17:48:002021-01-18T12:21:002020-12-282021-09-01 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441301104413012020-12-29T14:58:002021-07-122020-12-29T14:58:002021-01-18T11:33:002020-12-292021-07-12 1044374169 Hartman, Aaron N. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441302104413022020-12-29T16:55:002021-07-062020-12-29T16:55:002021-06-07T10:24:002020-12-292021-07-06 1044374169 Hartman, Aaron N. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441303104413032020-12-29T16:57:002021-06-142020-12-29T16:57:002021-05-13T10:23:002020-12-292021-06-14 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441304104413042020-12-29T17:54:002021-07-142020-12-29T17:54:002021-01-19T15:04:002020-12-292021-07-14 1044374169 Hartman, Aaron N. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441306104413062020-12-30T12:00:002021-07-122020-12-30T12:00:002021-01-18T10:20:002020-12-302021-07-12 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441307104413072020-12-30T12:01:002021-08-172020-12-30T12:01:002021-08-17T10:16:002020-12-30 1044374169 Hartman, Aaron N. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441308104413082020-12-30T12:24:002021-07-072020-12-30T12:24:002021-06-09T13:54:002020-12-302021-07-07 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441309104413092020-12-30T13:13:002021-07-162020-12-30T13:13:002021-01-18T13:49:002020-12-302021-07-16 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441310104413102020-12-30T14:40:002021-07-212020-12-30T14:40:002021-01-18T14:21:002020-12-302021-07-21 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441311104413112021-01-04T10:45:002021-07-202021-01-04T10:45:002021-01-25T10:23:002021-01-042021-07-20 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441312104413122021-01-04T10:51:002021-06-302021-01-04T10:51:002021-06-02T11:26:002021-01-042021-06-30 1044374169 Hartman, Aaron N. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441313104413132021-01-04T11:53:002021-08-172021-01-04T11:53:002021-08-17T10:08:002021-01-04 1044374169 Hartman, Aaron N. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441314104413142021-01-04T14:15:002021-08-022021-01-04T14:15:002021-01-25T15:40:002021-01-042021-08-02 1044374169 Hartman, Aaron N. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441315104413152021-01-04T14:14:002021-07-062021-01-04T14:14:002021-06-08T10:04:002021-01-042021-07-06 1044374169 Hartman, Aaron N. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441316104413162021-01-04T15:38:002021-07-202021-01-04T15:38:002021-01-25T12:52:002021-01-042021-07-20 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441317104413172021-01-04T16:07:002021-07-092021-01-04T16:07:002021-06-09T13:06:002021-01-042021-07-09 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441318104413182021-01-05T10:48:002021-07-062021-01-05T10:48:002021-06-04T14:32:002021-01-052021-07-06 1044374169 Hartman, Aaron N. (b)(6)AàYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441319104413192021-01-05T10:49:002021-08-022021-01-05T10:49:002021-01-25T10:33:002021-01-052021-08-02 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441320104413202021-01-05T12:56:002021-07-022021-01-05T12:56:002021-06-04T13:57:002021-01-052021-07-02 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441321104413212021-01-05T13:37:002021-08-032021-01-05T13:37:002021-01-26T14:07:002021-01-052021-08-03 1044374169 Hartman, Aaron N. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441322104413222021-01-05T15:31:002021-05-132021-01-05T15:31:002021-01-27T16:39:002021-01-052021-05-13 1044374169 Hartman, Aaron N. (b)(6)AàYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441323104413232021-01-05T17:17:002021-07-062021-01-05T17:17:002021-06-08T10:05:002021-01-052021-07-06 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441324104413242021-01-05T18:39:002021-07-062021-01-05T18:39:002021-06-03T10:23:002021-01-052021-07-06 1044374169 Hartman, Aaron N. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441325104413252021-01-05T18:43:002021-07-262021-01-05T18:43:002021-01-26T16:39:002021-01-052021-07-26 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441326104413262021-01-06T10:31:002021-07-122021-01-06T10:31:002021-06-09T14:01:002021-01-062021-07-12 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441327104413272021-01-06T10:32:002021-07-122021-01-06T10:32:002021-06-09T14:02:002021-01-062021-07-12 1044374169 Hartman, Aaron N. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441328104413282021-01-06T11:52:002021-08-032021-01-06T11:52:002021-01-26T10:20:002021-01-062021-08-03 1044374169 Hartman, Aaron N. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441329104413292021-01-06T13:54:002021-08-102021-01-06T13:54:002021-01-27T15:58:002021-01-062021-08-10 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441330104413302021-01-06T15:27:002021-09-012021-01-06T15:27:002021-06-08T14:30:002021-01-06 1044374169 Hartman, Aaron N. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441331104413312021-01-06T17:42:002021-07-262021-01-06T17:42:002021-01-27T16:41:002021-01-062021-07-26 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441332104413322021-01-06T17:43:002021-07-062021-01-06T17:43:002021-06-04T16:14:002021-01-062021-07-06 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441333104413332021-01-06T18:48:002021-08-022021-01-06T18:48:002021-01-27T14:35:002021-01-062021-08-02 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441334104413342021-01-07T10:24:002021-08-032021-01-07T10:24:002021-01-26T10:10:002021-01-072021-08-03 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441335104413352021-01-07T15:29:002021-07-082021-01-07T15:29:002021-06-07T16:22:002021-01-072021-07-08 1044374169 Hartman, Aaron N. (b)(6)AğYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441336104413362021-01-07T16:35:002021-07-272021-01-07T16:35:002021-01-28T16:15:002021-01-072021-07-27 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441337104413372021-01-08T10:15:002021-07-062021-01-08T10:15:002021-06-07T11:50:002021-01-082021-07-06 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441338104413382021-01-08T10:15:002021-07-282021-01-08T10:15:002021-01-29T11:32:002021-01-082021-07-28 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441339104413392021-01-08T16:02:002021-08-032021-01-08T16:02:002021-01-29T15:47:002021-01-082021-08-03 1044374169 Hartman, Aaron N. (b)(6)AğYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441340104413402021-01-08T16:06:002021-07-062021-01-08T16:06:002021-06-01T11:49:002021-01-082021-07-06 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441341104413412021-01-08T16:07:002021-07-062021-01-08T16:07:002021-06-01T11:50:002021-01-082021-07-06 1044374169 Hartman, Aaron N. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441342104413422021-01-09T10:20:002021-07-222021-01-09T10:20:002021-01-28T15:33:002021-01-092021-07-22 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441343104413432021-01-09T10:24:002021-07-292021-01-09T10:24:002021-01-29T15:26:002021-01-092021-07-29 1044374169 Hartman, Aaron N. (b)(6)AàYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441344104413442021-01-09T10:23:002021-04-132021-01-09T10:23:002021-03-16T10:34:002021-01-09 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441345104413452021-01-09T11:35:002021-07-062021-01-09T11:35:002021-06-07T10:28:002021-01-092021-07-06 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441346104413462021-01-09T11:33:002021-07-262021-01-09T11:33:002021-01-28T10:13:002021-01-092021-07-26 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441347104413472021-01-09T11:38:002021-05-282021-01-09T11:38:002021-01-29T13:04:002021-01-092021-05-28 1044374169 Hartman, Aaron N. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441348104413482021-01-09T12:16:002021-07-062021-01-09T12:16:002021-06-08T15:57:002021-01-092021-07-06 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441349104413492021-01-09T12:19:002021-08-022021-01-09T12:19:002021-01-29T10:26:002021-01-092021-08-02 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441350104413502021-01-09T12:48:002021-07-272021-01-09T12:48:002021-01-29T12:35:002021-01-092021-07-27 1044374169 Hartman, Aaron N. (b)(6)AğYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441351104413512021-01-10T10:09:002021-08-232021-01-10T10:09:002021-08-23T15:52:002021-01-10 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441352104413522021-01-10T10:16:002021-08-052021-01-10T10:16:002021-01-29T13:00:002021-01-102021-08-05 1044374169 Hartman, Aaron N. (b)(6)AğYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441353104413532021-01-10T10:19:002021-07-292021-01-10T10:19:002021-02-01T15:33:002021-01-102021-07-29 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441354104413542021-01-10T11:33:002021-07-092021-01-10T11:33:002021-06-09T10:14:002021-01-10 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441355104413552021-01-10T11:34:002021-07-282021-01-10T11:34:002021-01-29T12:42:002021-01-102021-07-28 1044374169 Hartman, Aaron N. (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441356104413562021-01-10T11:38:002021-07-292021-01-10T11:38:002021-02-02T17:25:002021-01-102021-07-29 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441357104413572021-01-10T12:34:002021-07-072021-01-10T12:34:002021-06-07T16:23:002021-01-102021-07-07 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441358104413582021-01-10T12:31:002021-08-092021-01-10T12:31:002021-02-01T13:25:002021-01-102021-08-09 1044374169 Hartman, Aaron N. (b)(6)AàYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441359104413592021-01-11T10:05:002021-08-232021-01-11T10:05:002021-02-25T16:55:002021-01-112021-08-23 1044374169 Hartman, Aaron N. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441360104413602021-01-11T10:04:002021-07-072021-01-11T10:04:002021-06-07T16:42:002021-01-112021-07-07 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441361104413612021-01-11T12:43:002021-07-282021-01-11T12:43:002021-02-03T12:57:002021-01-112021-07-28 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441362104413622021-01-11T13:51:002021-07-022021-01-11T13:51:002021-06-04T14:52:002021-01-112021-07-02 1044374169 Hartman, Aaron N. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441363104413632021-01-11T14:43:002021-07-062021-01-11T14:43:002021-06-04T15:43:002021-01-112021-07-06 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441364104413642021-01-11T15:16:002021-08-042021-01-11T15:16:002021-02-03T15:34:002021-01-112021-08-04 1044374169 Hartman, Aaron N. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441365104413652021-01-11T15:42:002021-07-062021-01-11T15:42:002021-06-02T10:33:002021-01-112021-07-06 1044374169 Hartman, Aaron N. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441366104413662021-01-11T15:40:002021-08-022021-01-11T15:40:002021-02-02T15:20:002021-01-112021-08-02 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441367104413672021-01-11T16:56:002021-07-282021-01-11T16:56:002021-02-03T11:59:002021-01-112021-07-28 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441368104413682021-01-11T17:28:002021-04-272021-01-11T17:28:002021-03-30T15:23:002021-01-11 1044374169 Hartman, Aaron N. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441369104413692021-01-11T17:45:002021-08-032021-01-11T17:45:002021-02-02T16:54:002021-01-112021-08-03 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441370104413702021-01-11T17:44:002021-07-202021-01-11T17:44:002021-06-21T11:19:002021-01-112021-07-20 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441371104413712021-01-11T18:41:002021-08-032021-01-11T18:41:002021-02-02T14:08:002021-01-112021-08-03 1044374169 Hartman, Aaron N. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441372104413722021-01-11T18:40:002021-08-032021-01-11T18:40:002021-02-02T14:07:002021-01-112021-08-03 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441373104413732021-01-12T10:33:002021-07-072021-01-12T10:33:002021-06-08T09:37:002021-01-122021-07-07 1044374169 Hartman, Aaron N. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441374104413742021-01-12T11:36:002021-08-202021-01-12T11:36:002021-08-20T11:24:002021-01-12 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441375104413752021-01-12T12:42:002021-07-292021-01-12T12:42:002021-02-02T11:30:002021-01-122021-07-29 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441376104413762021-01-12T12:43:002021-07-292021-01-12T12:43:002021-02-02T11:29:002021-01-122021-07-29 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441377104413772021-02-01T13:29:002021-08-252021-02-01T13:29:002021-02-22T15:40:002021-01-122021-08-25 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441378104413782021-01-12T14:31:002021-08-022021-01-12T14:31:002021-02-04T15:57:002021-01-122021-08-02 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441379104413792021-01-12T14:32:002021-08-022021-01-12T14:32:002021-02-04T15:58:002021-01-122021-08-02 1044374169 Hartman, Aaron N. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441380104413802021-01-12T16:15:002021-07-012021-01-12T16:15:002021-06-03T15:48:002021-01-122021-07-01 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441381104413812021-01-12T16:20:002021-07-092021-01-12T16:20:002021-06-11T14:54:002021-01-122021-07-09 1044374169 Hartman, Aaron N. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441382104413822021-01-12T17:46:002021-06-302021-01-12T17:46:002021-06-02T15:37:002021-01-122021-06-30 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1044 10441383104413832021-01-12T17:45:002021-07-292021-01-12T17:45:002021-02-03T15:13:002021-01-122021-07-29 1044374169 Hartman, Aaron N. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1044 10441384104413842021-01-12T17:50:002021-07-062021-01-12T17:50:002021-06-08T15:41:002021-01-122021-07-06 1044374169 Hartman, Aaron N. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571376105713762020-12-07T10:39:002021-06-282020-12-07T10:39:002021-01-04T13:53:002020-12-072021-06-28 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571377105713772020-12-07T14:52:002021-08-252020-12-07T14:52:002020-12-28T11:14:002020-12-072021-08-25 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571378105713782020-12-07T15:18:002021-08-252020-12-07T15:18:002020-12-28T11:17:002020-12-072021-08-25 1057350735 Chalhoub, Fadi (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571379105713792020-12-07T16:33:002021-07-062020-12-07T16:33:002021-06-04T11:35:002020-12-072021-07-06 1057350735 Chalhoub, Fadi (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571380105713802020-12-08T09:51:002021-07-232020-12-08T09:51:002021-01-04T09:00:002020-12-082021-07-23 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571382105713822020-12-08T16:32:002021-09-022020-12-08T16:32:002021-01-05T10:27:002020-12-082021-09-02 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571383105713832020-12-08T15:54:002021-08-192020-12-08T15:54:002021-06-11T12:00:002020-12-082021-08-19 1057350735 Chalhoub, Fadi (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571384105713842020-12-08T16:25:002021-08-172020-12-08T16:25:002021-07-20T10:42:002020-12-082021-08-17 1057350735 Chalhoub, Fadi (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571385105713852020-12-08T16:45:002021-07-222020-12-08T16:45:002020-12-28T14:43:002020-12-082021-07-22 1057350735 Chalhoub, Fadi (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571386105713862020-12-08T16:44:002021-06-222020-12-08T16:44:002020-12-29T15:54:002020-12-082021-06-22 1057350735 Chalhoub, Fadi (b)(6)AàYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571387105713872020-12-09T14:03:002021-08-052020-12-09T14:03:002021-06-23T16:12:002020-12-092021-08-05 1057350735 Chalhoub, Fadi (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571388105713882020-12-09T14:22:002021-07-122020-12-09T14:22:002020-12-28T10:57:002020-12-092021-07-12 1057350735 Chalhoub, Fadi (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571389105713892020-12-09T14:27:002021-07-122020-12-09T14:27:002021-01-04T16:42:002020-12-092021-07-12 1057350735 Chalhoub, Fadi (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571390105713902020-12-09T14:45:002021-07-302020-12-09T14:45:002020-12-28T14:50:002020-12-092021-07-30 1057350735 Chalhoub, Fadi (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571391105713912020-12-09T14:50:002021-04-142020-12-09T14:50:002021-03-17T15:44:002020-12-09 1057350735 Chalhoub, Fadi (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571392105713922020-12-09T16:00:002021-07-222020-12-09T16:00:002020-12-28T14:03:002020-12-092021-07-22 1057350735 Chalhoub, Fadi (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571393105713932020-12-09T16:14:002021-07-132020-12-09T16:14:002021-06-15T16:10:002020-12-092021-07-13 1057350735 Chalhoub, Fadi (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571394105713942020-12-09T16:31:002021-07-082020-12-09T16:31:002021-06-08T15:53:002020-12-092021-07-08 1057350735 Chalhoub, Fadi (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571395105713952020-12-09T16:39:002021-06-162020-12-09T16:39:002021-01-14T16:16:002020-12-092021-06-16 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571396105713962020-12-10T14:42:002021-08-252020-12-10T14:42:002020-12-28T14:05:002020-12-10 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571397105713972020-12-10T16:10:002021-06-232020-12-10T16:10:002020-12-30T15:37:002020-12-10 1057350735 Chalhoub, Fadi (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571398105713982020-12-10T16:17:002021-07-012020-12-10T16:17:002021-06-03T13:58:002020-12-102021-07-01 1057350735 Chalhoub, Fadi (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571399105713992020-12-10T16:35:002021-06-232020-12-10T16:35:002020-12-29T15:10:002020-12-102021-06-23 1057350735 Chalhoub, Fadi (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571400105714002020-12-11T10:55:002021-08-042020-12-11T10:55:002021-06-07T15:17:002020-12-112021-08-04 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571401105714012020-12-11T12:14:002021-06-142020-12-11T12:14:002020-12-30T13:58:002020-12-112021-06-14 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571402105714022020-12-14T16:12:002021-04-212020-12-14T16:12:002021-03-24T15:57:002020-12-14 1057350735 Chalhoub, Fadi (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571403105714032020-12-14T16:37:002021-06-282020-12-14T16:37:002021-01-04T14:00:002020-12-142021-06-28 1057350735 Chalhoub, Fadi (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571404105714042020-12-16T11:22:002021-08-192020-12-16T11:22:002021-07-21T14:30:002020-12-162021-08-19 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571405105714052020-12-16T16:35:002021-08-172020-12-16T16:35:002021-01-05T16:02:002020-12-16 1057350735 Chalhoub, Fadi (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571406105714062020-12-16T16:40:002021-07-052020-12-16T16:40:002021-06-07T13:53:002020-12-16 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571407105714072020-12-17T14:30:002021-04-302020-12-17T14:30:002021-04-02T10:48:002020-12-17 1057350735 Chalhoub, Fadi (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571408105714082020-12-17T14:38:002021-07-142020-12-17T14:38:002021-06-16T14:30:002020-12-172021-07-14 1057350735 Chalhoub, Fadi (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571409105714092020-12-17T14:09:002021-06-292020-12-17T14:09:002021-01-05T15:58:002020-12-172021-06-29 1057350735 Chalhoub, Fadi (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571410105714102020-12-17T16:10:002021-07-072020-12-17T16:10:002021-06-09T09:50:002020-12-172021-07-07 1057350735 Chalhoub, Fadi (b)(6)AÀYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571411105714112020-12-17T16:42:002021-06-252020-12-17T16:42:002021-01-06T09:52:002020-12-172021-06-25 1057350735 Chalhoub, Fadi (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571412105714122020-12-17T16:43:002021-07-212020-12-17T16:43:002021-01-06T09:53:002020-12-172021-07-21 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571413105714132020-12-21 2020-12-21 2020-12-212020-12-21 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) NOTTRT Not Treated USAC4591001DMC4591001 1057 10571414105714142020-12-21T15:20:002021-06-082020-12-21T15:20:002021-01-12T15:40:002020-12-212021-06-08 1057350735 Chalhoub, Fadi (b)(6)AğYEARSFMULTIPLE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571415105714152020-12-21T15:22:002021-08-062020-12-21T15:22:002021-07-09T11:57:002020-12-212021-08-06 1057350735 Chalhoub, Fadi (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571416105714162020-12-21T15:30:002021-07-192020-12-21T15:30:002021-01-13T15:50:002020-12-212021-07-19 1057350735 Chalhoub, Fadi (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571417105714172020-12-21T15:38:002021-07-122020-12-21T15:38:002021-06-14T14:40:002020-12-212021-07-12 1057350735 Chalhoub, Fadi (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571418105714182020-12-22T15:27:002021-08-272020-12-22T15:27:002021-01-11T14:26:002020-12-222021-08-27 1057350735 Chalhoub, Fadi (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571419105714192020-12-22T15:35:002021-05-142020-12-22T15:35:002021-01-11T11:53:002020-12-22 1057350735 Chalhoub, Fadi (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571420105714202020-12-23T11:13:002021-02-242020-12-23T11:13:002021-01-11T11:47:002020-12-232021-02-24 1057350735 Chalhoub, Fadi (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571421105714212020-12-23T14:36:002021-07-092020-12-23T14:36:002021-01-11T15:45:002020-12-232021-07-09 1057350735 Chalhoub, Fadi (b)(6)AğYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571422105714222020-12-23T15:50:002021-07-082020-12-23T15:50:002021-01-13T15:52:002020-12-232021-07-08 1057350735 Chalhoub, Fadi (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571423105714232020-12-24T09:47:002021-07-122020-12-24T09:47:002021-01-15T10:07:002020-12-242021-07-12 1057350735 Chalhoub, Fadi (b)(6)AğYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571424105714242020-12-24T09:42:002021-07-082020-12-24T09:42:002021-06-09T09:45:002020-12-242021-07-08 1057350735 Chalhoub, Fadi (b)(6)AÀYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571425105714252020-12-24T11:08:002021-07-152020-12-24T11:08:002021-01-12T14:01:002020-12-242021-07-15 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571426105714262020-12-24T11:18:002021-08-022020-12-24T11:18:002021-01-21T16:24:002020-12-242021-08-02 1057350735 Chalhoub, Fadi (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571427105714272020-12-24T11:24:002021-08-022020-12-24T11:24:002021-01-21T16:17:002020-12-242021-08-02 1057350735 Chalhoub, Fadi (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571428105714282020-12-24T11:40:002021-08-022020-12-24T11:40:002021-01-21T16:24:002020-12-242021-08-02 1057350735 Chalhoub, Fadi (b)(6)AàYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571429105714292020-12-24T11:44:002021-08-022020-12-24T11:44:002021-01-21T16:15:002020-12-242021-08-02 1057350735 Chalhoub, Fadi (b)(6)AğYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571430105714302020-12-29T14:37:002021-05-142020-12-29T14:37:002021-01-18T14:05:002020-12-29 1057350735 Chalhoub, Fadi (b)(6)AÀYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571431105714312020-12-30T14:25:002021-07-192020-12-30T14:25:002021-06-21T15:21:002020-12-302021-07-19 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571432105714322020-12-30T14:39:002021-06-292020-12-30T14:39:002021-06-01T15:48:002020-12-302021-06-29 1057350735 Chalhoub, Fadi (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571433105714332020-12-30T16:28:002021-07-162020-12-30T16:28:002021-01-22T08:45:002020-12-302021-07-16 1057350735 Chalhoub, Fadi (b)(6)AÀYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571434105714342020-12-31T11:15:002021-07-272020-12-31T11:15:002021-06-29T11:51:002020-12-312021-07-27 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571435105714352021-01-04T14:34:002021-07-212021-01-04T14:34:002021-01-25T09:40:002021-01-042021-07-21 1057350735 Chalhoub, Fadi (b)(6)AÀYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571436105714362021-01-04T14:38:002021-08-172021-01-04T14:38:002021-08-17T15:49:002021-01-04 1057350735 Chalhoub, Fadi (b)(6)AàYEARSFBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571437105714372021-01-04T16:15:002021-08-102021-01-04T16:15:002021-08-10T10:54:002021-01-04 1057350735 Chalhoub, Fadi (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571438105714382021-01-04T16:26:002021-07-202021-01-04T16:26:002021-01-25T15:41:002021-01-042021-07-20 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571439105714392021-01-06T14:15:002021-07-052021-01-06T14:15:002021-06-07T14:46:002021-01-062021-07-05 1057350735 Chalhoub, Fadi (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571440105714402021-01-06T16:06:002021-07-192021-01-06T16:06:002021-01-27T14:33:002021-01-062021-07-19 1057350735 Chalhoub, Fadi (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571441105714412021-01-06T16:21:002021-07-072021-01-06T16:21:002021-06-09T16:45:002021-01-062021-07-07 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571442105714422021-01-07T11:27:002021-08-192021-01-07T11:27:002021-07-22T10:04:002021-01-072021-08-19 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571443105714432021-01-08T11:21:002021-08-112021-01-08T11:21:002021-01-28T14:38:002021-01-082021-08-11 1057350735 Chalhoub, Fadi (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571444105714442021-01-08T11:28:002021-08-112021-01-08T11:28:002021-01-28T14:49:002021-01-082021-08-11 1057350735 Chalhoub, Fadi (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571445105714452021-01-11T11:07:002021-08-032021-01-11T11:07:002021-02-01T12:01:002021-01-112021-08-03 1057350735 Chalhoub, Fadi (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571446105714462021-01-11T14:22:002021-09-012021-01-11T14:22:002021-02-01T15:57:002021-01-112021-09-01 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571447105714472021-01-11T16:34:002021-07-052021-01-11T16:34:002021-06-07T08:56:002021-01-112021-07-05 1057350735 Chalhoub, Fadi (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571448105714482021-01-11T16:43:002021-07-262021-01-11T16:43:002021-02-01T15:50:002021-01-112021-07-26 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571449105714492021-01-12T11:14:002021-07-062021-01-12T11:14:002021-06-08T15:48:002021-01-122021-07-06 1057350735 Chalhoub, Fadi (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571450105714502021-01-12T11:20:002021-08-262021-01-12T11:20:002021-02-02T13:59:002021-01-122021-08-26 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571451105714512021-01-12T14:27:002021-07-272021-01-12T14:27:002021-02-02T14:07:002021-01-122021-07-27 1057350735 Chalhoub, Fadi (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571452105714522021-01-12T14:32:002021-07-282021-01-12T14:32:002021-02-03T15:10:002021-01-122021-07-28 1057350735 Chalhoub, Fadi (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1057 10571453105714532021-01-12T16:00:002021-07-052021-01-12T16:00:002021-06-07T13:38:002021-01-122021-07-05 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1057 10571454105714542021-01-12T15:58:002021-08-022021-01-12T15:58:002021-02-03T14:45:002021-01-122021-08-02 1057350735 Chalhoub, Fadi (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661394106613942020-12-09T11:15:002021-07-152020-12-09T11:15:002021-06-15T13:31:002020-12-012021-07-15 1066270090 Butuk, David J. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661395106613952020-12-01T14:38:002021-06-152020-12-01T14:38:002020-12-21T12:40:002020-12-012021-06-15 1066270090 Butuk, David J. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661397106613972020-12-01T17:27:002021-07-072020-12-01T17:27:002021-06-09T11:52:002020-12-012021-07-07 1066270090 Butuk, David J. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661401106614012020-12-02T15:00:002021-07-082020-12-02T15:00:002021-06-07T08:34:002020-12-022021-07-08 1066270090 Butuk, David J. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661402106614022020-12-02T15:50:002021-06-172020-12-02T15:50:002020-12-21T15:50:002020-12-022021-06-17 1066270090 Butuk, David J. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661403106614032020-12-03T11:41:002021-07-072020-12-03T11:41:002021-06-09T09:27:002020-12-032021-07-07 1066270090 Butuk, David J. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661404106614042020-12-03T11:40:002021-06-162020-12-03T11:40:002020-12-23T10:42:002020-12-032021-06-16 1066270090 Butuk, David J. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661405106614052020-12-03T16:18:002021-07-052020-12-03T16:18:002021-06-07T14:37:002020-12-032021-07-05 1066270090 Butuk, David J. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661407106614072020-12-04T10:50:002021-06-172020-12-04T10:50:002020-12-22T09:10:002020-12-042021-06-17 1066270090 Butuk, David J. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661408106614082020-12-08T16:33:002021-08-022020-12-08T16:33:002020-12-28T13:50:002020-12-082021-08-02 1066270090 Butuk, David J. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661409106614092020-12-08T16:35:002021-06-222020-12-08T16:35:002020-12-28T13:51:002020-12-082021-06-22 1066270090 Butuk, David J. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661410106614102020-12-09T13:50:002021-07-082020-12-09T13:50:002021-06-08T12:21:002020-12-092021-07-08 1066270090 Butuk, David J. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661411106614112020-12-09T16:47:002021-06-232020-12-09T16:47:002020-12-29T13:41:002020-12-092021-06-23 1066270090 Butuk, David J. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661412106614122020-12-09T16:45:002021-07-202020-12-09T16:45:002021-06-09T14:11:002020-12-092021-07-20 1066270090 Butuk, David J. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661414106614142020-12-14T15:50:002021-06-282020-12-14T15:50:002021-01-04T12:04:002020-12-142021-06-28 1066270090 Butuk, David J. (b)(6)AğYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661415106614152020-12-14T15:42:002021-08-232020-12-14T15:42:002021-07-26T10:38:002020-12-142021-08-23 1066270090 Butuk, David J. (b)(6)AàYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661416106614162020-12-15T16:25:002021-07-142020-12-15T16:25:002021-06-16T09:22:002020-12-152021-07-14 1066270090 Butuk, David J. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661417106614172020-12-16T14:55:002021-08-182020-12-16T14:55:002021-01-06T15:20:002020-12-162021-08-18 1066270090 Butuk, David J. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661418106614182020-12-16T15:17:002021-07-202020-12-16T15:17:002021-06-17T09:29:002020-12-162021-07-20 1066270090 Butuk, David J. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661419106614192020-12-16T16:00:002021-07-192020-12-16T16:00:002021-01-06T13:50:002020-12-162021-07-19 1066270090 Butuk, David J. (b)(6)AàYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661420106614202020-12-17T15:28:002021-03-082020-12-17T15:28:002021-01-05T16:00:002020-12-17 1066270090 Butuk, David J. (b)(6)AğYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661421106614212020-12-22T10:35:002021-07-152020-12-22T10:35:002021-06-17T10:17:002020-12-222021-07-15 1066270090 Butuk, David J. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661422106614222020-12-22T10:37:002021-07-082020-12-22T10:37:002021-01-13T10:03:002020-12-222021-07-08 1066270090 Butuk, David J. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661423106614232020-12-30T08:20:002021-07-122020-12-30T08:20:002021-06-14T12:25:002020-12-302021-07-12 1066270090 Butuk, David J. (b)(6)AàYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661424106614242020-12-30T10:18:002021-07-282020-12-30T10:18:002021-01-20T11:36:002020-12-302021-07-28 1066270090 Butuk, David J. (b)(6)AàYEARSMNATIVE HAWAIIAN OR OTHER PACIFIC ISLANDERHISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661425106614252021-01-05T16:01:002021-07-082021-01-05T16:01:002021-06-08T10:35:002021-01-052021-07-08 1066270090 Butuk, David J. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661426106614262021-01-06T11:05:002021-07-052021-01-06T11:05:002021-06-07T09:18:002021-01-062021-07-05 1066270090 Butuk, David J. (b)(6)AğYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661427106614272021-01-06T11:06:002021-07-212021-01-06T11:06:002021-01-27T10:24:002021-01-062021-07-21 1066270090 Butuk, David J. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661428106614282021-01-06T13:00:002021-05-032021-01-06T13:00:002021-04-05T13:11:002021-01-062021-05-03 1066270090 Butuk, David J. (b)(6)AğYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661429106614292021-01-06T15:50:002021-08-162021-01-06T15:50:002021-08-16T15:33:002021-01-06 1066270090 Butuk, David J. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661430106614302021-01-07T08:00:002021-07-272021-01-07T08:00:002021-01-26T07:20:002021-01-072021-07-27 1066270090 Butuk, David J. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661431106614312021-01-07T12:05:002021-07-282021-01-07T12:05:002021-01-27T07:57:002021-01-072021-07-28 1066270090 Butuk, David J. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661432106614322021-01-07T12:20:002021-07-142021-01-07T12:20:002021-06-09T13:21:002021-01-072021-07-14 1066270090 Butuk, David J. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661433106614332021-01-07T16:00:002021-07-082021-01-07T16:00:002021-06-07T12:04:002021-01-072021-07-08 1066270090 Butuk, David J. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1066 10661434106614342021-01-12T12:25:002021-07-302021-01-12T12:25:002021-02-02T11:25:002021-01-122021-07-30 1066270090 Butuk, David J. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1066 10661435106614352021-01-12T12:24:002021-07-302021-01-12T12:24:002021-02-02T11:26:002021-01-122021-07-30 1066270090 Butuk, David J. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771274107712742020-12-03T15:02:002021-06-152020-12-03T15:02:002020-12-22T16:39:002020-12-032021-06-15 107774381 Patel, Suchet R. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771275107712752020-12-03T15:03:002021-07-072020-12-03T15:03:002021-06-07T13:48:002020-12-032021-07-07 107774381 Patel, Suchet R. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771277107712772020-12-04T09:47:002021-07-202020-12-04T09:47:002021-06-16T12:15:002020-12-042021-07-20 107774381 Patel, Suchet R. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771278107712782020-12-04T09:45:002021-06-162020-12-04T09:45:002020-12-23T10:09:002020-12-042021-06-16 107774381 Patel, Suchet R. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771279107712792020-12-14T09:13:002021-06-302020-12-14T09:13:002021-01-04T09:15:002020-12-142021-06-30 107774381 Patel, Suchet R. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771280107712802020-12-14T09:10:002021-07-162020-12-14T09:10:002021-06-18T10:59:002020-12-142021-07-16 107774381 Patel, Suchet R. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771281107712812020-12-14T09:55:002021-07-082020-12-14T09:55:002021-01-04T15:07:002020-12-142021-07-08 107774381 Patel, Suchet R. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771282107712822020-12-14T17:08:002021-05-172020-12-14T17:08:002021-01-05T16:33:002020-12-142021-05-17 107774381 Patel, Suchet R. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771283107712832020-12-15T09:18:002021-07-072020-12-15T09:18:002021-06-08T08:23:002020-12-152021-07-07 107774381 Patel, Suchet R. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771284107712842020-12-15T09:16:002021-06-282020-12-15T09:16:002021-01-06T08:07:002020-12-152021-06-28 107774381 Patel, Suchet R. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771285107712852020-12-15T09:20:002021-07-072020-12-15T09:20:002021-06-07T08:50:002020-12-152021-07-07 107774381 Patel, Suchet R. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771286107712862020-12-15T14:03:002021-07-022020-12-15T14:03:002021-01-04T11:15:002020-12-152021-07-02 107774381 Patel, Suchet R. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771287107712872020-12-15T14:25:002021-07-062020-12-15T14:25:002021-01-06T12:12:002020-12-152021-07-06 107774381 Patel, Suchet R. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771288107712882020-12-16T15:30:002021-07-122020-12-16T15:30:002021-01-06T10:47:002020-12-162021-07-12 107774381 Patel, Suchet R. (b)(6)AğYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771289107712892020-12-18T15:05:002021-05-142020-12-18T15:05:002021-01-08T14:36:002020-12-182021-05-14 107774381 Patel, Suchet R. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771290107712902020-12-18T15:06:002021-05-142020-12-18T15:06:002021-01-08T14:38:002020-12-182021-05-14 107774381 Patel, Suchet R. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771291107712912020-12-18T16:10:002021-06-302020-12-18T16:10:002021-01-06T12:29:002020-12-182021-06-30 107774381 Patel, Suchet R. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771292107712922020-12-18T16:11:002021-05-182020-12-18T16:11:002021-01-06T12:30:002020-12-182021-05-18 107774381 Patel, Suchet R. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771293107712932020-12-18 2020-12-18 2020-12-182020-12-18 107774381 Patel, Suchet R. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo NOTTRT Not Treated USAC4591001DMC4591001 1077 10771294107712942020-12-28T13:31:002021-07-162020-12-28T13:31:002021-06-18T14:10:002020-12-282021-07-16 107774381 Patel, Suchet R. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771295107712952020-12-28T14:07:002021-08-232020-12-28T14:07:002021-03-17T13:50:002020-12-28 107774381 Patel, Suchet R. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771296107712962020-12-29T12:00:002021-07-072020-12-29T12:00:002021-01-20T11:10:002020-12-292021-07-07 107774381 Patel, Suchet R. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771297107712972021-01-06T14:46:002021-07-302021-01-06T14:46:002021-01-28T15:50:002021-01-062021-07-30 107774381 Patel, Suchet R. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771298107712982021-01-07T12:20:002021-07-072021-01-07T12:20:002021-06-04T15:53:002021-01-072021-07-07 107774381 Patel, Suchet R. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1077 10771299107712992021-01-07T14:29:002021-07-212021-01-07T14:29:002021-01-27T13:42:002021-01-072021-07-21 107774381 Patel, Suchet R. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1077 10771300107713002021-01-07T16:38:002021-07-222021-01-07T16:38:002021-01-27T16:16:002021-01-072021-07-22 107774381 Patel, Suchet R. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841541108415412020-12-11T10:05:002021-08-302020-12-11T10:05:002020-12-30T15:45:002020-12-112021-08-30 1084215414 Denham, Douglas Scott (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841542108415422020-12-11T12:05:002021-07-012020-12-11T12:05:002020-12-30T15:30:002020-12-112021-07-01 1084215414 Denham, Douglas Scott (b)(6)AğYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841543108415432020-12-18T16:31:002021-07-052020-12-18T16:31:002021-06-07T15:36:002020-12-182021-07-05 1084215414 Denham, Douglas Scott (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841544108415442020-12-18T17:19:002021-06-302020-12-18T17:19:002021-01-06T16:29:002020-12-182021-06-30 1084215414 Denham, Douglas Scott (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841545108415452020-12-18T17:25:002021-07-062020-12-18T17:25:002021-06-09T09:04:002020-12-182021-07-06 1084215414 Denham, Douglas Scott (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841546108415462020-12-18T17:30:002021-06-302020-12-18T17:30:002021-01-06T16:36:002020-12-182021-06-30 1084215414 Denham, Douglas Scott (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841547108415472020-12-21T10:00:002021-07-072020-12-21T10:00:002021-06-09T11:14:002020-12-212021-07-07 1084215414 Denham, Douglas Scott (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841548108415482020-12-21T14:36:002021-07-092020-12-21T14:36:002021-01-13T15:55:002020-12-212021-07-09 1084215414 Denham, Douglas Scott (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841549108415492020-12-21T11:52:002021-07-122020-12-21T11:52:002021-01-11T10:34:002020-12-212021-07-12 1084215414 Denham, Douglas Scott (b)(6)AàYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841550108415502020-12-21T14:41:002021-08-252020-12-21T14:41:002021-08-25T10:13:002020-12-212021-08-25 1084215414 Denham, Douglas Scott (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841551108415512020-12-21T14:47:002021-08-022020-12-21T14:47:002021-01-13T15:38:002020-12-212021-08-02 1084215414 Denham, Douglas Scott (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841552108415522020-12-21T14:53:002021-07-132020-12-21T14:53:002021-06-11T13:21:002020-12-212021-07-13 1084215414 Denham, Douglas Scott (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841553108415532020-12-21T16:13:002021-07-072020-12-21T16:13:002021-01-11T11:06:002020-12-21 1084215414 Denham, Douglas Scott (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841555108415552020-12-21T16:30:002021-08-202020-12-21T16:30:002021-08-20T10:28:002020-12-21 1084215414 Denham, Douglas Scott (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841556108415562020-12-28T11:10:002021-07-192020-12-28T11:10:002021-01-18T09:12:002020-12-282021-07-19 1084215414 Denham, Douglas Scott (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841557108415572020-12-28T10:31:002021-05-132020-12-28T10:31:002021-01-18T09:21:002020-12-282021-05-13 1084215414 Denham, Douglas Scott (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841558108415582020-12-28T13:14:002021-07-122020-12-28T13:14:002021-01-18T10:11:002020-12-282021-07-12 1084215414 Denham, Douglas Scott (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841559108415592020-12-28T13:43:002021-07-122020-12-28T13:43:002021-01-18T10:02:002020-12-282021-07-12 1084215414 Denham, Douglas Scott (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841560108415602020-12-28T12:50:002021-07-192020-12-28T12:50:002021-06-21T11:26:002020-12-282021-07-19 1084215414 Denham, Douglas Scott (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841561108415612020-12-28T13:52:002021-07-052020-12-28T13:52:002021-06-07T14:09:002020-12-282021-07-05 1084215414 Denham, Douglas Scott (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841562108415622020-12-28T16:00:002021-07-122020-12-28T16:00:002021-01-18T10:50:002020-12-282021-07-12 1084215414 Denham, Douglas Scott (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841563108415632020-12-30T11:06:002021-07-122020-12-30T11:06:002021-01-18T11:23:002020-12-302021-07-12 1084215414 Denham, Douglas Scott (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841564108415642020-12-30T11:09:002021-08-052020-12-30T11:09:002021-06-11T14:37:002020-12-302021-08-05 1084215414 Denham, Douglas Scott (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841565108415652020-12-30T12:11:002021-07-072020-12-30T12:11:002021-06-11T14:40:002020-12-302021-07-07 1084215414 Denham, Douglas Scott (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841566108415662020-12-30T13:41:002021-07-262020-12-30T13:41:002021-01-18T10:42:002020-12-302021-07-26 1084215414 Denham, Douglas Scott (b)(6)AğYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841567108415672020-12-30T14:19:002021-07-122020-12-30T14:19:002021-01-18T15:36:002020-12-302021-07-12 1084215414 Denham, Douglas Scott (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841568108415682020-12-30T15:21:002021-06-152020-12-30T15:21:002021-01-18T10:54:002020-12-302021-06-15 1084215414 Denham, Douglas Scott (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841569108415692020-12-30T16:33:002021-07-072020-12-30T16:33:002021-06-11T11:05:002020-12-302021-07-07 1084215414 Denham, Douglas Scott (b)(6)AàYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841570108415702020-12-30T16:36:002021-07-072020-12-30T16:36:002021-06-11T11:07:002020-12-302021-07-07 1084215414 Denham, Douglas Scott (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841571108415712020-12-30T16:43:002021-09-012020-12-30T16:43:002021-08-04T17:30:002020-12-302021-09-01 1084215414 Denham, Douglas Scott (b)(6)AğYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841572108415722021-01-04T10:12:002021-07-162021-01-04T10:12:002021-06-18T14:35:002021-01-04 1084215414 Denham, Douglas Scott (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841573108415732021-01-04T16:30:002021-07-282021-01-04T16:30:002021-01-27T15:42:002021-01-042021-07-28 1084215414 Denham, Douglas Scott (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841574108415742021-01-04T16:38:002021-07-282021-01-04T16:38:002021-01-27T15:31:002021-01-042021-07-28 1084215414 Denham, Douglas Scott (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841575108415752021-01-04T16:57:002021-06-302021-01-04T16:57:002021-05-07T16:21:002021-01-04 1084215414 Denham, Douglas Scott (b)(6)AğYEARSMASIAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841576108415762021-01-06T09:58:002021-07-192021-01-06T09:58:002021-01-25T09:09:002021-01-062021-07-19 1084215414 Denham, Douglas Scott (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841577108415772021-01-06T12:51:002021-07-072021-01-06T12:51:002021-06-09T10:17:002021-01-062021-07-07 1084215414 Denham, Douglas Scott (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841578108415782021-01-06T12:53:002021-07-282021-01-06T12:53:002021-01-27T16:08:002021-01-062021-07-28 1084215414 Denham, Douglas Scott (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841579108415792021-01-06T14:17:002021-05-242021-01-06T14:17:002021-01-27T17:05:002021-01-062021-05-24 1084215414 Denham, Douglas Scott (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841580108415802021-01-06T14:20:002021-07-232021-01-06T14:20:002021-01-27T17:16:002021-01-062021-07-23 1084215414 Denham, Douglas Scott (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841581108415812021-01-06T15:40:002021-08-042021-01-06T15:40:002021-06-07T15:58:002021-01-062021-08-04 1084215414 Denham, Douglas Scott (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841582108415822021-01-06T15:54:002021-07-262021-01-06T15:54:002021-01-27T17:26:002021-01-062021-07-26 1084215414 Denham, Douglas Scott (b)(6)AÀYEARSMASIAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841583108415832021-01-08T10:47:002021-08-042021-01-08T10:47:002021-01-27T16:46:002021-01-082021-08-04 1084215414 Denham, Douglas Scott (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841584108415842021-01-08T11:20:002021-07-262021-01-08T11:20:002021-01-29T14:20:002021-01-082021-07-26 1084215414 Denham, Douglas Scott (b)(6)AàYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841586108415862021-01-08T12:16:002021-07-072021-01-08T12:16:002021-06-11T09:07:002021-01-082021-07-07 1084215414 Denham, Douglas Scott (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841587108415872021-01-08T13:01:002021-07-072021-01-08T13:01:002021-06-09T10:13:002021-01-082021-07-07 1084215414 Denham, Douglas Scott (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841588108415882021-01-08T13:42:002021-07-072021-01-08T13:42:002021-06-11T10:43:002021-01-082021-07-07 1084215414 Denham, Douglas Scott (b)(6)AàYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841589108415892021-01-08T13:24:002021-07-232021-01-08T13:24:002021-01-29T11:14:002021-01-08 1084215414 Denham, Douglas Scott (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841590108415902021-01-08T14:59:002021-07-072021-01-08T14:59:002021-06-07T09:55:002021-01-082021-07-07 1084215414 Denham, Douglas Scott (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841591108415912021-01-08T14:56:002021-07-232021-01-08T14:56:002021-01-29T10:01:002021-01-082021-07-23 1084215414 Denham, Douglas Scott (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841592108415922021-01-08T14:29:002021-07-302021-01-08T14:29:002021-01-27T11:14:002021-01-082021-07-30 1084215414 Denham, Douglas Scott (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841593108415932021-01-08T15:29:002021-07-232021-01-08T15:29:002021-01-29T11:49:002021-01-082021-07-23 1084215414 Denham, Douglas Scott (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841594108415942021-01-08T16:21:002021-07-302021-01-08T16:21:002021-01-29T12:03:002021-01-082021-07-30 1084215414 Denham, Douglas Scott (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1084 10841595108415952021-01-08T16:29:002021-07-052021-01-08T16:29:002021-06-07T14:52:002021-01-082021-07-05 1084215414 Denham, Douglas Scott (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841596108415962021-01-08T16:35:002021-07-062021-01-08T16:35:002021-06-07T09:48:002021-01-082021-07-06 1084215414 Denham, Douglas Scott (b)(6)AàYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1084 10841597108415972021-01-08T16:42:002021-06-292021-01-08T16:42:002021-05-28T15:36:002021-01-082021-06-29 1084215414 Denham, Douglas Scott (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911394109113942020-12-02T13:29:002021-06-172020-12-02T13:29:002020-12-21T12:44:002020-12-022021-06-17 1091110670 Arora, Samir (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911395109113952020-12-02T13:27:002021-06-172020-12-02T13:27:002020-12-21T12:46:002020-12-02 1091110670 Arora, Samir (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911396109113962020-12-02T16:14:002021-07-012020-12-02T16:14:002021-06-01T11:02:002020-12-022021-07-01 1091110670 Arora, Samir (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911399109113992020-12-04T10:55:002021-07-212020-12-04T10:55:002021-01-07T16:30:002020-12-042021-07-21 1091110670 Arora, Samir (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911400109114002020-12-04T11:26:002021-08-242020-12-04T11:26:002021-07-06T15:27:002020-12-042021-08-24 1091110670 Arora, Samir (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911402109114022020-12-07T10:08:002021-06-302020-12-07T10:08:002020-12-29T10:40:002020-12-072021-06-30 1091110670 Arora, Samir (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911403109114032020-12-07T11:39:002021-06-222020-12-07T11:39:002020-12-29T09:07:002020-12-072021-06-22 1091110670 Arora, Samir (b)(6)AğYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911404109114042020-12-07T13:39:002021-07-142020-12-07T13:39:002020-12-28T11:59:002020-12-072021-07-14 1091110670 Arora, Samir (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911405109114052020-12-07T15:54:002021-07-212020-12-07T15:54:002021-06-16T12:17:002020-12-072021-07-21 1091110670 Arora, Samir (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911406109114062020-12-07T16:37:002021-06-152020-12-07T16:37:002020-12-28T11:33:002020-12-072021-06-15 1091110670 Arora, Samir (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911407109114072020-12-08T15:53:002021-08-312020-12-08T15:53:002021-08-03T12:48:002020-12-082021-08-31 1091110670 Arora, Samir (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911408109114082020-12-08T15:55:002021-06-282020-12-08T15:55:002020-12-30T13:58:002020-12-082021-06-28 1091110670 Arora, Samir (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911409109114092020-12-09T10:43:002021-05-262020-12-09T10:43:002020-12-28T09:36:002020-12-092021-05-26 1091110670 Arora, Samir (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911410109114102020-12-09T11:54:002021-06-242020-12-09T11:54:002020-12-28T11:29:002020-12-092021-06-24 1091110670 Arora, Samir (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911411109114112020-12-09T11:58:002021-08-032020-12-09T11:58:002021-06-24T11:17:002020-12-092021-08-03 1091110670 Arora, Samir (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911412109114122020-12-09T16:17:002021-06-232020-12-09T16:17:002020-12-30T15:47:002020-12-092021-06-23 1091110670 Arora, Samir (b)(6)AğYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911413109114132020-12-09T16:13:002021-07-012020-12-09T16:13:002021-01-07T13:20:002020-12-092021-07-01 1091110670 Arora, Samir (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911414109114142020-12-09T16:15:002021-07-012020-12-09T16:15:002021-05-25T17:25:002020-12-092021-07-01 1091110670 Arora, Samir (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911415109114152020-12-10T11:03:002021-07-222020-12-10T11:03:002021-06-22T15:40:002020-12-102021-07-22 1091110670 Arora, Samir (b)(6)AğYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911416109114162020-12-10T12:48:002021-07-072020-12-10T12:48:002020-12-30T15:00:002020-12-102021-07-07 1091110670 Arora, Samir (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911417109114172020-12-10T12:49:002021-08-042020-12-10T12:49:002021-06-09T13:56:002020-12-102021-08-04 1091110670 Arora, Samir (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911418109114182020-12-10T12:08:002021-08-172020-12-10T12:08:002021-06-07T12:14:002020-12-102021-08-17 1091110670 Arora, Samir (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911419109114192020-12-10T15:49:002021-06-232020-12-10T15:49:002020-12-30T12:34:002020-12-102021-06-23 1091110670 Arora, Samir (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911420109114202020-12-10T15:45:002021-06-282020-12-10T15:45:002020-12-30T16:33:002020-12-102021-06-28 1091110670 Arora, Samir (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911421109114212020-12-10T15:46:002021-07-062020-12-10T15:46:002021-06-08T16:20:002020-12-102021-07-06 1091110670 Arora, Samir (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911422109114222020-12-14T10:31:002021-07-062020-12-14T10:31:002021-01-06T08:38:002020-12-142021-07-06 1091110670 Arora, Samir (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911423109114232020-12-14T10:32:002021-08-232020-12-14T10:32:002021-07-21T15:42:002020-12-142021-08-23 1091110670 Arora, Samir (b)(6)AàYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911424109114242020-12-15T11:29:002021-07-072020-12-15T11:29:002021-06-07T08:17:002020-12-152021-07-07 1091110670 Arora, Samir (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911425109114252020-12-15T12:35:002021-07-122020-12-15T12:35:002021-06-14T11:13:002020-12-152021-07-12 1091110670 Arora, Samir (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911426109114262020-12-16T13:28:002021-07-012020-12-16T13:28:002021-01-07T14:10:002020-12-162021-07-01 1091110670 Arora, Samir (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911427109114272020-12-16T14:39:002021-07-092020-12-16T14:39:002021-01-06T11:51:002020-12-162021-07-09 1091110670 Arora, Samir (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911428109114282020-12-16T14:41:002021-06-302020-12-16T14:41:002021-01-06T11:49:002020-12-162021-06-30 1091110670 Arora, Samir (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911429109114292020-12-16T15:26:002021-05-272020-12-16T15:26:002021-04-27T16:31:002020-12-162021-05-27 1091110670 Arora, Samir (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911430109114302020-12-16T15:59:002021-07-072020-12-16T15:59:002021-06-07T09:29:002020-12-162021-07-07 1091110670 Arora, Samir (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911431109114312020-12-17T10:29:002021-07-012020-12-17T10:29:002021-01-12T08:04:002020-12-172021-07-01 1091110670 Arora, Samir (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911432109114322020-12-17T10:27:002021-06-212020-12-17T10:27:002021-01-06T14:13:002020-12-172021-06-21 1091110670 Arora, Samir (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911433109114332020-12-17T15:30:002021-05-252020-12-17T15:30:002021-01-07T16:33:002020-12-172021-05-25 1091110670 Arora, Samir (b)(6)AàYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911434109114342020-12-17T15:28:002021-07-122020-12-17T15:28:002021-06-10T10:16:002020-12-172021-07-12 1091110670 Arora, Samir (b)(6)AàYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911435109114352020-12-17T16:50:002021-07-012020-12-17T16:50:002021-01-07T16:43:002020-12-172021-07-01 1091110670 Arora, Samir (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911436109114362020-12-17T16:53:002021-06-302020-12-17T16:53:002021-01-06T09:41:002020-12-172021-06-30 1091110670 Arora, Samir (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911437109114372020-12-17T16:54:002021-07-142020-12-17T16:54:002021-06-15T16:09:002020-12-17 1091110670 Arora, Samir (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911438109114382020-12-18T10:42:002021-07-062020-12-18T10:42:002021-01-08T09:22:002020-12-182021-07-06 1091110670 Arora, Samir (b)(6)AÀYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911439109114392020-12-18T10:44:002021-07-212020-12-18T10:44:002021-06-23T14:33:002020-12-182021-07-21 1091110670 Arora, Samir (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911440109114402020-12-18T11:05:002021-07-062020-12-18T11:05:002021-01-08T09:35:002020-12-182021-07-06 1091110670 Arora, Samir (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911441109114412020-12-18T11:08:002021-06-082020-12-18T11:08:002021-06-08T08:47:002020-12-182021-06-08 1091110670 Arora, Samir (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911442109114422020-12-18T11:10:002021-06-082020-12-18T11:10:002021-06-08T08:49:002020-12-182021-06-08 1091110670 Arora, Samir (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911443109114432020-12-21T15:14:002021-08-122020-12-21T15:14:002021-01-15T09:05:002020-12-212021-08-12 1091110670 Arora, Samir (b)(6)AÀYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911444109114442020-12-21T14:51:002021-07-122020-12-21T14:51:002021-01-11T10:20:002020-12-212021-07-12 1091110670 Arora, Samir (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911445109114452020-12-21T15:16:002021-07-122020-12-21T15:16:002021-06-14T15:11:002020-12-212021-07-12 1091110670 Arora, Samir (b)(6)AĞYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911446109114462020-12-22T09:38:002021-08-312020-12-22T09:38:002021-01-13T08:36:002020-12-222021-08-31 1091110670 Arora, Samir (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911447109114472020-12-22T10:41:002021-07-082020-12-22T10:41:002021-01-14T11:25:002020-12-222021-07-08 1091110670 Arora, Samir (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911448109114482020-12-22T10:42:002021-07-062020-12-22T10:42:002021-06-07T08:13:002020-12-222021-07-06 1091110670 Arora, Samir (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911449109114492020-12-22T11:29:002021-05-142020-12-22T11:29:002021-01-11T14:11:002020-12-222021-05-14 1091110670 Arora, Samir (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911450109114502020-12-22T15:22:002021-07-072020-12-22T15:22:002021-06-09T09:10:002020-12-222021-07-07 1091110670 Arora, Samir (b)(6)AĞYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911451109114512020-12-22 2021-01-04 2020-12-222021-01-04 1091110670 Arora, Samir (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) NOTTRT Not Treated USAC4591001DMC4591001 1091 10911452109114522020-12-22T16:41:002021-07-122020-12-22T16:41:002021-06-14T12:23:002020-12-222021-07-12 1091110670 Arora, Samir (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911453109114532020-12-22T16:13:002021-07-132020-12-22T16:13:002021-01-12T10:18:002020-12-222021-07-13 1091110670 Arora, Samir (b)(6)AğYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911454109114542020-12-28T15:55:002021-07-212020-12-28T15:55:002021-01-18T11:05:002020-12-282021-07-21 1091110670 Arora, Samir (b)(6)AàYEARSMMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911455109114552020-12-29T10:38:002021-07-262020-12-29T10:38:002021-01-19T09:13:002020-12-292021-07-26 1091110670 Arora, Samir (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911456109114562020-12-29T16:52:002021-07-152020-12-29T16:52:002021-01-18T14:35:002020-12-292021-07-15 1091110670 Arora, Samir (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911457109114572020-12-29T16:53:002021-07-152020-12-29T16:53:002021-01-18T14:37:002020-12-292021-07-15 1091110670 Arora, Samir (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911458109114582020-12-29T16:48:002021-07-132020-12-29T16:48:002021-01-19T12:13:002020-12-292021-07-13 1091110670 Arora, Samir (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911459109114592020-12-29T16:49:002021-07-132020-12-29T16:49:002021-06-10T10:28:002020-12-292021-07-13 1091110670 Arora, Samir (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911460109114602020-12-30T12:15:002021-07-132020-12-30T12:15:002021-01-19T14:17:002020-12-302021-07-13 1091110670 Arora, Samir (b)(6)AĞYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911461109114612020-12-30T12:16:002021-07-132020-12-30T12:16:002021-01-19T14:19:002020-12-302021-07-13 1091110670 Arora, Samir (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911462109114622021-01-04T11:30:002021-07-272021-01-04T11:30:002021-01-27T11:18:002021-01-042021-07-27 1091110670 Arora, Samir (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911463109114632021-01-04T16:35:002021-07-072021-01-04T16:35:002021-06-07T09:27:002021-01-042021-07-07 1091110670 Arora, Samir (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1091 10911464109114642021-01-04T16:37:002021-07-292021-01-04T16:37:002021-01-27T15:41:002021-01-042021-07-29 1091110670 Arora, Samir (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911465109114652021-01-05T11:32:002021-08-022021-01-05T11:32:002021-01-27T10:25:002021-01-052021-08-02 1091110670 Arora, Samir (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1091 10911466109114662021-01-11T15:19:002021-07-202021-01-11T15:19:002021-06-07T15:38:002021-01-112021-07-20 1091110670 Arora, Samir (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231422112314222020-12-01T09:44:002021-06-092020-12-01T09:44:002020-12-21T09:44:002020-12-012021-06-09 1123113680 Essink, Brandon James (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231425112314252020-12-02T09:38:002021-06-282020-12-02T09:38:002020-12-21T09:17:002020-12-022021-06-28 1123113680 Essink, Brandon James (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231428112314282020-12-03T15:10:002021-06-152020-12-03T15:10:002020-12-22T09:19:002020-12-032021-06-15 1123113680 Essink, Brandon James (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231431112314312020-12-04T09:41:002021-07-072020-12-04T09:41:002021-06-07T10:04:002020-12-042021-07-07 1123113680 Essink, Brandon James (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231432112314322020-12-04T09:39:002021-06-182020-12-04T09:39:002020-12-23T12:00:002020-12-042021-06-18 1123113680 Essink, Brandon James (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231434112314342020-12-07T10:15:002021-05-132020-12-07T10:15:002020-12-28T09:18:002020-12-072021-05-13 1123113680 Essink, Brandon James (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231438112314382020-12-08T10:33:002021-06-152020-12-08T10:33:002021-01-06T10:08:002020-12-082021-06-15 1123113680 Essink, Brandon James (b)(6)AàYEARSFAMERICAN INDIAN OR ALASKA NATIVE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231439112314392020-12-08T10:31:002021-07-072020-12-08T10:31:002021-01-06T10:23:002020-12-082021-07-07 1123113680 Essink, Brandon James (b)(6)AÀYEARSFAMERICAN INDIAN OR ALASKA NATIVE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231440112314402020-12-09T09:38:002021-06-282020-12-09T09:38:002020-12-28T09:16:002020-12-092021-06-28 1123113680 Essink, Brandon James (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231441112314412020-12-09T11:58:002021-05-102020-12-09T11:58:002021-01-04T14:12:002020-12-092021-05-10 1123113680 Essink, Brandon James (b)(6)AàYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231442112314422020-12-09T12:33:002021-07-232020-12-09T12:33:002021-06-22T13:52:002020-12-092021-07-23 1123113680 Essink, Brandon James (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231443112314432020-12-09T12:31:002021-07-062020-12-09T12:31:002021-01-04T13:51:002020-12-092021-07-06 1123113680 Essink, Brandon James (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231445112314452020-12-09T14:35:002021-06-102020-12-09T14:35:002020-12-30T15:30:002020-12-092021-06-10 1123113680 Essink, Brandon James (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231446112314462020-12-09T14:55:002021-06-302020-12-09T14:55:002020-12-30T15:32:002020-12-092021-06-30 1123113680 Essink, Brandon James (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231447112314472020-12-10T15:13:002021-06-302020-12-10T15:13:002020-12-29T10:43:002020-12-102021-06-30 1123113680 Essink, Brandon James (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231448112314482020-12-11T09:05:002021-04-202020-12-11T09:05:002020-12-30T09:24:002020-12-112021-04-20 1123113680 Essink, Brandon James (b)(6)AĞYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231449112314492020-12-11T10:14:002021-08-272020-12-11T10:14:002020-12-30T16:23:002020-12-112021-08-27 1123113680 Essink, Brandon James (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231450112314502020-12-11T10:43:002021-07-142020-12-11T10:43:002021-06-16T09:21:002020-12-112021-07-14 1123113680 Essink, Brandon James (b)(6)AğYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231451112314512020-12-15T09:45:002021-06-282020-12-15T09:45:002021-01-04T16:17:002020-12-152021-06-28 1123113680 Essink, Brandon James (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231452112314522020-12-15T14:58:002021-06-302020-12-15T14:58:002021-05-26T14:08:002020-12-152021-06-30 1123113680 Essink, Brandon James (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231453112314532020-12-15T15:13:002021-07-132020-12-15T15:13:002021-01-07T15:26:002020-12-152021-07-13 1123113680 Essink, Brandon James (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231454112314542020-12-15T15:15:002021-04-122020-12-15T15:15:002021-03-15T14:48:002020-12-15 1123113680 Essink, Brandon James (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231455112314552020-12-15T17:09:002021-06-292020-12-15T17:09:002021-01-04T16:50:002020-12-152021-06-29 1123113680 Essink, Brandon James (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231456112314562020-12-16T09:53:002021-07-062020-12-16T09:53:002021-06-08T09:02:002020-12-162021-07-06 1123113680 Essink, Brandon James (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231457112314572020-12-16T12:56:002021-07-022020-12-16T12:56:002021-06-04T09:49:002020-12-162021-07-02 1123113680 Essink, Brandon James (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231458112314582020-12-16T14:41:002021-08-112020-12-16T14:41:002021-01-04T16:01:002020-12-16 1123113680 Essink, Brandon James (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231459112314592020-12-16T15:43:002021-07-122020-12-16T15:43:002021-01-04T15:01:002020-12-162021-07-12 1123113680 Essink, Brandon James (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231460112314602020-12-17T12:41:002021-04-082020-12-17T12:41:002021-03-10T15:41:002020-12-17 1123113680 Essink, Brandon James (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231461112314612020-12-17T12:59:002021-06-292020-12-17T12:59:002021-01-05T09:31:002020-12-17 1123113680 Essink, Brandon James (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231462112314622020-12-17T15:18:002021-07-022020-12-17T15:18:002021-01-08T15:26:002020-12-172021-07-02 1123113680 Essink, Brandon James (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231463112314632020-12-18T12:52:002021-07-162020-12-18T12:52:002021-06-17T11:36:002020-12-182021-07-16 1123113680 Essink, Brandon James (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231465112314652020-12-18T14:38:002021-07-072020-12-18T14:38:002021-06-09T14:05:002020-12-182021-07-07 1123113680 Essink, Brandon James (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231466112314662020-12-18T15:24:002021-06-302020-12-18T15:24:002021-01-06T14:38:002020-12-182021-06-30 1123113680 Essink, Brandon James (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231467112314672020-12-21T09:18:002021-06-302020-12-21T09:18:002021-06-02T09:10:002020-12-212021-06-30 1123113680 Essink, Brandon James (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231468112314682020-12-21T09:21:002021-08-132020-12-21T09:21:002021-06-23T09:56:002020-12-212021-08-13 1123113680 Essink, Brandon James (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231469112314692020-12-21T11:29:002021-07-162020-12-21T11:29:002021-01-12T10:25:002020-12-212021-07-16 1123113680 Essink, Brandon James (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231470112314702020-12-21T12:14:002021-07-152020-12-21T12:14:002021-06-15T10:55:002020-12-212021-07-15 1123113680 Essink, Brandon James (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231472112314722020-12-21T12:49:002021-07-062020-12-21T12:49:002021-01-12T09:28:002020-12-212021-07-06 1123113680 Essink, Brandon James (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231473112314732020-12-21T12:53:002021-07-062020-12-21T12:53:002021-06-08T12:06:002020-12-212021-07-06 1123113680 Essink, Brandon James (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231474112314742020-12-21T15:03:002021-07-182020-12-21T15:03:002021-01-11T08:54:002020-12-212021-07-18 1123113680 Essink, Brandon James (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231475112314752020-12-21T15:01:002021-07-182020-12-21T15:01:002021-01-11T08:52:002020-12-212021-07-18 1123113680 Essink, Brandon James (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231476112314762020-12-21T15:35:002021-06-302020-12-21T15:35:002021-06-02T12:10:002020-12-212021-06-30 1123113680 Essink, Brandon James (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231477112314772020-12-21T16:33:002021-07-192020-12-21T16:33:002021-01-11T11:02:002020-12-212021-07-19 1123113680 Essink, Brandon James (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231478112314782020-12-21T16:35:002021-06-092020-12-21T16:35:002021-01-11T11:01:002020-12-212021-06-09 1123113680 Essink, Brandon James (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231479112314792020-12-21T15:58:002021-05-142020-12-21T15:58:002021-01-11T14:45:002020-12-212021-05-14 1123113680 Essink, Brandon James (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231481112314812020-12-21T17:02:002021-08-032020-12-21T17:02:002021-01-12T12:30:002020-12-212021-08-03 1123113680 Essink, Brandon James (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231482112314822020-12-22T09:20:002021-07-092020-12-22T09:20:002021-01-11T15:14:002020-12-222021-07-09 1123113680 Essink, Brandon James (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231483112314832020-12-22T09:54:002021-06-102020-12-22T09:54:002021-01-11T09:41:002020-12-222021-06-10 1123113680 Essink, Brandon James (b)(6)AÀYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231484112314842020-12-22T10:18:002021-07-162020-12-22T10:18:002021-01-12T09:35:002020-12-222021-07-16 1123113680 Essink, Brandon James (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231485112314852020-12-22T11:19:002021-07-232020-12-22T11:19:002021-06-23T15:19:002020-12-222021-07-23 1123113680 Essink, Brandon James (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231486112314862020-12-22T11:43:002021-07-212020-12-22T11:43:002021-01-11T14:05:002020-12-222021-07-21 1123113680 Essink, Brandon James (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231487112314872020-12-22T11:22:002021-07-152020-12-22T11:22:002021-06-15T15:10:002020-12-222021-07-15 1123113680 Essink, Brandon James (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231488112314882020-12-22T14:48:002021-07-122020-12-22T14:48:002021-01-13T11:35:002020-12-222021-07-12 1123113680 Essink, Brandon James (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231489112314892020-12-22T15:22:002021-07-252020-12-22T15:22:002021-01-11T12:14:002020-12-222021-07-25 1123113680 Essink, Brandon James (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231491112314912020-12-22T16:02:002021-06-092020-12-22T16:02:002021-01-11T11:46:002020-12-222021-06-09 1123113680 Essink, Brandon James (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231492112314922020-12-23T10:13:002021-07-072020-12-23T10:13:002021-06-07T13:41:002020-12-23 1123113680 Essink, Brandon James (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231493112314932020-12-23T10:51:002021-07-142020-12-23T10:51:002021-01-15T14:23:002020-12-232021-07-14 1123113680 Essink, Brandon James (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231494112314942020-12-23T11:28:002021-07-122020-12-23T11:28:002021-01-14T15:36:002020-12-232021-07-12 1123113680 Essink, Brandon James (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231495112314952020-12-23T12:04:002021-07-152020-12-23T12:04:002021-01-13T14:37:002020-12-232021-07-15 1123113680 Essink, Brandon James (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231496112314962020-12-23T12:03:002021-07-142020-12-23T12:03:002021-06-16T10:46:002020-12-23 1123113680 Essink, Brandon James (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231497112314972020-12-23T12:53:002021-07-202020-12-23T12:53:002021-06-18T14:11:002020-12-232021-07-20 1123113680 Essink, Brandon James (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231499112314992020-12-28T10:13:002021-06-302020-12-28T10:13:002021-06-02T09:50:002020-12-282021-06-30 1123113680 Essink, Brandon James (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231500112315002020-12-28T10:39:002021-06-152020-12-28T10:39:002021-01-18T10:00:002020-12-282021-06-15 1123113680 Essink, Brandon James (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231501112315012020-12-28T12:31:002021-07-092020-12-28T12:31:002021-06-11T13:42:002020-12-282021-07-09 1123113680 Essink, Brandon James (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231502112315022020-12-28T12:33:002021-07-132020-12-28T12:33:002021-01-19T16:22:002020-12-282021-07-13 1123113680 Essink, Brandon James (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231503112315032020-12-28T12:20:002021-07-082020-12-28T12:20:002021-06-09T14:07:002020-12-282021-07-08 1123113680 Essink, Brandon James (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231504112315042020-12-28T15:30:002021-07-192020-12-28T15:30:002021-01-18T09:35:002020-12-282021-07-19 1123113680 Essink, Brandon James (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231505112315052020-12-28T15:31:002021-07-202020-12-28T15:31:002021-06-22T10:31:002020-12-282021-07-20 1123113680 Essink, Brandon James (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231506112315062020-12-28T16:01:002021-08-312020-12-28T16:01:002021-01-18T11:20:002020-12-282021-08-31 1123113680 Essink, Brandon James (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231507112315072020-12-28T16:52:002021-05-262020-12-28T16:52:002021-01-18T11:50:002020-12-282021-05-26 1123113680 Essink, Brandon James (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231508112315082020-12-28T16:53:002021-07-142020-12-28T16:53:002021-01-20T09:22:002020-12-282021-07-14 1123113680 Essink, Brandon James (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231509112315092020-12-29T12:04:002021-07-152020-12-29T12:04:002021-06-17T14:56:002020-12-292021-07-15 1123113680 Essink, Brandon James (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231510112315102020-12-29T12:42:002021-07-152020-12-29T12:42:002021-06-15T11:52:002020-12-29 1123113680 Essink, Brandon James (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231511112315112020-12-30T10:16:002021-05-102020-12-30T10:16:002021-01-19T15:38:002020-12-302021-05-10 1123113680 Essink, Brandon James (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231512112315122020-12-30T10:17:002021-05-102020-12-30T10:17:002021-01-19T15:39:002020-12-302021-05-10 1123113680 Essink, Brandon James (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231513112315132020-12-30T10:40:002021-07-282020-12-30T10:40:002021-06-30T10:09:002020-12-302021-07-28 1123113680 Essink, Brandon James (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231514112315142020-12-30T14:10:002021-07-152020-12-30T14:10:002021-06-15T10:54:002020-12-302021-07-15 1123113680 Essink, Brandon James (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231515112315152020-12-30T15:53:002021-05-282020-12-30T15:53:002021-01-18T14:03:002020-12-302021-05-28 1123113680 Essink, Brandon James (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231516112315162020-12-30T16:18:002021-08-122020-12-30T16:18:002021-07-08T16:05:002020-12-302021-08-12 1123113680 Essink, Brandon James (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231517112315172020-12-30T15:35:002021-07-142020-12-30T15:35:002021-01-18T12:50:002020-12-302021-07-14 1123113680 Essink, Brandon James (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231518112315182020-12-30T16:17:002021-07-142020-12-30T16:17:002021-01-20T14:52:002020-12-302021-07-14 1123113680 Essink, Brandon James (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231519112315192020-12-30T16:57:002021-07-142020-12-30T16:57:002021-01-20T11:15:002020-12-302021-07-14 1123113680 Essink, Brandon James (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231520112315202020-12-30T17:14:002021-07-122020-12-30T17:14:002021-06-11T09:46:002020-12-302021-07-12 1123113680 Essink, Brandon James (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231521112315212020-12-30T17:14:002021-07-122020-12-30T17:14:002021-01-18T12:47:002020-12-302021-07-12 1123113680 Essink, Brandon James (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231522112315222021-01-05T13:59:002021-07-072021-01-05T13:59:002021-06-08T13:38:002021-01-052021-07-07 1123113680 Essink, Brandon James (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231523112315232021-01-05T13:59:002021-07-072021-01-05T13:59:002021-06-08T13:39:002021-01-052021-07-07 1123113680 Essink, Brandon James (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1123 11231524112315242021-01-05T15:44:002021-07-222021-01-05T15:44:002021-01-28T16:12:002021-01-052021-07-22 1123113680 Essink, Brandon James (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231525112315252021-01-07T16:34:002021-07-282021-01-07T16:34:002021-01-29T15:31:002021-01-072021-07-28 1123113680 Essink, Brandon James (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1123 11231526112315262021-01-08T09:33:002021-06-302021-01-08T09:33:002021-05-25T15:52:002021-01-082021-06-30 1123113680 Essink, Brandon James (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241236112412362020-12-14T11:17:002021-06-012020-12-14T11:17:002021-01-04T10:50:002020-12-142021-06-01 112428769 Fried, David L. (b)(6)AĞYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241238112412382020-12-14T15:16:002021-06-302020-12-14T15:16:002021-01-06T15:48:002020-12-142021-06-30 112428769 Fried, David L. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241239112412392020-12-14T15:21:002021-06-302020-12-14T15:21:002021-01-06T16:21:002020-12-142021-06-30 112428769 Fried, David L. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241240112412402020-12-14T15:58:002021-07-142020-12-14T15:58:002021-06-09T16:07:002020-12-142021-07-14 112428769 Fried, David L. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241241112412412020-12-14T15:57:002021-07-142020-12-14T15:57:002021-06-09T16:09:002020-12-142021-07-14 112428769 Fried, David L. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241242112412422020-12-14T17:03:002021-06-212020-12-14T17:03:002021-01-05T14:49:002020-12-142021-06-21 112428769 Fried, David L. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241243112412432020-12-15T13:39:002021-06-292020-12-15T13:39:002021-01-05T16:39:002020-12-152021-06-29 112428769 Fried, David L. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241244112412442020-12-15T14:29:002021-06-292020-12-15T14:29:002021-01-05T14:00:002020-12-152021-06-29 112428769 Fried, David L. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241245112412452020-12-15T17:12:002021-07-142020-12-15T17:12:002021-01-06T17:54:002020-12-152021-07-14 112428769 Fried, David L. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241246112412462020-12-15T17:10:002021-06-302020-12-15T17:10:002021-01-06T17:56:002020-12-152021-06-30 112428769 Fried, David L. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241247112412472020-12-16T09:40:002021-07-222020-12-16T09:40:002021-07-22T16:19:002020-12-16 112428769 Fried, David L. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241248112412482020-12-16T10:40:002021-07-082020-12-16T10:40:002021-06-09T15:41:002020-12-162021-07-08 112428769 Fried, David L. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241249112412492020-12-16T14:24:002021-07-212020-12-16T14:24:002021-01-04T16:07:002020-12-162021-07-21 112428769 Fried, David L. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241250112412502020-12-17T16:15:002021-07-062020-12-17T16:15:002021-06-07T16:18:002020-12-172021-07-06 112428769 Fried, David L. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241251112412512020-12-18T09:49:002021-07-162020-12-18T09:49:002021-01-08T11:45:002020-12-182021-07-16 112428769 Fried, David L. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241252112412522020-12-18T09:42:002021-07-082020-12-18T09:42:002021-06-08T14:07:002020-12-182021-07-08 112428769 Fried, David L. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241253112412532020-12-18T14:56:002021-07-232020-12-18T14:56:002021-01-08T11:53:002020-12-182021-07-23 112428769 Fried, David L. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241254112412542020-12-18T14:53:002021-07-302020-12-18T14:53:002021-01-08T11:51:002020-12-182021-07-30 112428769 Fried, David L. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241255112412552020-12-18T16:52:002021-07-122020-12-18T16:52:002021-06-09T15:27:002020-12-182021-07-12 112428769 Fried, David L. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241256112412562020-12-21T12:23:002021-05-212020-12-21T12:23:002021-01-13T15:50:002020-12-212021-05-21 112428769 Fried, David L. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241257112412572020-12-22T16:08:002021-07-072020-12-22T16:08:002021-06-08T16:26:002020-12-222021-07-07 112428769 Fried, David L. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241258112412582020-12-23T11:55:002021-07-062020-12-23T11:55:002021-06-08T15:45:002020-12-232021-07-06 112428769 Fried, David L. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241259112412592020-12-23T11:51:002021-07-142020-12-23T11:51:002021-01-14T16:10:002020-12-232021-07-14 112428769 Fried, David L. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241260112412602020-12-23T12:00:002021-07-092020-12-23T12:00:002021-01-13T15:56:002020-12-232021-07-09 112428769 Fried, David L. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241261112412612020-12-23T12:42:002021-06-232020-12-23T12:42:002021-01-13T15:54:002020-12-232021-06-23 112428769 Fried, David L. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241262112412622020-12-23T14:42:002021-07-092020-12-23T14:42:002021-01-11T16:40:002020-12-232021-07-09 112428769 Fried, David L. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241263112412632020-12-29T10:04:002021-07-122020-12-29T10:04:002021-06-10T15:05:002020-12-292021-07-12 112428769 Fried, David L. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241264112412642020-12-29T10:05:002021-07-122020-12-29T10:05:002021-06-10T15:05:002020-12-292021-07-12 112428769 Fried, David L. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241265112412652020-12-29T12:24:002021-07-202020-12-29T12:24:002021-01-18T09:51:002020-12-292021-07-20 112428769 Fried, David L. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241266112412662020-12-29T12:28:002021-07-192020-12-29T12:28:002021-01-18T09:49:002020-12-292021-07-19 112428769 Fried, David L. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241267112412672020-12-29T12:31:002021-07-062020-12-29T12:31:002021-06-07T16:17:002020-12-292021-07-06 112428769 Fried, David L. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241268112412682021-01-04T13:56:002021-07-062021-01-04T13:56:002021-06-08T15:29:002021-01-042021-07-06 112428769 Fried, David L. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241269112412692021-01-04T16:28:002021-07-202021-01-04T16:28:002021-01-25T15:19:002021-01-042021-07-20 112428769 Fried, David L. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241270112412702021-01-05T16:03:002021-04-132021-01-05T16:03:002021-03-16T15:20:002021-01-052021-04-13 112428769 Fried, David L. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241271112412712021-01-05T16:53:002021-07-212021-01-05T16:53:002021-01-26T16:23:002021-01-052021-07-21 112428769 Fried, David L. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241272112412722021-01-05T17:10:002021-07-132021-01-05T17:10:002021-06-09T14:58:002021-01-052021-07-13 112428769 Fried, David L. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241273112412732021-01-06T17:37:002021-07-212021-01-06T17:37:002021-01-27T16:58:002021-01-062021-07-21 112428769 Fried, David L. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1124 11241274112412742021-01-06T17:34:002021-07-142021-01-06T17:34:002021-06-09T16:59:002021-01-062021-07-14 112428769 Fried, David L. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1124 11241275112412752021-01-08T15:18:002021-08-112021-01-08T15:18:002021-01-27T16:40:002021-01-082021-08-11 112428769 Fried, David L. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1125 11251241112512412020-12-07T09:06:002021-06-252020-12-07T09:06:002020-12-30T09:29:002020-12-072021-06-25 1125399369 Harper, Charles Harold (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1125 11251242112512422020-12-07T09:29:002021-07-122020-12-07T09:29:002021-06-07T16:50:002020-12-072021-07-12 1125399369 Harper, Charles Harold (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1125 11251244112512442020-12-08T18:31:002021-08-062020-12-08T18:31:002021-07-09T18:06:002020-12-082021-08-06 1125399369 Harper, Charles Harold (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1125 11251246112512462020-12-10T10:10:002021-06-232020-12-10T10:10:002020-12-30T12:45:002020-12-102021-06-23 1125399369 Harper, Charles Harold (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1125 11251248112512482020-12-11T14:25:002021-07-012020-12-11T14:25:002020-12-30T13:35:002020-12-112021-07-01 1125399369 Harper, Charles Harold (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1125 11251249112512492020-12-11T15:05:002021-07-122020-12-11T15:05:002021-06-08T14:56:002020-12-112021-07-12 1125399369 Harper, Charles Harold (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1125 11251250112512502020-12-14T12:01:002021-06-302020-12-14T12:01:002021-01-06T16:47:002020-12-142021-06-30 1125399369 Harper, Charles Harold (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1125 11251251112512512020-12-14T12:31:002021-06-302020-12-14T12:31:002021-01-06T14:18:002020-12-142021-06-30 1125399369 Harper, Charles Harold (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1125 11251252112512522020-12-16T14:46:002021-07-082020-12-16T14:46:002021-01-13T08:40:002020-12-162021-07-08 1125399369 Harper, Charles Harold (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1125 11251253112512532020-12-16T16:06:002021-07-202020-12-16T16:06:002021-06-15T09:08:002020-12-162021-07-20 1125399369 Harper, Charles Harold (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1125 11251254112512542020-12-28T11:54:002021-07-122020-12-28T11:54:002021-06-08T16:29:002020-12-282021-07-12 1125399369 Harper, Charles Harold (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1125 11251255112512552021-01-06T17:04:002021-07-262021-01-06T17:04:002021-01-27T16:49:002021-01-062021-07-26 1125399369 Harper, Charles Harold (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261229112612292020-11-30T13:43:002021-06-162020-11-30T13:43:002020-12-21T10:39:002020-11-302021-06-16 1126280164 Klein, Nicola P. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261230112612302020-11-30T16:10:002021-08-262020-11-30T16:10:002020-12-21T14:27:002020-11-302021-08-26 1013347220 Dever, Michael Edward (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261233112612332020-12-01T11:55:002021-07-072020-12-01T11:55:002021-06-09T13:42:002020-12-012021-07-07 1126280164 Klein, Nicola P. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261235112612352020-12-01T15:41:002021-07-092020-12-01T15:41:002021-06-08T11:41:002020-12-012021-07-09 1126280164 Klein, Nicola P. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261239112612392020-12-02T10:00:002021-07-122020-12-02T10:00:002021-06-07T09:58:002020-12-022021-07-12 1126280164 Klein, Nicola P. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261240112612402020-12-02T10:01:002021-07-122020-12-02T10:01:002021-06-10T13:04:002020-12-022021-07-12 1126280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261241112612412020-12-02T11:23:002021-08-132020-12-02T11:23:002020-12-21T12:16:002020-12-022021-08-13 1126280164 Klein, Nicola P. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261243112612432020-12-02T12:37:002021-07-282020-12-02T12:37:002020-12-21T09:40:002020-12-022021-07-28 1126280164 Klein, Nicola P. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261246112612462020-12-02T15:19:002021-06-222020-12-02T15:19:002020-12-23T10:23:002020-12-022021-06-22 1126280164 Klein, Nicola P. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261249112612492020-12-02T17:48:002021-06-182020-12-02T17:48:002020-12-22T14:15:002020-12-022021-06-18 1126280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261250112612502020-12-02T17:51:002021-07-162020-12-02T17:51:002021-06-15T16:10:002020-12-022021-07-16 1126280164 Klein, Nicola P. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261253112612532020-12-03T12:39:002021-07-062020-12-03T12:39:002021-06-08T09:43:002020-12-032021-07-06 1126280164 Klein, Nicola P. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261254112612542020-12-03T15:42:002021-08-192020-12-03T15:42:002021-07-12T09:59:002020-12-032021-08-19 1126280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261255112612552020-12-03T15:46:002021-08-032020-12-03T15:46:002020-12-23T11:22:002020-12-032021-08-03 1126280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261258112612582020-12-03T17:45:002021-08-312020-12-03T17:45:002020-12-22T09:40:002020-12-032021-08-31 1126280164 Klein, Nicola P. (b)(6)AĞYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261262112612622020-12-04T16:09:002021-07-192020-12-04T16:09:002021-03-03T12:25:002020-12-04 1126280164 Klein, Nicola P. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261263112612632020-12-04T16:51:002021-06-242020-12-04T16:51:002020-12-23T15:39:002020-12-042021-06-24 1126280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261264112612642020-12-04T17:51:002021-06-252020-12-04T17:51:002020-12-23T14:22:002020-12-042021-06-25 1126280164 Klein, Nicola P. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261265112612652020-12-14T18:09:002021-07-122020-12-14T18:09:002021-06-14T12:06:002020-12-142021-07-12 1126280164 Klein, Nicola P. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261266112612662020-12-14T09:34:002021-07-122020-12-14T09:34:002021-06-14T12:08:002020-12-142021-07-12 1126280164 Klein, Nicola P. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261267112612672020-12-14T10:18:002021-07-122020-12-14T10:18:002021-06-11T09:44:002020-12-142021-07-12 1126280164 Klein, Nicola P. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261268112612682020-12-14T11:08:002021-07-072020-12-14T11:08:002021-01-05T16:05:002020-12-142021-07-07 1126280164 Klein, Nicola P. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261269112612692020-12-14T13:04:002021-07-122020-12-14T13:04:002021-01-06T11:41:002020-12-142021-07-12 1126280164 Klein, Nicola P. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261270112612702020-12-14T14:48:002021-07-082020-12-14T14:48:002021-06-10T09:55:002020-12-142021-07-08 1126280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261271112612712020-12-14T16:16:002021-07-162020-12-14T16:16:002021-01-06T14:15:002020-12-142021-07-16 1126280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261273112612732020-12-14T17:54:002021-07-132020-12-14T17:54:002021-01-06T16:54:002020-12-142021-07-13 1126280164 Klein, Nicola P. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261274112612742020-12-15T12:09:002021-07-132020-12-15T12:09:002021-06-10T19:39:002020-12-152021-07-13 1126280164 Klein, Nicola P. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261275112612752020-12-15T16:25:002021-08-262020-12-15T16:25:002021-03-03T13:23:002020-12-152021-08-26 1126280164 Klein, Nicola P. (b)(6)AğYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261276112612762020-12-15T16:26:002021-08-262020-12-15T16:26:002021-03-03T13:22:002020-12-15 1126280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261277112612772020-12-15T17:02:002021-07-132020-12-15T17:02:002021-01-05T14:37:002020-12-152021-07-13 1126280164 Klein, Nicola P. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261278112612782020-12-15T17:53:002021-07-132020-12-15T17:53:002021-01-05T14:39:002020-12-152021-07-13 1126280164 Klein, Nicola P. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261279112612792020-12-16T09:55:002021-07-092020-12-16T09:55:002021-06-11T13:04:002020-12-162021-07-09 1126280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261280112612802020-12-16T09:58:002021-07-092020-12-16T09:58:002021-06-11T13:05:002020-12-162021-07-09 1126280164 Klein, Nicola P. (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261281112612812020-12-16T11:43:002021-07-152020-12-16T11:43:002021-01-07T16:23:002020-12-162021-07-15 1126280164 Klein, Nicola P. (b)(6)AÀYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261282112612822020-12-16T12:10:002021-06-302020-12-16T12:10:002021-01-06T11:24:002020-12-162021-06-30 1126280164 Klein, Nicola P. (b)(6)AĞYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261283112612832020-12-16T14:19:002021-07-072020-12-16T14:19:002021-06-09T14:53:002020-12-162021-07-07 1126280164 Klein, Nicola P. (b)(6)AĞYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261284112612842020-12-16T15:04:002021-07-092020-12-16T15:04:002021-06-07T15:12:002020-12-162021-07-09 1126280164 Klein, Nicola P. (b)(6)AĞYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261285112612852020-12-16T17:02:002021-06-302020-12-16T17:02:002021-01-06T10:13:002020-12-162021-06-30 1126280164 Klein, Nicola P. (b)(6)AàYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261286112612862020-12-16T17:06:002021-07-072020-12-16T17:06:002021-01-13T13:28:002020-12-162021-07-07 1126280164 Klein, Nicola P. (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261287112612872020-12-16T17:08:002021-07-082020-12-16T17:08:002021-06-10T11:27:002020-12-162021-07-08 1126280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261288112612882020-12-16T17:25:002021-07-062020-12-16T17:25:002021-01-06T11:49:002020-12-162021-07-06 1126280164 Klein, Nicola P. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261289112612892020-12-17T13:19:002021-07-072020-12-17T13:19:002021-06-09T14:49:002020-12-172021-07-07 1126280164 Klein, Nicola P. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261290112612902020-12-17T16:12:002021-07-162020-12-17T16:12:002021-06-09T14:08:002020-12-172021-07-16 1126280164 Klein, Nicola P. (b)(6)AÀYEARSMNOT REPORTED NOT REPORTED PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261291112612912020-12-17T15:34:002021-07-152020-12-17T15:34:002021-01-07T15:24:002020-12-172021-07-15 1126280164 Klein, Nicola P. (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261292112612922020-12-17T17:21:002021-07-082020-12-17T17:21:002021-06-07T11:34:002020-12-172021-07-08 1126280164 Klein, Nicola P. (b)(6)AÀYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261293112612932020-12-18T09:08:002021-07-172020-12-18T09:08:002021-01-08T17:04:002020-12-182021-07-17 1126280164 Klein, Nicola P. (b)(6)AàYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261294112612942020-12-18T11:53:002021-08-062020-12-18T11:53:002021-08-06T10:25:002020-12-18 1126280164 Klein, Nicola P. (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261295112612952020-12-18T13:45:002021-07-072020-12-18T13:45:002021-01-08T15:35:002020-12-182021-07-07 1126280164 Klein, Nicola P. (b)(6)AàYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261296112612962020-12-18T15:35:002021-05-242020-12-18T15:35:002021-04-26T15:15:002020-12-182021-05-24 1126280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261297112612972020-12-18T15:34:002021-07-142020-12-18T15:34:002021-06-09T15:54:002020-12-182021-07-14 1126280164 Klein, Nicola P. (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261298112612982020-12-18T16:16:002021-07-012020-12-18T16:16:002021-01-07T16:50:002020-12-182021-07-01 1126280164 Klein, Nicola P. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261299112612992020-12-21T12:31:002021-07-192020-12-21T12:31:002021-01-12T15:25:002020-12-212021-07-19 1126280164 Klein, Nicola P. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261300112613002020-12-22T08:30:002021-07-092020-12-22T08:30:002021-06-11T15:01:002020-12-222021-07-09 1126280164 Klein, Nicola P. (b)(6)AĞYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261301112613012020-12-22T13:30:002021-07-082020-12-22T13:30:002021-01-14T15:48:002020-12-222021-07-08 1126280164 Klein, Nicola P. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261302112613022020-12-23T13:43:002021-07-092020-12-23T13:43:002021-06-11T14:03:002020-12-23 1126280164 Klein, Nicola P. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261303112613032020-12-29T11:14:002021-07-122020-12-29T11:14:002021-01-18T16:10:002020-12-292021-07-12 1126280164 Klein, Nicola P. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261304112613042020-12-29T11:21:002021-07-122020-12-29T11:21:002021-01-18T16:12:002020-12-292021-07-12 1126280164 Klein, Nicola P. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261305112613052020-12-30T11:37:002021-04-162020-12-30T11:37:002021-03-17T10:19:002020-12-30 1126280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261306112613062020-12-30T11:40:002021-07-062020-12-30T11:40:002021-06-08T09:45:002020-12-302021-07-06 1126280164 Klein, Nicola P. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261307112613072021-01-04T16:26:002021-07-212021-01-04T16:26:002021-01-25T15:10:002021-01-042021-07-21 1126280164 Klein, Nicola P. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261308112613082021-01-04T16:31:002021-08-062021-01-04T16:31:002021-07-09T13:08:002021-01-042021-08-06 1126280164 Klein, Nicola P. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261309112613092021-01-04T16:34:002021-08-092021-01-04T16:34:002021-01-25T15:13:002021-01-042021-08-09 1126280164 Klein, Nicola P. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261310112613102021-01-05T10:23:002021-07-202021-01-05T10:23:002021-01-26T11:01:002021-01-05 1126280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261311112613112021-01-05T15:11:002021-07-222021-01-05T15:11:002021-06-21T09:39:002021-01-052021-07-22 1126280164 Klein, Nicola P. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261312112613122021-01-05T15:43:002021-07-122021-01-05T15:43:002021-06-09T09:40:002021-01-052021-07-12 1126280164 Klein, Nicola P. (b)(6)AàYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261313112613132021-01-06T14:31:002021-07-262021-01-06T14:31:002021-01-28T15:19:002021-01-062021-07-26 1126280164 Klein, Nicola P. (b)(6)AğYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261314112613142021-01-06T14:20:002021-07-072021-01-06T14:20:002021-06-07T16:10:002021-01-062021-07-07 1126280164 Klein, Nicola P. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261315112613152021-01-06T17:48:002021-07-232021-01-06T17:48:002021-01-29T14:02:002021-01-062021-07-23 1126280164 Klein, Nicola P. (b)(6)AĞYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261316112613162021-01-07T09:54:002021-07-232021-01-07T09:54:002021-01-27T08:19:002021-01-072021-07-23 1126280164 Klein, Nicola P. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261317112613172021-01-07T09:57:002021-08-302021-01-07T09:57:002021-06-09T15:49:002021-01-072021-08-30 1126280164 Klein, Nicola P. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261318112613182021-01-07T13:15:002021-08-242021-01-07T13:15:002021-08-24T16:11:002021-01-07 1126280164 Klein, Nicola P. (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261319112613192021-01-07T15:20:002021-08-042021-01-07T15:20:002021-01-27T11:52:002021-01-072021-08-04 1126280164 Klein, Nicola P. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261320112613202021-01-07T16:55:002021-07-062021-01-07T16:55:002021-06-08T14:07:002021-01-072021-07-06 1126280164 Klein, Nicola P. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261321112613212021-01-07T17:55:002021-07-222021-01-07T17:55:002021-01-28T16:13:002021-01-072021-07-22 1126280164 Klein, Nicola P. (b)(6)AĞYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261322112613222021-01-07T17:57:002021-07-122021-01-07T17:57:002021-06-14T09:42:002021-01-072021-07-12 1126280164 Klein, Nicola P. (b)(6)AĞYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1126 11261323112613232021-01-08T16:46:002021-07-262021-01-08T16:46:002021-01-28T16:46:002021-01-082021-07-26 1126280164 Klein, Nicola P. (b)(6)AğYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261324112613242021-01-08T16:48:002021-07-262021-01-08T16:48:002021-01-28T16:44:002021-01-082021-07-26 1126280164 Klein, Nicola P. (b)(6)AÀYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1126 11261325112613252021-01-08T17:29:002021-07-062021-01-08T17:29:002021-06-08T14:12:002021-01-082021-07-06 1126280164 Klein, Nicola P. (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311275113112752020-12-04T11:17:002021-08-312020-12-04T11:17:002020-12-23T12:21:002020-12-042021-08-31 1131220331 Randall, William (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311277113112772020-12-08T12:32:002021-07-012020-12-08T12:32:002020-12-29T13:03:002020-12-082021-07-01 1131220331 Randall, William (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311278113112782020-12-08T17:15:002021-06-282020-12-08T17:15:002020-12-30T15:17:002020-12-082021-06-28 1131220331 Randall, William (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311279113112792020-12-21T14:16:002021-07-122020-12-21T14:16:002021-01-11T16:49:002020-12-172021-07-12 1131220331 Randall, William (b)(6)AğYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311280113112802020-12-17T18:24:002021-09-022020-12-17T18:24:002021-08-03T10:43:002020-12-172021-09-02 1131220331 Randall, William (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311281113112812020-12-21T16:23:002021-07-092020-12-21T16:23:002021-01-11T16:16:002020-12-212021-07-09 1131220331 Randall, William (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311282113112822020-12-22T11:01:002021-07-132020-12-22T11:01:002021-01-14T14:20:002020-12-222021-07-13 1131220331 Randall, William (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311283113112832020-12-22T16:59:002021-07-162020-12-22T16:59:002021-06-17T16:34:002020-12-222021-07-16 1131220331 Randall, William (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311285113112852020-12-23T11:47:002021-08-042020-12-23T11:47:002021-07-07T14:24:002020-12-232021-08-04 1131220331 Randall, William (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311286113112862020-12-29T10:32:002021-07-122020-12-29T10:32:002021-01-18T11:25:002020-12-292021-07-12 1131220331 Randall, William (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311287113112872020-12-29T11:35:002021-07-142020-12-29T11:35:002021-06-16T10:53:002020-12-29 1131220331 Randall, William (b)(6)AÀYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311288113112882020-12-29T11:37:002021-07-142020-12-29T11:37:002021-06-16T10:52:002020-12-292021-07-14 1131220331 Randall, William (b)(6)AÀYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311289113112892020-12-30T12:23:002021-08-312020-12-30T12:23:002021-01-21T10:07:002020-12-302021-08-31 1131220331 Randall, William (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311290113112902020-12-30T12:46:002021-07-142020-12-30T12:46:002021-01-20T17:02:002020-12-302021-07-14 1131220331 Randall, William (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311291113112912020-12-30T14:45:002021-07-142020-12-30T14:45:002021-01-20T10:09:002020-12-302021-07-14 1131220331 Randall, William (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311292113112922021-01-04T16:05:002021-08-302021-01-04T16:05:002021-08-30T12:37:002021-01-042021-08-30 1131220331 Randall, William (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311293113112932021-01-04T17:20:002021-09-022021-01-04T17:20:002021-08-03T10:41:002021-01-042021-09-02 1131220331 Randall, William (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311294113112942021-01-05T18:13:002021-07-202021-01-05T18:13:002021-01-26T17:32:002021-01-052021-07-20 1131220331 Randall, William (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311295113112952021-01-07T14:07:002021-07-122021-01-07T14:07:002021-06-14T15:19:002021-01-072021-07-12 1131220331 Randall, William (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311296113112962021-01-08T11:40:002021-05-282021-01-08T11:40:002021-04-30T12:27:002021-01-082021-05-28 1131220331 Randall, William (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311297113112972021-01-08T11:43:002021-08-022021-01-08T11:43:002021-01-27T12:36:002021-01-082021-08-02 1131220331 Randall, William (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311298113112982021-01-08T11:43:002021-07-232021-01-08T11:43:002021-01-29T15:42:002021-01-082021-07-23 1131220331 Randall, William (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311299113112992021-01-08T17:45:002021-08-312021-01-08T17:45:002021-06-10T10:41:002021-01-08 1131220331 Randall, William (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311300113113002021-01-08T17:47:002021-07-082021-01-08T17:47:002021-06-10T10:43:002021-01-08 1131220331 Randall, William (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1131 11311301113113012021-01-11T14:50:002021-08-092021-01-11T14:50:002021-02-05T14:06:002021-01-112021-08-09 1131220331 Randall, William (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1131 11311302113113022021-01-11T17:49:002021-08-052021-01-11T17:49:002021-02-01T11:09:002021-01-112021-08-05 1131220331 Randall, William (b)(6)AğYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391144113911442020-12-11T15:51:002021-06-242020-12-11T15:51:002020-12-30T13:20:002020-12-012021-06-24 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391145113911452020-12-01T11:33:002021-06-292020-12-01T11:33:002020-12-21T13:16:002020-12-012021-06-29 1139121963 Walter, Emmanuel Benjamin(b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391151113911512020-12-04T14:27:002021-06-182020-12-04T14:27:002020-12-23T12:15:002020-12-042021-06-18 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391152113911522020-12-04T17:25:002021-07-012020-12-04T17:25:002021-06-03T13:45:002020-12-042021-07-01 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391154113911542020-12-04T17:34:002021-07-012020-12-04T17:34:002021-06-03T16:20:002020-12-042021-07-01 1139121963 Walter, Emmanuel Benjamin(b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391155113911552020-12-04T17:38:002021-08-172020-12-04T17:38:002020-12-28T15:25:002020-12-042021-08-17 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391156113911562020-12-07T11:03:002021-06-222020-12-07T11:03:002020-12-29T15:30:002020-12-072021-06-22 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391157113911572020-12-08T11:25:002021-05-042020-12-08T11:25:002021-04-06T13:15:002020-12-082021-05-04 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391158113911582020-12-08T15:18:002021-07-012020-12-08T15:18:002021-06-03T14:14:002020-12-082021-07-01 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391159113911592020-12-08T14:58:002021-08-122020-12-08T14:58:002021-06-10T12:45:002020-12-082021-08-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391161113911612020-12-08T16:07:002021-06-232020-12-08T16:07:002020-12-29T12:18:002020-12-082021-06-23 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391162113911622020-12-08T16:11:002021-06-222020-12-08T16:11:002020-12-29T13:24:002020-12-082021-06-22 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391163113911632020-12-08T16:15:002021-07-082020-12-08T16:15:002021-06-04T15:06:002020-12-082021-07-08 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391165113911652020-12-11T15:59:002021-06-082020-12-11T15:59:002020-12-30T14:18:002020-12-112021-06-08 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391166113911662020-12-11T16:06:002021-04-142020-12-11T16:06:002021-03-11T13:19:002020-12-11 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391168113911682020-12-11T16:15:002021-08-122020-12-11T16:15:002021-06-10T16:16:002020-12-112021-08-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391169113911692020-12-15T11:13:002021-07-082020-12-15T11:13:002021-01-14T12:59:002020-12-152021-07-08 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391170113911702020-12-15T11:18:002021-07-082020-12-15T11:18:002021-01-14T12:59:002020-12-152021-07-08 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391171113911712020-12-15T11:24:002021-08-272020-12-15T11:24:002021-01-05T12:43:002020-12-152021-08-27 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391172113911722020-12-15T15:48:002021-05-312020-12-15T15:48:002021-01-05T12:36:002020-12-152021-05-31 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391173113911732020-12-15T17:24:002021-07-162020-12-15T17:24:002021-01-07T17:05:002020-12-152021-07-16 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391174113911742020-12-15T17:28:002021-08-182020-12-15T17:28:002021-07-16T14:22:002020-12-152021-08-18 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391175113911752020-12-15T17:15:002021-07-012020-12-15T17:15:002021-06-03T12:32:002020-12-152021-07-01 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391177113911772020-12-17T11:50:002021-07-192020-12-17T11:50:002021-01-15T14:15:002020-12-17 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391178113911782020-12-18T12:58:002021-08-272020-12-18T12:58:002021-01-08T15:52:002020-12-182021-08-27 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391179113911792020-12-18T15:03:002021-08-282020-12-18T15:03:002021-01-08T15:40:002020-12-182021-08-28 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391180113911802020-12-18T15:20:002021-07-072020-12-18T15:20:002021-06-03T12:19:002020-12-182021-07-07 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391181113911812020-12-18T15:02:002021-04-082020-12-18T15:02:002021-03-08T13:02:002020-12-18 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391182113911822020-12-18T15:27:002021-07-082020-12-18T15:27:002021-06-04T12:20:002020-12-182021-07-08 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391183113911832020-12-18T16:56:002021-07-152020-12-18T16:56:002021-01-08T14:04:002020-12-18 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391185113911852020-12-18T17:00:002021-07-072020-12-18T17:00:002021-06-03T12:25:002020-12-182021-07-07 1139121963 Walter, Emmanuel Benjamin(b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391186113911862020-12-21T11:53:002021-07-092020-12-21T11:53:002021-01-11T14:51:002020-12-212021-07-09 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391187113911872020-12-21T11:58:002021-08-122020-12-21T11:58:002021-06-11T12:54:002020-12-212021-08-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391188113911882020-12-21T12:15:002021-07-192020-12-21T12:15:002021-01-12T15:27:002020-12-212021-07-19 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391189113911892020-12-21T16:15:002021-05-132020-12-21T16:15:002021-01-11T14:28:002020-12-212021-05-13 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391190113911902020-12-21T16:32:002021-07-152020-12-21T16:32:002021-01-11T15:16:002020-12-212021-07-15 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391191113911912020-12-21T16:37:002021-07-152020-12-21T16:37:002021-01-11T15:20:002020-12-212021-07-15 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391192113911922020-12-21T16:27:002021-07-142020-12-21T16:27:002021-01-11T14:36:002020-12-212021-07-14 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391193113911932020-12-21T16:21:002021-07-012020-12-21T16:21:002021-06-03T15:03:002020-12-212021-07-01 1139121963 Walter, Emmanuel Benjamin(b)(6)AÀYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391195113911952020-12-21T16:43:002021-07-272020-12-21T16:43:002021-06-11T12:37:002020-12-212021-07-27 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391196113911962020-12-21T16:49:002021-07-272020-12-21T16:49:002021-06-03T13:45:002020-12-212021-07-27 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391197113911972020-12-22T12:05:002021-07-122020-12-22T12:05:002021-01-12T16:05:002020-12-222021-07-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391198113911982020-12-22T11:55:002021-08-132020-12-22T11:55:002021-06-11T13:27:002020-12-222021-08-13 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391199113911992020-12-22T11:48:002021-07-082020-12-22T11:48:002021-01-14T14:32:002020-12-222021-07-08 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391200113912002020-12-22T12:01:002021-07-062020-12-22T12:01:002021-01-12T16:57:002020-12-222021-07-06 1139121963 Walter, Emmanuel Benjamin(b)(6)AÀYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391201113912012020-12-22T15:02:002021-08-042020-12-22T15:02:002021-01-12T16:30:002020-12-222021-08-04 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391202113912022020-12-22T15:06:002021-08-122020-12-22T15:06:002021-06-17T16:07:002020-12-222021-08-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391203113912032020-12-22T16:50:002021-04-272020-12-22T16:50:002021-04-06T15:00:002020-12-222021-04-27 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391204113912042020-12-22T16:55:002021-05-122020-12-22T16:55:002021-01-12T15:51:002020-12-222021-05-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391205113912052020-12-22T16:29:002021-08-182020-12-22T16:29:002021-07-16T15:05:002020-12-222021-08-18 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391206113912062020-12-22T16:34:002021-07-152020-12-22T16:34:002021-01-12T17:12:002020-12-222021-07-15 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391207113912072020-12-22T16:39:002021-08-122020-12-22T16:39:002021-06-10T12:22:002020-12-222021-08-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391208113912082020-12-22T16:44:002021-08-122020-12-22T16:44:002021-06-10T12:22:002020-12-222021-08-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391209113912092020-12-23T10:40:002021-07-282020-12-23T10:40:002021-01-14T13:47:002020-12-222021-07-28 1139121963 Walter, Emmanuel Benjamin(b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391210113912102020-12-28T12:21:002021-08-122020-12-28T12:21:002021-06-18T12:50:002020-12-282021-08-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391211113912112020-12-28T13:05:002021-07-142020-12-28T13:05:002021-01-19T12:57:002020-12-282021-07-14 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391212113912122020-12-28T12:59:002021-04-142020-12-28T12:59:002021-03-15T16:10:002020-12-28 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391213113912132020-12-28T13:48:002021-08-032020-12-28T13:48:002021-01-19T15:32:002020-12-282021-08-03 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391214113912142020-12-28T15:13:002021-07-192020-12-28T15:13:002021-01-21T11:45:002020-12-282021-07-19 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391215113912152020-12-29T12:05:002021-07-062020-12-29T12:05:002021-06-04T13:36:002020-12-292021-07-06 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391216113912162020-12-29T12:01:002021-08-042020-12-29T12:01:002021-01-19T14:46:002020-12-292021-08-04 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391217113912172020-12-29T12:59:002021-07-082020-12-29T12:59:002021-06-08T15:33:002020-12-292021-07-08 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391218113912182020-12-29T15:48:002021-08-182020-12-29T15:48:002021-01-19T10:45:002020-12-292021-08-18 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391219113912192020-12-29T15:42:002021-07-022020-12-29T15:42:002021-06-03T13:55:002020-12-292021-07-02 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391220113912202020-12-29T15:52:002021-08-132020-12-29T15:52:002021-06-10T13:04:002020-12-292021-08-13 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391221113912212021-01-04T13:06:002021-08-022021-01-04T13:06:002021-01-26T13:42:002021-01-042021-08-02 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391222113912222021-01-04T13:32:002021-08-132021-01-04T13:32:002021-06-11T15:56:002021-01-042021-08-13 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391223113912232021-01-04T12:57:002021-07-202021-01-04T12:57:002021-01-26T14:13:002021-01-042021-07-20 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391224113912242021-01-04T14:43:002021-07-072021-01-04T14:43:002021-06-03T16:08:002021-01-042021-07-07 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391225113912252021-01-04T13:26:002021-08-022021-01-04T13:26:002021-01-28T14:25:002021-01-042021-08-02 1139121963 Walter, Emmanuel Benjamin(b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391226113912262021-01-05T12:12:002021-08-052021-01-05T12:12:002021-01-28T14:09:002021-01-052021-08-05 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391227113912272021-01-05T12:15:002021-07-162021-01-05T12:15:002021-06-11T12:49:002021-01-052021-07-16 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391228113912282021-01-05T12:31:002021-08-132021-01-05T12:31:002021-06-11T13:12:002021-01-052021-08-13 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391229113912292021-01-05T12:21:002021-08-132021-01-05T12:21:002021-06-10T14:30:002021-01-052021-08-13 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391230113912302021-01-05T12:27:002021-07-272021-01-05T12:27:002021-01-26T12:57:002021-01-052021-07-27 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391231113912312021-01-05T16:28:002021-07-212021-01-05T16:28:002021-01-26T15:34:002021-01-052021-07-21 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391232113912322021-01-05T16:33:002021-08-232021-01-05T16:33:002021-01-26T15:27:002021-01-052021-08-23 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391233113912332021-01-05T16:38:002021-07-212021-01-05T16:38:002021-01-26T15:30:002021-01-052021-07-21 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391235113912352021-01-05T16:47:002021-04-052021-01-05T16:47:002021-03-08T12:44:002021-01-05 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391236113912362021-01-05T16:52:002021-07-282021-01-05T16:52:002021-01-25T14:10:002021-01-052021-07-28 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391237113912372021-01-07T16:46:002021-07-152021-01-07T16:46:002021-06-17T15:44:002021-01-072021-07-15 1139121963 Walter, Emmanuel Benjamin(b)(6)AÀYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391238113912382021-01-07T16:38:002021-07-162021-01-07T16:38:002021-01-29T14:53:002021-01-072021-07-16 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391239113912392021-01-07T16:52:002021-08-162021-01-07T16:52:002021-06-11T14:48:002021-01-072021-08-16 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391240113912402021-01-08T13:57:002021-07-302021-01-08T13:57:002021-01-28T13:59:002021-01-082021-07-30 1139121963 Walter, Emmanuel Benjamin(b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391241113912412021-01-08T16:24:002021-08-162021-01-08T16:24:002021-06-11T16:06:002021-01-082021-08-16 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391242113912422021-01-08T16:42:002021-08-232021-01-08T16:42:002021-01-29T13:40:002021-01-082021-08-23 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391243113912432021-01-08T16:32:002021-07-122021-01-08T16:32:002021-06-10T14:39:002021-01-082021-07-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391244113912442021-01-08T16:36:002021-08-182021-01-08T16:36:002021-01-29T16:11:002021-01-082021-08-18 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391245113912452021-01-08T17:24:002021-08-112021-01-08T17:24:002021-02-02T14:45:002021-01-082021-08-11 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391246113912462021-01-08T16:52:002021-08-162021-01-08T16:52:002021-06-10T11:51:002021-01-082021-08-16 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391247113912472021-01-08T17:04:002021-07-012021-01-08T17:04:002021-06-03T15:50:002021-01-082021-07-01 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391248113912482021-01-08T17:09:002021-07-232021-01-08T17:09:002021-01-29T16:45:002021-01-082021-07-23 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391249113912492021-01-11T14:19:002021-08-252021-01-11T14:19:002021-02-01T12:07:002021-01-112021-08-25 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391250113912502021-01-11T15:47:002021-06-082021-01-11T15:47:002021-05-11T15:51:002021-01-112021-06-08 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391251113912512021-01-11T13:41:002021-08-222021-01-11T13:41:002021-02-01T12:48:002021-01-11 1139121963 Walter, Emmanuel Benjamin(b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391252113912522021-01-11T13:46:002021-07-012021-01-11T13:46:002021-06-03T13:35:002021-01-112021-07-01 1139121963 Walter, Emmanuel Benjamin(b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391253113912532021-01-11T15:53:002021-07-302021-01-11T15:53:002021-02-01T13:56:002021-01-112021-07-30 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391254113912542021-01-11T15:58:002021-07-232021-01-11T15:58:002021-06-04T15:06:002021-01-112021-07-23 1139121963 Walter, Emmanuel Benjamin(b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391255113912552021-01-11T16:07:002021-07-262021-01-11T16:07:002021-02-01T12:34:002021-01-112021-07-26 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391256113912562021-01-12T14:38:002021-07-272021-01-12T14:38:002021-02-01T14:52:002021-01-122021-07-27 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391257113912572021-01-12T12:35:002021-08-162021-01-12T12:35:002021-06-11T12:44:002021-01-122021-08-16 1139121963 Walter, Emmanuel Benjamin(b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391258113912582021-01-12T16:12:002021-07-232021-01-12T16:12:002021-06-04T12:07:002021-01-122021-07-23 1139121963 Walter, Emmanuel Benjamin(b)(6)AÀYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391259113912592021-01-12T12:43:002021-08-022021-01-12T12:43:002021-02-02T14:25:002021-01-122021-08-02 1139121963 Walter, Emmanuel Benjamin(b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391260113912602021-01-12T16:22:002021-08-162021-01-12T16:22:002021-06-11T13:32:002021-01-122021-08-16 1139121963 Walter, Emmanuel Benjamin(b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1139 11391261113912612021-01-12T16:08:002021-08-032021-01-12T16:08:002021-02-02T13:02:002021-01-122021-08-03 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391262113912622021-01-12T17:00:002021-08-042021-01-12T17:00:002021-02-04T15:41:002021-01-122021-08-04 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1139 11391263113912632021-01-12T17:12:002021-04-122021-01-12T17:12:002021-03-12T15:23:002021-01-12 1139121963 Walter, Emmanuel Benjamin(b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401323114013232020-12-10T14:15:002021-07-092020-12-10T14:15:002021-01-09T12:28:002020-12-102021-07-09 11401449872Thomas, Stephen (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401324114013242020-12-10T14:20:002021-07-092020-12-10T14:20:002021-06-11T14:31:002020-12-102021-07-09 11401449872Thomas, Stephen (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401325114013252020-12-10T15:02:002021-08-232020-12-10T15:02:002021-08-23T12:02:002020-12-10 11401449872Thomas, Stephen (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401326114013262020-12-10T15:07:002021-07-022020-12-10T15:07:002021-01-07T12:01:002020-12-102021-07-02 11401449872Thomas, Stephen (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401327114013272020-12-11T14:46:002021-07-122020-12-11T14:46:002021-06-08T14:37:002020-12-112021-07-12 11401449872Thomas, Stephen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401328114013282020-12-14T14:08:002021-06-302020-12-14T14:08:002021-01-05T13:49:002020-12-142021-06-30 11401449872Thomas, Stephen (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401329114013292020-12-14T15:53:002021-07-122020-12-14T15:53:002021-01-05T15:24:002020-12-142021-07-12 11401449872Thomas, Stephen (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401330114013302020-12-15T10:32:002021-07-062020-12-15T10:32:002021-06-08T16:18:002020-12-152021-07-06 11401449872Thomas, Stephen (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401331114013312020-12-16T11:21:002021-08-272020-12-16T11:21:002021-01-06T11:40:002020-12-162021-08-27 11401449872Thomas, Stephen (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401332114013322020-12-16T11:25:002021-08-022020-12-16T11:25:002021-01-06T11:42:002020-12-162021-08-02 11401449872Thomas, Stephen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401333114013332020-12-16T16:03:002021-07-072020-12-16T16:03:002021-06-08T15:54:002020-12-162021-07-07 11401449872Thomas, Stephen (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401334114013342020-12-16T16:07:002021-07-072020-12-16T16:07:002021-06-08T15:56:002020-12-162021-07-07 11401449872Thomas, Stephen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401335114013352020-12-17T13:29:002021-07-072020-12-17T13:29:002021-06-07T09:36:002020-12-172021-07-07 11401449872Thomas, Stephen (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401336114013362020-12-17T13:54:002021-07-092020-12-17T13:54:002021-01-08T14:03:002020-12-172021-07-09 11401449872Thomas, Stephen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401337114013372020-12-17T15:23:002021-06-292020-12-17T15:23:002021-01-05T11:12:002020-12-172021-06-29 11401449872Thomas, Stephen (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401338114013382020-12-17T16:09:002021-07-072020-12-17T16:09:002021-06-07T09:47:002020-12-172021-07-07 11401449872Thomas, Stephen (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401340114013402020-12-21T09:29:002021-07-072020-12-21T09:29:002021-06-09T12:08:002020-12-212021-07-07 11401449872Thomas, Stephen (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401343114013432020-12-21T15:19:002021-07-162020-12-21T15:19:002021-01-13T15:32:002020-12-212021-07-16 11401449872Thomas, Stephen (b)(6)AĞYEARSFAMERICAN INDIAN OR ALASKA NATIVE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401344114013442020-12-21T15:21:002021-07-162020-12-21T15:21:002021-01-13T15:35:002020-12-212021-07-16 11401449872Thomas, Stephen (b)(6)AĞYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401345114013452020-12-22T09:36:002021-07-062020-12-22T09:36:002021-06-07T14:38:002020-12-222021-07-06 11401449872Thomas, Stephen (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401346114013462020-12-22 2020-12-22 2020-12-222020-12-22 11401449872Thomas, Stephen (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) NOTTRT Not Treated USAC4591001DMC4591001 1140 11401347114013472020-12-22T10:08:002021-07-072020-12-22T10:08:002021-06-09T11:10:002020-12-222021-07-07 11401449872Thomas, Stephen (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401348114013482020-12-22T10:12:002021-07-072020-12-22T10:12:002021-06-09T11:08:002020-12-222021-07-07 11401449872Thomas, Stephen (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401349114013492020-12-22T10:33:002021-07-142020-12-22T10:33:002021-01-12T08:53:002020-12-222021-07-14 11401449872Thomas, Stephen (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401350114013502020-12-22T12:21:002021-07-132020-12-22T12:21:002021-01-13T12:20:002020-12-222021-07-13 11401449872Thomas, Stephen (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401351114013512020-12-22T12:24:002021-08-232020-12-22T12:24:002021-08-23T12:05:002020-12-22 11401449872Thomas, Stephen (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401352114013522020-12-22T12:27:002021-07-132020-12-22T12:27:002021-01-13T12:24:002020-12-222021-07-13 11401449872Thomas, Stephen (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401353114013532020-12-22T14:58:002021-07-282020-12-22T14:58:002021-06-11T10:38:002020-12-222021-07-28 11401449872Thomas, Stephen (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401354114013542020-12-23T09:56:002021-07-072020-12-23T09:56:002021-01-13T14:52:002020-12-232021-07-07 11401449872Thomas, Stephen (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401356114013562020-12-23T13:30:002021-07-152020-12-23T13:30:002021-06-11T11:12:002020-12-232021-07-15 11401449872Thomas, Stephen (b)(6)AàYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401357114013572020-12-23T14:07:002021-05-142020-12-23T14:07:002021-01-11T14:58:002020-12-232021-05-14 11401449872Thomas, Stephen (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401358114013582020-12-23T15:49:002021-07-072020-12-23T15:49:002021-01-13T13:15:002020-12-232021-07-07 11401449872Thomas, Stephen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401359114013592020-12-23T15:45:002021-07-192020-12-23T15:45:002021-01-13T15:11:002020-12-232021-07-19 11401449872Thomas, Stephen (b)(6)AàYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401361114013612020-12-28T11:58:002021-07-152020-12-28T11:58:002021-01-19T10:40:002020-12-282021-07-15 11401449872Thomas, Stephen (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401362114013622020-12-28T12:04:002021-07-072020-12-28T12:04:002021-06-07T10:39:002020-12-282021-07-07 11401449872Thomas, Stephen (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401363114013632020-12-28T12:59:002021-07-092020-12-28T12:59:002021-06-11T15:47:002020-12-282021-07-09 11401449872Thomas, Stephen (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401364114013642020-12-28T14:08:002021-07-082020-12-28T14:08:002021-06-09T14:56:002020-12-282021-07-08 11401449872Thomas, Stephen (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401365114013652020-12-28T14:05:002021-07-302020-12-28T14:05:002021-01-19T14:06:002020-12-282021-07-30 11401449872Thomas, Stephen (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401366114013662020-12-28T14:12:002021-07-082020-12-28T14:12:002021-06-09T14:58:002020-12-282021-07-08 11401449872Thomas, Stephen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401367114013672020-12-28T15:38:002021-07-162020-12-28T15:38:002021-01-20T09:39:002020-12-282021-07-16 11401449872Thomas, Stephen (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401369114013692020-12-29T11:11:002021-07-062020-12-29T11:11:002021-06-07T15:47:002020-12-292021-07-06 11401449872Thomas, Stephen (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401370114013702020-12-29T12:12:002021-07-162020-12-29T12:12:002021-01-21T11:41:002020-12-292021-07-16 11401449872Thomas, Stephen (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401371114013712020-12-29T12:31:002021-07-192020-12-29T12:31:002021-01-20T12:45:002020-12-292021-07-19 11401449872Thomas, Stephen (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401372114013722020-12-29T12:34:002021-07-082020-12-29T12:34:002021-06-09T09:32:002020-12-292021-07-08 11401449872Thomas, Stephen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401373114013732020-12-29T12:56:002021-07-162020-12-29T12:56:002021-01-20T12:59:002020-12-292021-07-16 11401449872Thomas, Stephen (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401374114013742020-12-29T13:38:002021-07-192020-12-29T13:38:002021-06-18T12:40:002020-12-292021-07-19 11401449872Thomas, Stephen (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401375114013752020-12-29T15:00:002021-07-072020-12-29T15:00:002021-06-09T10:42:002020-12-292021-07-07 11401449872Thomas, Stephen (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401376114013762020-12-29T14:52:002021-07-142020-12-29T14:52:002021-01-20T14:20:002020-12-292021-07-14 11401449872Thomas, Stephen (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401377114013772020-12-29T14:56:002021-07-072020-12-29T14:56:002021-06-09T10:40:002020-12-292021-07-07 11401449872Thomas, Stephen (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401378114013782020-12-29T15:20:002021-07-142020-12-29T15:20:002021-01-20T12:22:002020-12-292021-07-14 11401449872Thomas, Stephen (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401379114013792020-12-30T10:03:002021-07-092020-12-30T10:03:002021-06-07T16:24:002020-12-302021-07-09 11401449872Thomas, Stephen (b)(6)AÀYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401380114013802020-12-30T10:13:002021-08-022020-12-30T10:13:002021-01-19T14:59:002020-12-302021-08-02 11401449872Thomas, Stephen (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401381114013812020-12-30T11:14:002021-07-162020-12-30T11:14:002021-01-21T14:54:002020-12-302021-07-16 11401449872Thomas, Stephen (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401382114013822020-12-30T11:17:002021-07-162020-12-30T11:17:002021-01-21T14:56:002020-12-302021-07-16 11401449872Thomas, Stephen (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401383114013832020-12-30T11:33:002021-07-122020-12-30T11:33:002021-06-11T10:21:002020-12-302021-07-12 11401449872Thomas, Stephen (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401384114013842020-12-30T12:17:002021-07-082020-12-30T12:17:002021-06-09T15:56:002020-12-302021-07-08 11401449872Thomas, Stephen (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401385114013852021-01-06T14:09:002021-07-232021-01-06T14:09:002021-01-27T15:02:002020-12-302021-07-23 11401449872Thomas, Stephen (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401386114013862021-01-05T12:17:002021-08-012021-01-05T12:17:002021-01-27T11:45:002020-12-302021-08-01 11401449872Thomas, Stephen (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401387114013872021-01-07T14:09:002021-07-092021-01-07T14:09:002021-06-09T13:15:002020-12-302021-07-09 11401449872Thomas, Stephen (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401388114013882021-01-05T14:24:002021-07-122021-01-05T14:24:002021-06-10T13:55:002021-01-052021-07-12 11401449872Thomas, Stephen (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401389114013892021-01-05T14:27:002021-07-122021-01-05T14:27:002021-06-10T13:53:002021-01-052021-07-12 11401449872Thomas, Stephen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401390114013902021-01-05T15:35:002021-07-232021-01-05T15:35:002021-01-27T14:14:002021-01-052021-07-23 11401449872Thomas, Stephen (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401391114013912021-01-06T09:21:002021-07-272021-01-06T09:21:002021-01-28T09:05:002021-01-062021-07-27 11401449872Thomas, Stephen (b)(6)AÀYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401392114013922021-01-06T10:20:002021-07-012021-01-06T10:20:002021-06-09T13:37:002021-01-062021-07-01 11401449872Thomas, Stephen (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401393114013932021-01-06T14:27:002021-07-272021-01-06T14:27:002021-01-27T14:28:002021-01-062021-07-27 11401449872Thomas, Stephen (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401394114013942021-01-06T15:44:002021-08-062021-01-06T15:44:002021-01-28T14:21:002021-01-062021-08-06 11401449872Thomas, Stephen (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401395114013952021-01-07T12:37:002021-07-262021-01-07T12:37:002021-06-11T09:52:002021-01-072021-07-26 11401449872Thomas, Stephen (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401396114013962021-01-07T15:17:002021-07-082021-01-07T15:17:002021-06-10T11:55:002021-01-072021-07-08 11401449872Thomas, Stephen (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401397114013972021-01-08T10:14:002021-07-092021-01-08T10:14:002021-06-07T16:01:002021-01-082021-07-09 11401449872Thomas, Stephen (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401398114013982021-01-08T13:08:002021-08-042021-01-08T13:08:002021-01-28T13:09:002021-01-082021-08-04 11401449872Thomas, Stephen (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401399114013992021-01-08T13:11:002021-08-042021-01-08T13:11:002021-01-28T13:12:002021-01-082021-08-04 11401449872Thomas, Stephen (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401400114014002021-01-08T13:46:002021-08-042021-01-08T13:46:002021-06-11T15:31:002021-01-082021-08-04 11401449872Thomas, Stephen (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401401114014012021-01-08T13:35:002021-07-302021-01-08T13:35:002021-01-28T13:41:002021-01-082021-07-30 11401449872Thomas, Stephen (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1140 11401402114014022021-01-08T16:17:002021-07-092021-01-08T16:17:002021-06-09T11:41:002021-01-082021-07-09 11401449872Thomas, Stephen (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1140 11401403114014032021-01-08T16:21:002021-07-092021-01-08T16:21:002021-06-09T11:43:002021-01-082021-07-09 11401449872Thomas, Stephen (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421318114213182020-12-01T12:20:002021-05-142020-12-01T12:20:002020-12-21T10:38:002020-12-01 1142281273 Rupp, Richard Earl (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421319114213192020-12-01T13:35:002021-06-162020-12-01T13:35:002020-12-21T13:57:002020-12-012021-06-16 1142281273 Rupp, Richard Earl (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421321114213212020-12-02T10:22:002021-06-212020-12-02T10:22:002020-12-21T09:24:002020-12-022021-06-21 1142281273 Rupp, Richard Earl (b)(6)AÀYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421323114213232020-12-03T11:12:002021-08-202020-12-03T11:12:002021-08-20T10:39:002020-12-03 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421324114213242020-12-03T11:05:002021-06-172020-12-03T11:05:002020-12-22T15:42:002020-12-032021-06-17 1142281273 Rupp, Richard Earl (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421325114213252020-12-03T15:48:002021-07-142020-12-03T15:48:002021-06-14T13:23:002020-12-032021-07-14 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421326114213262020-12-03T15:44:002021-07-142020-12-03T15:44:002021-06-14T13:20:002020-12-032021-07-14 1142281273 Rupp, Richard Earl (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421327114213272020-12-03T14:31:002021-08-172020-12-03T14:31:002020-12-22T15:54:002020-12-032021-08-17 1142281273 Rupp, Richard Earl (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421329114213292020-12-04T10:31:002021-08-102020-12-04T10:31:002021-06-04T10:21:002020-12-042021-08-10 1142281273 Rupp, Richard Earl (b)(6)AàYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421330114213302020-12-04T10:34:002021-07-212020-12-04T10:34:002020-12-23T09:35:002020-12-042021-07-21 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421333114213332020-12-18T09:52:002021-08-112020-12-18T09:52:002021-01-07T13:45:002020-12-182021-08-11 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSMNOT REPORTED HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421335114213352020-12-04T14:30:002021-08-202020-12-04T14:30:002021-08-20T12:34:002020-12-04 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421340114213402020-12-07T10:46:002021-07-062020-12-07T10:46:002020-12-28T09:22:002020-12-072021-07-06 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421341114213412020-12-07T10:47:002021-06-232020-12-07T10:47:002020-12-28T09:28:002020-12-072021-06-23 1142281273 Rupp, Richard Earl (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421342114213422020-12-07T12:36:002021-06-112020-12-07T12:36:002021-04-27T15:38:002020-12-072021-06-11 1142281273 Rupp, Richard Earl (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421343114213432020-12-08T10:13:002021-06-212020-12-08T10:13:002020-12-28T09:20:002020-12-082021-06-21 1142281273 Rupp, Richard Earl (b)(6)AàYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421344114213442020-12-08T13:10:002021-08-232020-12-08T13:10:002021-08-23T14:58:002020-12-08 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSFNOT REPORTED HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421345114213452020-12-08T13:16:002021-08-312020-12-08T13:16:002021-08-31T13:34:002020-12-08 1142281273 Rupp, Richard Earl (b)(6)AğYEARSFNOT REPORTED HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421346114213462020-12-10T10:47:002021-06-252020-12-10T10:47:002020-12-29T10:25:002020-12-10 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421348114213482020-12-10T10:46:002021-06-252020-12-10T10:46:002020-12-31T12:03:002020-12-102021-06-25 1142281273 Rupp, Richard Earl (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421349114213492020-12-10T13:23:002021-08-202020-12-10T13:23:002021-08-20T14:58:002020-12-10 1142281273 Rupp, Richard Earl (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421350114213502020-12-10T12:56:002021-07-022020-12-10T12:56:002020-12-30T11:40:002020-12-102021-07-02 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421351114213512020-12-11T10:40:002021-08-202020-12-11T10:40:002021-08-20T11:31:002020-12-11 1142281273 Rupp, Richard Earl (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421352114213522020-12-11T15:06:002021-08-202020-12-11T15:06:002021-08-20T13:12:002020-12-11 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421353114213532020-12-11T15:10:002021-07-012020-12-11T15:10:002020-12-31T09:39:002020-12-112021-07-01 1142281273 Rupp, Richard Earl (b)(6)AàYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421354114213542020-12-11T15:14:002021-06-302020-12-11T15:14:002020-12-30T16:11:002020-12-112021-06-30 1142281273 Rupp, Richard Earl (b)(6)AàYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421355114213552020-12-14T10:45:002021-08-162020-12-14T10:45:002021-08-16T13:52:002020-12-14 1142281273 Rupp, Richard Earl (b)(6)AÀYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421356114213562020-12-14T11:00:002021-08-162020-12-14T11:00:002021-08-16T13:54:002020-12-14 1142281273 Rupp, Richard Earl (b)(6)AàYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421358114213582020-12-15T10:52:002021-07-142020-12-15T10:52:002021-01-05T16:50:002020-12-152021-07-14 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421359114213592020-12-15T13:42:002021-07-142020-12-15T13:42:002021-06-09T15:00:002020-12-152021-07-14 1142281273 Rupp, Richard Earl (b)(6)AğYEARSMMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421360114213602020-12-15T13:35:002021-08-132020-12-15T13:35:002021-01-04T13:49:002020-12-152021-08-13 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421361114213612020-12-16T10:13:002021-08-202020-12-16T10:13:002021-08-20T14:55:002020-12-16 1142281273 Rupp, Richard Earl (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421362114213622020-12-16T10:28:002021-06-292020-12-16T10:28:002021-01-04T12:36:002020-12-162021-06-29 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421363114213632020-12-16T14:06:002021-08-302020-12-16T14:06:002021-02-03T09:15:002020-12-162021-08-30 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421364114213642020-12-18T13:07:002021-07-132020-12-18T13:07:002021-01-08T16:06:002020-12-182021-07-13 1142281273 Rupp, Richard Earl (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421365114213652020-12-18T15:13:002021-08-102020-12-18T15:13:002021-07-07T09:14:002020-12-182021-08-10 1142281273 Rupp, Richard Earl (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421366114213662020-12-21T11:10:002021-08-162020-12-21T11:10:002021-08-16T15:42:002020-12-21 1142281273 Rupp, Richard Earl (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421367114213672020-12-21T11:15:002021-07-132020-12-21T11:15:002021-01-11T15:10:002020-12-212021-07-13 1142281273 Rupp, Richard Earl (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421368114213682020-12-21T10:48:002021-07-082020-12-21T10:48:002021-06-09T13:29:002020-12-212021-07-08 1142281273 Rupp, Richard Earl (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421369114213692020-12-21T14:04:002021-07-202020-12-21T14:04:002021-01-15T15:06:002020-12-212021-07-20 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421370114213702020-12-21T14:10:002021-08-302020-12-21T14:10:002021-08-30T16:14:002020-12-212021-08-30 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421371114213712020-12-21T14:11:002021-07-122020-12-21T14:11:002021-01-11T15:35:002020-12-212021-07-12 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421372114213722020-12-22T10:32:002021-07-132020-12-22T10:32:002021-01-11T14:47:002020-12-222021-07-13 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421373114213732020-12-22T10:40:002021-07-132020-12-22T10:40:002021-06-04T11:30:002020-12-222021-07-13 1142281273 Rupp, Richard Earl (b)(6)AğYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421374114213742020-12-22T10:45:002021-07-132020-12-22T10:45:002021-01-12T15:56:002020-12-222021-07-13 1142281273 Rupp, Richard Earl (b)(6)AàYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421375114213752020-12-22T13:28:002021-07-082020-12-22T13:28:002021-06-04T13:57:002020-12-222021-07-08 1142281273 Rupp, Richard Earl (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421376114213762020-12-22T13:19:002021-07-082020-12-22T13:19:002021-01-14T15:37:002020-12-222021-07-08 1142281273 Rupp, Richard Earl (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421377114213772020-12-22T13:27:002021-07-112020-12-22T13:27:002021-06-04T15:22:002020-12-222021-07-11 1142281273 Rupp, Richard Earl (b)(6)AàYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421379114213792020-12-28T10:22:002021-07-162020-12-28T10:22:002021-06-11T15:01:002020-12-282021-07-16 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421380114213802020-12-28T13:32:002021-08-162020-12-28T13:32:002021-08-16T16:01:002020-12-28 1142281273 Rupp, Richard Earl (b)(6)AğYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421383114213832020-12-29T10:20:002021-07-142020-12-29T10:20:002021-01-19T15:21:002020-12-292021-07-14 1142281273 Rupp, Richard Earl (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421384114213842020-12-29T14:34:002021-08-052020-12-29T14:34:002021-01-20T15:54:002020-12-292021-08-05 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSFNOT REPORTED HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421385114213852020-12-31T10:42:002021-07-262020-12-31T10:42:002021-01-22T09:57:002020-12-312021-07-26 1142281273 Rupp, Richard Earl (b)(6)AğYEARSMNOT REPORTED HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421386114213862020-12-31T10:50:002021-07-202020-12-31T10:50:002021-06-02T09:27:002020-12-312021-07-20 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSMNOT REPORTED HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421388114213882021-01-05T10:17:002021-05-202021-01-05T10:17:002021-01-26T11:01:002021-01-052021-05-20 1142281273 Rupp, Richard Earl (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421389114213892021-01-06T10:32:002021-08-022021-01-06T10:32:002021-01-27T09:30:002021-01-062021-08-02 1142281273 Rupp, Richard Earl (b)(6)AàYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421390114213902021-01-06T10:42:002021-07-202021-01-06T10:42:002021-01-26T15:57:002021-01-06 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421391114213912021-01-06T13:00:002021-07-082021-01-06T13:00:002021-06-09T13:32:002021-01-062021-07-08 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421392114213922021-01-08T10:19:002021-07-282021-01-08T10:19:002021-01-29T16:01:002021-01-082021-07-28 1142281273 Rupp, Richard Earl (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421393114213932021-01-08T13:37:002021-08-312021-01-08T13:37:002021-08-31T12:34:002021-01-08 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1142 11421394114213942021-01-11T10:52:002021-07-272021-01-11T10:52:002021-02-02T09:43:002021-01-112021-07-27 1142281273 Rupp, Richard Earl (b)(6)AàYEARSMNOT REPORTED HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421395114213952021-01-11T11:01:002021-08-042021-01-11T11:01:002021-02-01T10:10:002021-01-112021-08-04 1142281273 Rupp, Richard Earl (b)(6)AĞYEARSMMULTIPLE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1142 11421396114213962021-01-11T12:58:002021-08-262021-01-11T12:58:002021-08-26T12:02:002021-01-112021-08-26 1142281273 Rupp, Richard Earl (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471261114712612020-12-12T13:55:002021-07-022020-12-12T13:55:002021-01-04T11:20:002020-12-012021-07-02 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471262114712622020-12-12T09:09:002021-07-022020-12-12T09:09:002021-01-04T10:25:002020-12-012021-07-02 114731313 Garcia-Diaz, Julia (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471263114712632020-12-05T10:38:002021-06-282020-12-05T10:38:002020-12-28T12:32:002020-12-052021-06-28 114731313 Garcia-Diaz, Julia (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471264114712642020-12-05T11:37:002021-07-072020-12-05T11:37:002021-06-04T08:58:002020-12-052021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471268114712682020-12-05T13:28:002021-06-302020-12-05T13:28:002020-12-28T11:00:002020-12-052021-06-30 114731313 Garcia-Diaz, Julia (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471269114712692020-12-05T13:56:002021-04-192020-12-05T13:56:002021-03-19T09:15:002020-12-05 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471270114712702020-12-05T13:58:002021-04-192020-12-05T13:58:002021-03-19T09:20:002020-12-05 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471271114712712020-12-05T13:46:002021-04-192020-12-05T13:46:002021-03-19T09:23:002020-12-05 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471273114712732020-12-05T14:45:002021-06-212020-12-05T14:45:002020-12-28T10:39:002020-12-052021-06-21 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471274114712742020-12-05T15:10:002021-06-212020-12-05T15:10:002020-12-28T11:19:002020-12-052021-06-21 114731313 Garcia-Diaz, Julia (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471275114712752020-12-05T15:27:002021-07-072020-12-05T15:27:002021-06-04T09:48:002020-12-052021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471277114712772020-12-08T18:15:002021-06-222020-12-08T18:15:002020-12-28T12:15:002020-12-082021-06-22 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471278114712782020-12-08T18:25:002021-07-162020-12-08T18:25:002021-06-14T09:12:002020-12-082021-07-16 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471279114712792020-12-08T18:13:002021-07-022020-12-08T18:13:002020-12-28T15:23:002020-12-082021-07-02 114731313 Garcia-Diaz, Julia (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471280114712802021-01-04T09:40:002021-07-162021-01-04T09:40:002021-06-14T09:07:002020-12-082021-07-16 114731313 Garcia-Diaz, Julia (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471281114712812020-12-12T10:44:002021-07-072020-12-12T10:44:002021-06-03T10:32:002020-12-122021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471282114712822020-12-12T11:21:002021-06-282020-12-12T11:21:002021-01-04T12:30:002020-12-122021-06-28 114731313 Garcia-Diaz, Julia (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471283114712832020-12-12T11:39:002021-06-252020-12-12T11:39:002021-01-04T09:45:002020-12-122021-06-25 114731313 Garcia-Diaz, Julia (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471284114712842020-12-12T11:53:002021-08-092020-12-12T11:53:002021-01-04T14:20:002020-12-122021-08-09 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471285114712852020-12-12T11:22:002021-06-302020-12-12T11:22:002021-05-31T12:52:002020-12-122021-06-30 114731313 Garcia-Diaz, Julia (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471286114712862020-12-12T14:20:002021-07-072020-12-12T14:20:002021-06-03T09:39:002020-12-122021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471287114712872020-12-12T14:31:002021-07-072020-12-12T14:31:002021-01-04T14:22:002020-12-122021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471288114712882020-12-12T15:06:002021-07-072020-12-12T15:06:002021-06-03T11:56:002020-12-122021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471289114712892020-12-19T10:10:002021-07-122020-12-19T10:10:002021-01-09T14:02:002020-12-192021-07-12 114731313 Garcia-Diaz, Julia (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471290114712902020-12-19T11:21:002021-07-072020-12-19T11:21:002021-06-03T09:34:002020-12-19 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471291114712912020-12-19T10:10:002021-06-182020-12-19T10:10:002021-05-20T11:30:002020-12-192021-06-18 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471292114712922020-12-19T10:57:002021-07-062020-12-19T10:57:002021-06-08T09:51:002020-12-192021-07-06 114731313 Garcia-Diaz, Julia (b)(6)AàYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471294114712942020-12-19T10:48:002021-07-072020-12-19T10:48:002021-01-09T09:10:002020-12-192021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471295114712952020-12-19T11:44:002021-07-072020-12-19T11:44:002021-06-03T15:44:002020-12-192021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471296114712962020-12-19T11:53:002021-07-022020-12-19T11:53:002021-01-09T12:01:002020-12-192021-07-02 114731313 Garcia-Diaz, Julia (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471297114712972020-12-19T11:20:002021-07-062020-12-19T11:20:002021-01-09T12:55:002020-12-192021-07-06 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471298114712982020-12-19T12:08:002021-06-302020-12-19T12:08:002021-06-02T10:54:002020-12-192021-06-30 1013347220 Dever, Michael Edward (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471299114712992020-12-19T12:51:002021-07-072020-12-19T12:51:002021-01-09T09:49:002020-12-192021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471300114713002020-12-19T12:40:002021-08-172020-12-19T12:40:002021-06-14T10:24:002020-12-192021-08-17 114731313 Garcia-Diaz, Julia (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471301114713012020-12-19T13:09:002021-07-072020-12-19T13:09:002021-01-09T13:27:002020-12-192021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471302114713022020-12-19T14:26:002021-07-072020-12-19T14:26:002021-01-09T10:16:002020-12-19 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471303114713032020-12-21T09:50:002021-07-062020-12-21T09:50:002021-01-09T09:24:002020-12-212021-07-06 114731313 Garcia-Diaz, Julia (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471304114713042020-12-21T10:05:002021-07-142020-12-21T10:05:002021-01-09T09:07:002020-12-212021-07-14 114731313 Garcia-Diaz, Julia (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471305114713052020-12-21T10:34:002021-07-072020-12-21T10:34:002021-01-11T17:00:002020-12-212021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471306114713062020-12-21T10:45:002021-07-062020-12-21T10:45:002021-06-04T08:48:002020-12-212021-07-06 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471307114713072020-12-21T10:53:002021-07-072020-12-21T10:53:002021-06-03T15:00:002020-12-212021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471308114713082020-12-21T12:31:002021-07-012020-12-21T12:31:002021-06-04T14:39:002020-12-212021-07-01 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471309114713092020-12-21T12:53:002021-07-062020-12-21T12:53:002021-01-09T13:35:002020-12-212021-07-06 114731313 Garcia-Diaz, Julia (b)(6)AàYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471310114713102020-12-21T13:52:002021-07-192020-12-21T13:52:002021-01-09T14:17:002020-12-212021-07-19 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471311114713112020-12-21T13:50:002021-07-202020-12-21T13:50:002021-06-01T09:30:002020-12-212021-07-20 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471312114713122020-12-21T14:35:002021-07-072020-12-21T14:35:002021-06-04T11:39:002020-12-212021-07-07 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471313114713132020-12-21T15:45:002021-08-132020-12-21T15:45:002021-01-09T12:57:002020-12-212021-08-13 114731313 Garcia-Diaz, Julia (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471314114713142020-12-21T15:53:002021-07-092020-12-21T15:53:002021-01-09T10:46:002020-12-212021-07-09 114731313 Garcia-Diaz, Julia (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471315114713152021-01-04T12:55:002021-07-272021-01-04T12:55:002021-01-23T12:03:002021-01-042021-07-27 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471316114713162021-01-04T13:02:002021-07-192021-01-04T13:02:002021-06-17T09:18:002021-01-042021-07-19 114731313 Garcia-Diaz, Julia (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471317114713172021-01-04T13:52:002021-09-012021-01-04T13:52:002021-01-23T10:35:002021-01-042021-09-01 1013347220 Dever, Michael Edward (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471318114713182021-01-04T17:25:002021-06-222021-01-04T17:25:002021-05-20T16:31:002021-01-042021-06-22 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471319114713192021-01-05T10:02:002021-07-282021-01-05T10:02:002021-01-28T10:44:002021-01-052021-07-28 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471320114713202021-01-05T11:04:002021-07-212021-01-05T11:04:002021-01-27T10:05:002021-01-052021-07-21 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471321114713212021-01-05T14:30:002021-08-122021-01-05T14:30:002021-06-07T10:39:002021-01-052021-08-12 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471322114713222021-01-05T14:51:002021-08-062021-01-05T14:51:002021-01-27T09:19:002021-01-05 114731313 Garcia-Diaz, Julia (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471323114713232021-01-05T16:23:002021-07-212021-01-05T16:23:002021-01-27T17:07:002021-01-052021-07-21 114731313 Garcia-Diaz, Julia (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471324114713242021-01-05T16:26:002021-07-062021-01-05T16:26:002021-06-07T13:54:002021-01-052021-07-06 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471325114713252021-01-05T16:20:002021-07-212021-01-05T16:20:002021-01-27T16:55:002021-01-052021-07-21 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471326114713262021-01-05T15:05:002021-07-282021-01-05T15:05:002021-01-27T15:55:002021-01-052021-07-28 114731313 Garcia-Diaz, Julia (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471327114713272021-01-05T17:10:002021-07-282021-01-05T17:10:002021-01-05T17:10:002021-01-052021-07-28 114731313 Garcia-Diaz, Julia (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471328114713282021-01-05T17:00:002021-08-182021-01-05T17:00:002021-07-23T15:30:002021-01-052021-08-18 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471329114713292021-01-05T17:40:002021-07-162021-01-05T17:40:002021-06-11T13:01:002021-01-052021-07-16 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471330114713302021-01-05T17:50:002021-07-162021-01-05T17:50:002021-06-14T15:27:002021-01-052021-07-16 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471331114713312021-01-05T17:55:002021-05-272021-01-05T17:55:002021-01-28T17:02:002021-01-052021-05-27 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471332114713322021-01-06T10:52:002021-08-172021-01-06T10:52:002021-06-10T12:00:002021-01-062021-08-17 114731313 Garcia-Diaz, Julia (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471333114713332021-01-06T11:22:002021-07-282021-01-06T11:22:002021-02-03T16:39:002021-01-062021-07-28 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471334114713342021-01-06T11:27:002021-07-212021-01-06T11:27:002021-01-27T09:00:002021-01-062021-07-21 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471335114713352021-01-06T11:31:002021-07-212021-01-06T11:31:002021-01-27T09:05:002021-01-062021-07-21 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471336114713362021-01-06T12:44:002021-07-122021-01-06T12:44:002021-01-27T11:28:002021-01-06 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471337114713372021-01-06T13:13:002021-07-212021-01-06T13:13:002021-01-27T15:45:002021-01-062021-07-21 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471338114713382021-01-06T14:32:002021-07-212021-01-06T14:32:002021-01-27T09:13:002021-01-062021-07-21 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471339114713392021-01-06T14:40:002021-08-042021-01-06T14:40:002021-06-29T12:05:002021-01-062021-08-04 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471340114713402021-01-06T16:20:002021-07-282021-01-06T16:20:002021-01-27T14:33:002021-01-062021-07-28 114731313 Garcia-Diaz, Julia (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471341114713412021-01-06T17:07:002021-08-042021-01-06T17:07:002021-06-15T13:37:002021-01-062021-08-04 114731313 Garcia-Diaz, Julia (b)(6)AàYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471342114713422021-01-06T17:05:002021-08-042021-01-06T17:05:002021-06-15T13:40:002021-01-062021-08-04 114731313 Garcia-Diaz, Julia (b)(6)AÀYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471343114713432021-01-06T16:57:002021-07-282021-01-06T16:57:002021-01-28T16:10:002021-01-062021-07-28 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSMNOT REPORTED NOT REPORTED B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471344114713442021-01-06T17:30:002021-08-132021-01-06T17:30:002021-02-12T16:55:002021-01-062021-08-13 114731313 Garcia-Diaz, Julia (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471345114713452021-01-06T17:38:002021-07-162021-01-06T17:38:002021-06-09T14:10:002021-01-062021-07-16 114731313 Garcia-Diaz, Julia (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1147 11471346114713462021-01-06T18:03:002021-07-222021-01-06T18:03:002021-01-27T13:14:002021-01-062021-07-22 114731313 Garcia-Diaz, Julia (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1147 11471347114713472021-01-06T18:13:002021-07-222021-01-06T18:13:002021-01-28T16:15:002021-01-062021-07-22 114731313 Garcia-Diaz, Julia (b)(6)AĞYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501118115011182020-10-15T09:16:002021-05-182020-10-15T09:16:002020-11-03T17:47:002020-10-152021-05-18 115036056 Senders, Shelly David (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501119115011192020-10-15T11:43:002021-05-132020-10-15T11:43:002020-11-05T14:12:002020-10-152021-05-13 115036056 Senders, Shelly David (b)(6)AàYEARSMMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501120115011202020-10-15T13:24:002021-07-082020-10-15T13:24:002021-06-10T14:39:002020-10-152021-07-08 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501121115011212020-10-15T16:35:002021-07-122020-10-15T16:35:002021-06-10T17:14:002020-10-152021-07-12 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501123115011232020-10-16T11:57:002021-07-012020-10-16T11:57:002021-06-03T16:32:002020-10-162021-07-01 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501124115011242020-10-19T09:35:002021-05-132020-10-19T09:35:002020-11-10T16:41:002020-10-192021-05-13 115036056 Senders, Shelly David (b)(6)AĞYEARSMASIAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501125115011252020-10-19T11:35:002021-07-152020-10-19T11:35:002021-06-10T10:47:002020-10-192021-07-15 115036056 Senders, Shelly David (b)(6)AàYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501126115011262020-10-19T12:23:002021-08-052020-10-19T12:23:002020-11-09T17:03:002020-10-192021-08-05 115036056 Senders, Shelly David (b)(6)AÀYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501127115011272020-10-19T13:57:002021-08-032020-10-19T13:57:002020-11-11T16:33:002020-10-192021-08-03 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501128115011282020-10-19T17:45:002021-07-052020-10-19T17:45:002021-06-07T13:38:002020-10-192021-07-05 115036056 Senders, Shelly David (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501129115011292020-10-20T08:47:002021-07-072020-10-20T08:47:002021-06-01T16:36:002020-10-202021-07-07 115036056 Senders, Shelly David (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501130115011302020-10-20T17:30:002021-05-142020-10-20T17:30:002020-11-09T09:50:002020-10-202021-05-14 115036056 Senders, Shelly David (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501131115011312020-10-20T17:34:002021-06-112020-10-20T17:34:002021-03-15T09:23:002020-10-20 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501132115011322020-10-20T17:33:002021-05-142020-10-20T17:33:002020-11-09T09:49:002020-10-202021-05-14 115036056 Senders, Shelly David (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501133115011332020-10-21T09:40:002021-05-112020-10-21T09:40:002020-11-10T13:43:002020-10-212021-05-11 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501134115011342020-10-21T12:36:002021-07-052020-10-21T12:36:002021-06-07T16:03:002020-10-21 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501135115011352020-10-21T12:47:002021-05-132020-10-21T12:47:002020-11-13T12:18:002020-10-21 115036056 Senders, Shelly David (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501136115011362020-10-21T16:14:002021-07-062020-10-21T16:14:002021-06-08T11:49:002020-10-21 115036056 Senders, Shelly David (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501166115011662020-11-30T11:25:002021-07-062020-11-30T11:25:002021-06-08T09:06:002020-11-302021-07-06 115036056 Senders, Shelly David (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501168115011682020-12-02T14:10:002021-06-112020-12-02T14:10:002020-12-23T11:51:002020-12-022021-06-11 115036056 Senders, Shelly David (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501171115011712020-12-03T09:47:002021-06-172020-12-03T09:47:002020-12-24T10:50:002020-12-032021-06-17 115036056 Senders, Shelly David (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501176115011762020-12-04T10:57:002021-07-062020-12-04T10:57:002021-06-08T11:45:002020-12-042021-07-06 115036056 Senders, Shelly David (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501178115011782020-12-07T12:41:002021-06-282020-12-07T12:41:002020-12-28T17:27:002020-12-072021-06-28 115036056 Senders, Shelly David (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501179115011792020-12-07T15:58:002021-07-022020-12-07T15:58:002021-06-04T11:39:002020-12-072021-07-02 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501180115011802020-12-08T09:17:002021-06-282020-12-08T09:17:002020-12-30T09:42:002020-12-082021-06-28 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501182115011822020-12-08T12:51:002021-04-152020-12-08T12:51:002021-03-18T12:14:002020-12-082021-04-15 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501183115011832020-12-08T12:53:002021-06-252020-12-08T12:53:002020-12-28T10:52:002020-12-082021-06-25 115036056 Senders, Shelly David (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501185115011852020-12-08T17:00:002021-07-022020-12-08T17:00:002021-06-03T12:14:002020-12-082021-07-02 115036056 Senders, Shelly David (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501186115011862020-12-09T11:27:002021-07-012020-12-09T11:27:002020-12-29T10:53:002020-12-092021-07-01 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501187115011872020-12-09T14:13:002021-07-232020-12-09T14:13:002020-12-28T09:07:002020-12-092021-07-23 115036056 Senders, Shelly David (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501189115011892020-12-10T09:31:002021-07-072020-12-10T09:31:002021-06-07T17:47:002020-12-102021-07-07 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501190115011902020-12-10T09:29:002021-07-072020-12-10T09:29:002021-06-07T17:46:002020-12-102021-07-07 115036056 Senders, Shelly David (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501191115011912020-12-10T10:59:002021-06-302020-12-10T10:59:002020-12-30T12:20:002020-12-102021-06-30 115036056 Senders, Shelly David (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501192115011922020-12-10T12:55:002021-07-082020-12-10T12:55:002021-06-09T15:54:002020-12-102021-07-08 115036056 Senders, Shelly David (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501193115011932020-12-10T15:02:002021-06-302020-12-10T15:02:002021-06-01T08:25:002020-12-102021-06-30 115036056 Senders, Shelly David (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501194115011942020-12-10T17:07:002021-06-242020-12-10T17:07:002020-12-31T11:16:002020-12-102021-06-24 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501195115011952020-12-11T09:41:002021-07-062020-12-11T09:41:002021-06-07T17:37:002020-12-112021-07-06 115036056 Senders, Shelly David (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501196115011962020-12-11T09:43:002021-07-062020-12-11T09:43:002021-06-07T17:39:002020-12-112021-07-06 115036056 Senders, Shelly David (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501197115011972020-12-11T13:07:002021-06-232020-12-11T13:07:002020-12-30T13:58:002020-12-112021-06-23 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501198115011982020-12-11T13:08:002021-06-252020-12-11T13:08:002020-12-30T16:07:002020-12-112021-06-25 115036056 Senders, Shelly David (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501199115011992020-12-11T15:29:002021-05-192020-12-11T15:29:002020-12-30T09:18:002020-12-112021-05-19 115036056 Senders, Shelly David (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501200115012002020-12-11T15:57:002021-06-292020-12-11T15:57:002021-06-01T16:47:002020-12-112021-06-29 115036056 Senders, Shelly David (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501201115012012020-12-11T15:56:002021-06-242020-12-11T15:56:002020-12-31T12:46:002020-12-112021-06-24 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501202115012022020-12-14T08:59:002021-07-052020-12-14T08:59:002021-01-05T18:03:002020-12-142021-07-05 115036056 Senders, Shelly David (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501203115012032020-12-14T09:30:002021-07-062020-12-14T09:30:002021-01-04T08:52:002020-12-142021-07-06 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501204115012042020-12-14T09:32:002021-07-062020-12-14T09:32:002021-06-07T08:09:002020-12-142021-07-06 115036056 Senders, Shelly David (b)(6)AàYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501205115012052020-12-14T11:23:002021-06-292020-12-14T11:23:002021-01-04T17:37:002020-12-142021-06-29 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501206115012062020-12-14T16:50:002021-07-122020-12-14T16:50:002021-06-14T16:40:002020-12-142021-07-12 115036056 Senders, Shelly David (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501207115012072020-12-14T17:13:002021-07-072020-12-14T17:13:002021-06-09T16:30:002020-12-142021-07-07 115036056 Senders, Shelly David (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501208115012082020-12-14T17:14:002021-07-062020-12-14T17:14:002021-01-04T18:02:002020-12-142021-07-06 115036056 Senders, Shelly David (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501209115012092020-12-15T10:21:002021-06-292020-12-15T10:21:002021-01-04T14:02:002020-12-15 115036056 Senders, Shelly David (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501210115012102020-12-15T15:10:002021-07-212020-12-15T15:10:002021-06-14T15:33:002020-12-152021-07-21 115036056 Senders, Shelly David (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501211115012112020-12-15T16:06:002021-07-092020-12-15T16:06:002021-01-07T08:32:002020-12-152021-07-09 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501212115012122020-12-15T16:05:002021-07-052020-12-15T16:05:002021-06-02T16:05:002020-12-152021-07-05 115036056 Senders, Shelly David (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501213115012132020-12-15T18:03:002021-07-012020-12-15T18:03:002021-01-04T13:33:002020-12-15 115036056 Senders, Shelly David (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501214115012142020-12-15T18:11:002021-07-142020-12-15T18:11:002021-06-10T17:46:002020-12-152021-07-14 115036056 Senders, Shelly David (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501215115012152020-12-15T18:10:002021-07-142020-12-15T18:10:002021-06-10T17:47:002020-12-152021-07-14 115036056 Senders, Shelly David (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501216115012162020-12-16T11:43:002021-07-012020-12-16T11:43:002021-01-06T17:44:002020-12-162021-07-01 115036056 Senders, Shelly David (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501217115012172020-12-16T17:07:002021-06-292020-12-16T17:07:002021-01-05T08:39:002020-12-162021-06-29 115036056 Senders, Shelly David (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501218115012182020-12-17T09:35:002021-07-062020-12-17T09:35:002021-06-08T09:43:002020-12-172021-07-06 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501219115012192020-12-17T09:51:002021-07-072020-12-17T09:51:002021-01-05T13:52:002020-12-172021-07-07 115036056 Senders, Shelly David (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501220115012202020-12-17T12:00:002021-07-062020-12-17T12:00:002021-06-07T12:07:002020-12-172021-07-06 115036056 Senders, Shelly David (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501221115012212020-12-17T13:25:002021-06-222020-12-17T13:25:002021-01-08T13:23:002020-12-172021-06-22 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501222115012222020-12-17T14:27:002021-06-292020-12-17T14:27:002021-06-01T11:10:002020-12-172021-06-29 115036056 Senders, Shelly David (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501223115012232020-12-17T14:52:002021-07-062020-12-17T14:52:002021-06-07T09:00:002020-12-172021-07-06 115036056 Senders, Shelly David (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501224115012242020-12-17T17:07:002021-07-052020-12-17T17:07:002021-06-07T15:45:002020-12-172021-07-05 115036056 Senders, Shelly David (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501225115012252020-12-17T17:04:002021-07-022020-12-17T17:04:002021-01-08T16:44:002020-12-172021-07-02 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501226115012262020-12-17T17:18:002021-07-052020-12-17T17:18:002021-01-08T17:09:002020-12-172021-07-05 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501227115012272020-12-18T14:59:002021-06-302020-12-18T14:59:002021-01-06T13:07:002020-12-182021-06-30 115036056 Senders, Shelly David (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501228115012282020-12-18T15:52:002021-07-012020-12-18T15:52:002021-06-03T13:45:002020-12-182021-07-01 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501229115012292020-12-20T09:36:002021-07-012020-12-20T09:36:002021-06-02T17:16:002020-12-202021-07-01 115036056 Senders, Shelly David (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501230115012302020-12-20T11:23:002021-07-062020-12-20T11:23:002021-01-11T18:01:002020-12-202021-07-06 115036056 Senders, Shelly David (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501231115012312020-12-20T13:27:002021-07-052020-12-20T13:27:002021-06-07T10:08:002020-12-202021-07-05 115036056 Senders, Shelly David (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501232115012322020-12-21T09:16:002021-08-172020-12-21T09:16:002021-06-07T09:11:002020-12-212021-08-17 115036056 Senders, Shelly David (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501233115012332020-12-21T09:15:002021-07-262020-12-21T09:15:002021-01-11T08:31:002020-12-212021-07-26 115036056 Senders, Shelly David (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501234115012342020-12-21T11:20:002021-07-082020-12-21T11:20:002021-01-13T15:52:002020-12-212021-07-08 115036056 Senders, Shelly David (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501235115012352020-12-21T12:36:002021-07-052020-12-21T12:36:002021-06-07T11:47:002020-12-212021-07-05 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501236115012362020-12-21T14:51:002021-09-022020-12-21T14:51:002021-01-12T08:40:002020-12-212021-09-02 115036056 Senders, Shelly David (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501237115012372020-12-21T17:21:002021-07-122020-12-21T17:21:002021-06-11T16:47:002020-12-212021-07-12 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501238115012382020-12-22T09:41:002021-08-172020-12-22T09:41:002021-01-14T16:11:002020-12-222021-08-17 115036056 Senders, Shelly David (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501239115012392020-12-22T15:53:002021-07-082020-12-22T15:53:002021-01-13T16:26:002020-12-222021-07-08 115036056 Senders, Shelly David (b)(6)AĞYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501240115012402020-12-22T17:02:002021-06-302020-12-22T17:02:002021-06-02T17:15:002020-12-222021-06-30 115036056 Senders, Shelly David (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501241115012412020-12-22T19:08:002021-07-092020-12-22T19:08:002021-01-14T16:50:002020-12-222021-07-09 115036056 Senders, Shelly David (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501242115012422020-12-23T12:14:002021-05-032020-12-23T12:14:002021-04-05T11:42:002020-12-232021-05-03 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501243115012432020-12-23T14:40:002021-07-012020-12-23T14:40:002021-06-03T14:58:002020-12-232021-07-01 115036056 Senders, Shelly David (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501244115012442020-12-28T09:13:002021-09-022020-12-28T09:13:002021-03-08T14:23:002020-12-282021-09-02 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501245115012452020-12-28T12:34:002021-09-022020-12-28T12:34:002021-01-19T17:19:002020-12-282021-09-02 115036056 Senders, Shelly David (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501246115012462020-12-28T16:38:002021-08-112020-12-28T16:38:002021-01-29T10:46:002020-12-282021-08-11 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501247115012472020-12-29T09:31:002021-07-132020-12-29T09:31:002021-01-19T11:38:002020-12-292021-07-13 115036056 Senders, Shelly David (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501248115012482020-12-29T11:28:002021-07-072020-12-29T11:28:002021-06-09T14:41:002020-12-292021-07-07 115036056 Senders, Shelly David (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501249115012492020-12-29T14:10:002021-07-062020-12-29T14:10:002021-06-04T16:35:002020-12-292021-07-06 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501250115012502020-12-29T14:08:002021-07-192020-12-29T14:08:002021-01-19T16:40:002020-12-292021-07-19 115036056 Senders, Shelly David (b)(6)AĞYEARSFNOT REPORTED HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501251115012512020-12-29T15:16:002021-06-302020-12-29T15:16:002021-06-02T09:15:002020-12-292021-06-30 115036056 Senders, Shelly David (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501252115012522020-12-29T15:43:002021-07-142020-12-29T15:43:002021-01-18T13:26:002020-12-292021-07-14 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501253115012532020-12-29T17:12:002021-07-222020-12-29T17:12:002021-01-18T11:45:002020-12-292021-07-22 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501254115012542020-12-29T17:41:002021-07-022020-12-29T17:41:002021-06-03T09:36:002020-12-292021-07-02 115036056 Senders, Shelly David (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501255115012552020-12-30T12:08:002021-07-122020-12-30T12:08:002021-01-18T17:07:002020-12-302021-07-12 115036056 Senders, Shelly David (b)(6)AğYEARSMMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501256115012562020-12-30T12:06:002021-07-122020-12-30T12:06:002021-01-18T15:05:002020-12-302021-07-12 115036056 Senders, Shelly David (b)(6)AÀYEARSMMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501257115012572020-12-30T13:51:002021-06-302020-12-30T13:51:002021-06-02T10:19:002020-12-302021-06-30 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501258115012582020-12-30T16:31:002021-07-132020-12-30T16:31:002021-06-11T15:40:002020-12-302021-07-13 115036056 Senders, Shelly David (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501259115012592020-12-30T16:32:002021-07-132020-12-30T16:32:002021-06-11T15:41:002020-12-302021-07-13 115036056 Senders, Shelly David (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501260115012602020-12-30T18:00:002021-07-142020-12-30T18:00:002021-01-20T17:41:002020-12-302021-07-14 115036056 Senders, Shelly David (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501261115012612020-12-31T10:38:002021-07-052020-12-31T10:38:002021-06-03T10:34:002020-12-312021-07-05 115036056 Senders, Shelly David (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501262115012622020-12-31T10:10:002021-08-052020-12-31T10:10:002021-01-20T17:06:002020-12-312021-08-05 115036056 Senders, Shelly David (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501263115012632021-01-04T09:11:002021-07-092021-01-04T09:11:002021-06-11T09:20:002021-01-042021-07-09 115036056 Senders, Shelly David (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501264115012642021-01-04T09:58:002021-07-132021-01-04T09:58:002021-06-15T17:59:002021-01-042021-07-13 115036056 Senders, Shelly David (b)(6)AàYEARSFMULTIPLE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501265115012652021-01-04T12:01:002021-07-222021-01-04T12:01:002021-01-25T16:56:002021-01-042021-07-22 115036056 Senders, Shelly David (b)(6)AàYEARSFNATIVE HAWAIIAN OR OTHER PACIFIC ISLANDERNOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501266115012662021-01-04T12:26:002021-07-202021-01-04T12:26:002021-01-26T15:42:002021-01-042021-07-20 115036056 Senders, Shelly David (b)(6)AàYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501267115012672021-01-04T17:22:002021-07-062021-01-04T17:22:002021-05-05T15:05:002021-01-042021-07-06 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501268115012682021-01-04T16:53:002021-07-302021-01-04T16:53:002021-01-25T15:08:002021-01-042021-07-30 115036056 Senders, Shelly David (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501269115012692021-01-04T17:00:002021-08-042021-01-04T17:00:002021-01-26T16:14:002021-01-042021-08-04 115036056 Senders, Shelly David (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501270115012702021-01-04T17:09:002021-07-062021-01-04T17:09:002021-06-08T09:18:002021-01-042021-07-06 115036056 Senders, Shelly David (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501271115012712021-01-05T09:05:002021-07-022021-01-05T09:05:002021-06-02T15:43:002021-01-052021-07-02 115036056 Senders, Shelly David (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501272115012722021-01-05T09:03:002021-07-022021-01-05T09:03:002021-06-02T15:43:002021-01-052021-07-02 115036056 Senders, Shelly David (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501273115012732021-01-05T09:18:002021-07-292021-01-05T09:18:002021-01-26T08:43:002021-01-052021-07-29 115036056 Senders, Shelly David (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501274115012742021-01-05T13:59:002021-07-202021-01-05T13:59:002021-01-25T17:13:002021-01-052021-07-20 115036056 Senders, Shelly David (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501275115012752021-01-05T14:13:002021-08-062021-01-05T14:13:002021-01-27T16:42:002021-01-052021-08-06 115036056 Senders, Shelly David (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501276115012762021-01-05T16:09:002021-07-222021-01-05T16:09:002021-01-26T16:38:002021-01-052021-07-22 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501277115012772021-01-05T16:53:002021-07-062021-01-05T16:53:002021-06-08T10:15:002021-01-052021-07-06 115036056 Senders, Shelly David (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501278115012782021-01-05T17:53:002021-07-192021-01-05T17:53:002021-06-21T16:18:002021-01-052021-07-19 115036056 Senders, Shelly David (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501279115012792021-01-06T09:04:002021-08-022021-01-06T09:04:002021-01-25T13:45:002021-01-062021-08-02 115036056 Senders, Shelly David (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501280115012802021-01-06T11:13:002021-07-082021-01-06T11:13:002021-06-10T16:43:002021-01-062021-07-08 115036056 Senders, Shelly David (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501281115012812021-01-06T13:24:002021-07-282021-01-06T13:24:002021-01-27T15:48:002021-01-062021-07-28 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501282115012822021-01-06T15:40:002021-07-072021-01-06T15:40:002021-06-09T08:41:002021-01-062021-07-07 115036056 Senders, Shelly David (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501283115012832021-01-06T16:43:002021-07-062021-01-06T16:43:002021-06-03T12:03:002021-01-062021-07-06 115036056 Senders, Shelly David (b)(6)AÀYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501284115012842021-01-07T11:14:002021-07-072021-01-07T11:14:002021-06-07T13:37:002021-01-072021-07-07 115036056 Senders, Shelly David (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501285115012852021-01-07T14:15:002021-07-212021-01-07T14:15:002021-01-27T12:37:002021-01-072021-07-21 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501286115012862021-01-07T14:17:002021-07-212021-01-07T14:17:002021-01-27T12:38:002021-01-072021-07-21 115036056 Senders, Shelly David (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501287115012872021-01-07T14:58:002021-07-282021-01-07T14:58:002021-01-28T16:35:002021-01-072021-07-28 115036056 Senders, Shelly David (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501288115012882021-01-08T09:39:002021-07-222021-01-08T09:39:002021-01-28T14:34:002021-01-082021-07-22 115036056 Senders, Shelly David (b)(6)AğYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501289115012892021-01-08T14:08:002021-07-012021-01-08T14:08:002021-06-03T16:07:002021-01-082021-07-01 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501290115012902021-01-11T09:24:002021-07-022021-01-11T09:24:002021-06-04T10:40:002021-01-112021-07-02 115036056 Senders, Shelly David (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501291115012912021-01-11T11:34:002021-07-062021-01-11T11:34:002021-06-08T13:34:002021-01-112021-07-06 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501292115012922021-01-11T11:36:002021-07-282021-01-11T11:36:002021-02-03T15:37:002021-01-112021-07-28 115036056 Senders, Shelly David (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501293115012932021-01-11T11:56:002021-08-062021-01-11T11:56:002021-02-12T14:43:002021-01-112021-08-06 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501294115012942021-01-11T14:04:002021-07-152021-01-11T14:04:002021-06-16T16:11:002021-01-11 115036056 Senders, Shelly David (b)(6)AÀYEARSFBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501295115012952021-01-11T14:13:002021-07-202021-01-11T14:13:002021-02-01T16:48:002021-01-112021-07-20 115036056 Senders, Shelly David (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501296115012962021-01-11T17:04:002021-07-052021-01-11T17:04:002021-06-02T15:32:002021-01-112021-07-05 115036056 Senders, Shelly David (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501297115012972021-01-11T17:23:002021-08-052021-01-11T17:23:002021-02-02T17:18:002021-01-11 115036056 Senders, Shelly David (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501298115012982021-01-12T11:15:002021-06-292021-01-12T11:15:002021-06-01T09:32:002021-01-122021-06-29 115036056 Senders, Shelly David (b)(6)AĞYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501299115012992021-01-12T14:26:002021-07-262021-01-12T14:26:002021-02-01T09:14:002021-01-122021-07-26 115036056 Senders, Shelly David (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501300115013002021-01-12T16:29:002021-07-022021-01-12T16:29:002021-06-04T16:01:002021-01-122021-07-02 115036056 Senders, Shelly David (b)(6)AàYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1150 11501301115013012021-01-12T16:40:002021-08-092021-01-12T16:40:002021-02-03T16:38:002021-01-122021-08-09 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1150 11501302115013022021-01-12T16:44:002021-05-242021-01-12T16:44:002021-04-26T15:49:002021-01-122021-05-24 115036056 Senders, Shelly David (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521604115216042020-12-02T15:10:002021-05-042020-12-02T15:10:002021-03-31T10:15:002020-12-022021-05-04 115211354 Brandon, Donald M. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521605115216052020-12-02T16:07:002021-06-152020-12-02T16:07:002020-12-22T10:37:002020-12-022021-06-15 115211354 Brandon, Donald M. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521607115216072020-12-03T11:41:002021-07-142020-12-03T11:41:002021-06-16T16:37:002020-12-032021-07-14 115211354 Brandon, Donald M. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521608115216082020-12-03T11:32:002021-06-162020-12-03T11:32:002020-12-23T11:30:002020-12-032021-06-16 115211354 Brandon, Donald M. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521611115216112020-12-03T15:02:002021-06-152020-12-03T15:02:002020-12-22T13:55:002020-12-032021-06-15 115211354 Brandon, Donald M. (b)(6)AàYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521612115216122020-12-03T14:44:002021-08-252020-12-03T14:44:002021-07-14T14:22:002020-12-032021-08-25 115211354 Brandon, Donald M. (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521613115216132020-12-03T14:37:002021-08-252020-12-03T14:37:002021-07-14T14:32:002020-12-032021-08-25 115211354 Brandon, Donald M. (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521614115216142020-12-03T15:45:002021-06-172020-12-03T15:45:002020-12-22T11:06:002020-12-032021-06-17 115211354 Brandon, Donald M. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521615115216152020-12-03T15:52:002021-07-082020-12-03T15:52:002021-06-10T09:38:002020-12-032021-07-08 115211354 Brandon, Donald M. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521617115216172020-12-03T17:37:002021-07-142020-12-03T17:37:002020-12-28T09:03:002020-12-032021-07-14 115211354 Brandon, Donald M. (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521619115216192020-12-03T18:08:002021-06-212020-12-03T18:08:002020-12-22T15:51:002020-12-032021-06-21 115211354 Brandon, Donald M. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521625115216252020-12-04T10:04:002021-07-192020-12-04T10:04:002020-12-23T12:10:002020-12-042021-07-19 115211354 Brandon, Donald M. (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521626115216262020-12-04T09:55:002021-08-192020-12-04T09:55:002021-07-22T14:18:002020-12-042021-08-19 115211354 Brandon, Donald M. (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521628115216282020-12-04T10:43:002021-06-162020-12-04T10:43:002020-12-23T12:41:002020-12-042021-06-16 115211354 Brandon, Donald M. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521629115216292020-12-04T10:57:002021-07-212020-12-04T10:57:002021-01-25T09:33:002020-12-042021-07-21 115211354 Brandon, Donald M. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521633115216332020-12-07T10:42:002021-07-282020-12-07T10:42:002021-06-17T15:16:002020-12-072021-07-28 115211354 Brandon, Donald M. (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521635115216352020-12-07T11:54:002021-06-302020-12-07T11:54:002020-12-28T11:19:002020-12-072021-06-30 115211354 Brandon, Donald M. (b)(6)AğYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521636115216362020-12-07T12:01:002021-08-112020-12-07T12:01:002020-12-28T08:42:002020-12-072021-08-11 115211354 Brandon, Donald M. (b)(6)AĞYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521637115216372020-12-07T13:10:002021-07-082020-12-07T13:10:002021-06-09T15:16:002020-12-072021-07-08 115211354 Brandon, Donald M. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521638115216382020-12-07T12:55:002021-05-192020-12-07T12:55:002021-04-21T14:48:002020-12-072021-05-19 115211354 Brandon, Donald M. (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521639115216392020-12-07T15:06:002021-07-072020-12-07T15:06:002021-06-08T10:34:002020-12-072021-07-07 115211354 Brandon, Donald M. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521640115216402020-12-07T15:24:002021-05-262020-12-07T15:24:002020-12-28T12:30:002020-12-072021-05-26 115211354 Brandon, Donald M. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521641115216412020-12-07T15:35:002021-05-262020-12-07T15:35:002020-12-07T15:35:002020-12-072021-05-26 115211354 Brandon, Donald M. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521642115216422020-12-07T15:51:002021-07-072020-12-07T15:51:002021-06-09T16:12:002020-12-072021-07-07 115211354 Brandon, Donald M. (b)(6)AàYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521644115216442020-12-07T17:09:002021-06-292020-12-07T17:09:002020-12-28T10:32:002020-12-072021-06-29 115211354 Brandon, Donald M. (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521645115216452020-12-08T09:20:002021-08-182020-12-08T09:20:002021-08-18T16:58:002020-12-082021-08-18 115211354 Brandon, Donald M. (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521646115216462020-12-08T12:48:002021-07-282020-12-08T12:48:002020-12-28T16:37:002020-12-082021-07-28 115211354 Brandon, Donald M. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521647115216472020-12-08T14:53:002021-07-162020-12-08T14:53:002021-06-18T08:41:002020-12-082021-07-16 115211354 Brandon, Donald M. (b)(6)AğYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521648115216482020-12-08T15:15:002021-06-282020-12-08T15:15:002020-12-28T09:37:002020-12-082021-06-28 115211354 Brandon, Donald M. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521649115216492020-12-08T15:26:002021-09-012020-12-08T15:26:002021-08-03T12:03:002020-12-082021-09-01 115211354 Brandon, Donald M. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521650115216502020-12-08T16:16:002021-08-022020-12-08T16:16:002020-12-28T11:41:002020-12-082021-08-02 115211354 Brandon, Donald M. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521651115216512020-12-08T16:44:002021-07-092020-12-08T16:44:002021-06-07T11:23:002020-12-082021-07-09 115211354 Brandon, Donald M. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521652115216522020-12-08T17:12:002021-07-082020-12-08T17:12:002021-06-01T10:00:002020-12-082021-07-08 115211354 Brandon, Donald M. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521653115216532020-12-09T10:59:002021-06-222020-12-09T10:59:002020-12-28T12:56:002020-12-092021-06-22 115211354 Brandon, Donald M. (b)(6)AĞYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521654115216542020-12-09T11:45:002021-08-162020-12-09T11:45:002021-07-19T10:08:002020-12-092021-08-16 115211354 Brandon, Donald M. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521655115216552020-12-09T12:21:002021-06-222020-12-09T12:21:002020-12-29T09:10:002020-12-092021-06-22 115211354 Brandon, Donald M. (b)(6)AÀYEARSFMULTIPLE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521656115216562020-12-10T11:04:002021-07-072020-12-10T11:04:002021-01-04T13:44:002020-12-102021-07-07 115211354 Brandon, Donald M. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521657115216572020-12-10T14:52:002021-06-222020-12-10T14:52:002020-12-29T12:33:002020-12-102021-06-22 115211354 Brandon, Donald M. (b)(6)AàYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521658115216582020-12-10T15:00:002021-07-192020-12-10T15:00:002021-07-19T10:42:002020-12-102021-07-19 115211354 Brandon, Donald M. (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521659115216592020-12-10T16:00:002021-07-082020-12-10T16:00:002021-06-07T15:10:002020-12-102021-07-08 115211354 Brandon, Donald M. (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521660115216602020-12-10T15:51:002021-07-272020-12-10T15:51:002021-06-29T12:59:002020-12-102021-07-27 115211354 Brandon, Donald M. (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521661115216612020-12-10T16:19:002021-07-142020-12-10T16:19:002021-06-16T15:19:002020-12-102021-07-14 115211354 Brandon, Donald M. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521662115216622020-12-10T16:50:002021-06-222020-12-10T16:50:002020-12-29T11:58:002020-12-102021-06-22 115211354 Brandon, Donald M. (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521663115216632020-12-10T17:11:002021-06-222020-12-10T17:11:002020-12-29T14:16:002020-12-102021-06-22 115211354 Brandon, Donald M. (b)(6)AĞYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521664115216642020-12-11T10:46:002021-08-202020-12-11T10:46:002021-07-21T09:58:002020-12-112021-08-20 115211354 Brandon, Donald M. (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521665115216652020-12-11T10:37:002021-06-242020-12-11T10:37:002020-12-30T10:00:002020-12-112021-06-24 115211354 Brandon, Donald M. (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521666115216662020-12-11T10:54:002021-08-112020-12-11T10:54:002021-07-14T09:24:002020-12-112021-08-11 115211354 Brandon, Donald M. (b)(6)AğYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521667115216672020-12-11T11:46:002021-07-062020-12-11T11:46:002021-06-07T16:26:002020-12-112021-07-06 115211354 Brandon, Donald M. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521668115216682020-12-11T11:37:002021-06-282020-12-11T11:37:002020-12-30T11:43:002020-12-112021-06-28 115211354 Brandon, Donald M. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521669115216692020-12-11T12:33:002021-07-142020-12-11T12:33:002021-06-16T16:45:002020-12-112021-07-14 115211354 Brandon, Donald M. (b)(6)AğYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521670115216702020-12-11T14:11:002021-08-052020-12-11T14:11:002020-12-30T09:39:002020-12-112021-08-05 115211354 Brandon, Donald M. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521671115216712020-12-14T14:59:002021-07-122020-12-14T14:59:002021-01-04T16:54:002020-12-142021-07-12 115211354 Brandon, Donald M. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521672115216722020-12-14T15:33:002021-07-092020-12-14T15:33:002021-06-11T13:27:002020-12-142021-07-09 115211354 Brandon, Donald M. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521673115216732020-12-14T15:39:002021-08-312020-12-14T15:39:002021-01-04T14:22:002020-12-142021-08-31 115211354 Brandon, Donald M. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521674115216742020-12-14T16:14:002021-07-072020-12-14T16:14:002021-01-08T12:21:002020-12-142021-07-07 115211354 Brandon, Donald M. (b)(6)AğYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521675115216752020-12-14T16:22:002021-07-302020-12-14T16:22:002021-06-14T10:52:002020-12-142021-07-30 115211354 Brandon, Donald M. (b)(6)AàYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521676115216762020-12-14T17:26:002021-07-082020-12-14T17:26:002021-06-09T15:09:002020-12-142021-07-08 115211354 Brandon, Donald M. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521677115216772020-12-15T11:57:002021-07-262020-12-15T11:57:002021-01-04T10:22:002020-12-152021-07-26 115211354 Brandon, Donald M. (b)(6)AÀYEARSFBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521678115216782020-12-15T12:21:002021-07-132020-12-15T12:21:002021-06-15T11:44:002020-12-152021-07-13 115211354 Brandon, Donald M. (b)(6)AàYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521679115216792020-12-15T14:58:002021-06-302020-12-15T14:58:002021-01-05T14:49:002020-12-152021-06-30 115211354 Brandon, Donald M. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521680115216802020-12-15T15:42:002021-07-022020-12-15T15:42:002021-06-04T14:01:002020-12-152021-07-02 115211354 Brandon, Donald M. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521681115216812020-12-15T16:27:002021-08-272020-12-15T16:27:002021-08-27T13:12:002020-12-152021-08-27 115211354 Brandon, Donald M. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521682115216822020-12-15T16:35:002021-07-082020-12-15T16:35:002021-01-05T14:06:002020-12-152021-07-08 115211354 Brandon, Donald M. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521683115216832020-12-15T17:06:002021-06-292020-12-15T17:06:002021-01-05T15:56:002020-12-152021-06-29 115211354 Brandon, Donald M. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521684115216842020-12-15T17:33:002021-07-072020-12-15T17:33:002021-01-05T17:06:002020-12-152021-07-07 115211354 Brandon, Donald M. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521685115216852020-12-15T17:43:002021-07-132020-12-15T17:43:002021-01-05T12:22:002020-12-152021-07-13 115211354 Brandon, Donald M. (b)(6)AàYEARSFBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521686115216862020-12-16T12:01:002021-08-162020-12-16T12:01:002021-08-16T10:03:002020-12-162021-08-16 115211354 Brandon, Donald M. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521687115216872020-12-16T15:49:002021-07-122020-12-16T15:49:002021-06-14T17:18:002020-12-162021-07-12 115211354 Brandon, Donald M. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521688115216882020-12-16T15:41:002021-07-122020-12-16T15:41:002021-06-14T16:19:002020-12-162021-07-12 115211354 Brandon, Donald M. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521689115216892020-12-16T16:19:002021-06-292020-12-16T16:19:002021-01-05T15:27:002020-12-162021-06-29 115211354 Brandon, Donald M. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521690115216902020-12-16T16:40:002021-07-142020-12-16T16:40:002021-06-16T15:59:002020-12-162021-07-14 115211354 Brandon, Donald M. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521691115216912020-12-16T16:29:002021-06-242020-12-16T16:29:002021-01-06T15:02:002020-12-162021-06-24 115211354 Brandon, Donald M. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521692115216922020-12-16T16:53:002021-08-052020-12-16T16:53:002021-01-06T13:40:002020-12-162021-08-05 115211354 Brandon, Donald M. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521693115216932020-12-16T17:14:002021-07-202020-12-16T17:14:002021-06-08T09:30:002020-12-162021-07-20 115211354 Brandon, Donald M. (b)(6)AğYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521694115216942020-12-16T17:28:002021-06-302020-12-16T17:28:002021-01-06T11:20:002020-12-162021-06-30 115211354 Brandon, Donald M. (b)(6)AÀYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521695115216952020-12-16T17:40:002021-07-162020-12-16T17:40:002021-06-16T15:32:002020-12-162021-07-16 115211354 Brandon, Donald M. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521696115216962020-12-17T18:12:002021-08-022020-12-17T18:12:002021-06-14T15:34:002020-12-172021-08-02 115211354 Brandon, Donald M. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521697115216972020-12-18T15:20:002021-07-092020-12-18T15:20:002021-01-08T14:35:002020-12-182021-07-09 115211354 Brandon, Donald M. (b)(6)AÀYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521698115216982020-12-18T15:30:002021-05-182020-12-18T15:30:002021-01-08T14:19:002020-12-182021-05-18 115211354 Brandon, Donald M. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521699115216992020-12-18T15:57:002021-07-062020-12-18T15:57:002021-01-08T14:46:002020-12-182021-07-06 115211354 Brandon, Donald M. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521700115217002020-12-18T16:07:002021-07-142020-12-18T16:07:002021-01-08T14:12:002020-12-182021-07-14 115211354 Brandon, Donald M. (b)(6)AÀYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521701115217012020-12-18T16:20:002021-07-152020-12-18T16:20:002021-06-17T16:41:002020-12-182021-07-15 115211354 Brandon, Donald M. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521702115217022020-12-21T10:23:002021-07-062020-12-21T10:23:002021-01-12T16:12:002020-12-212021-07-06 115211354 Brandon, Donald M. (b)(6)AĞYEARSMWHITE NOT REPORTED B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521703115217032020-12-21T10:32:002021-07-262020-12-21T10:32:002021-06-28T10:18:002020-12-212021-07-26 115211354 Brandon, Donald M. (b)(6)AĞYEARSMWHITE NOT REPORTED PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521704115217042020-12-21T11:21:002021-07-062020-12-21T11:21:002021-01-11T11:58:002020-12-212021-07-06 115211354 Brandon, Donald M. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521705115217052020-12-21T11:45:002021-05-182020-12-21T11:45:002021-04-14T14:52:002020-12-212021-05-18 115211354 Brandon, Donald M. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521706115217062020-12-21T12:35:002021-07-212020-12-21T12:35:002021-06-16T16:18:002020-12-212021-07-21 115211354 Brandon, Donald M. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521707115217072020-12-21T14:17:002021-07-142020-12-21T14:17:002021-01-11T13:34:002020-12-212021-07-14 115211354 Brandon, Donald M. (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521708115217082020-12-21T15:29:002021-07-192020-12-21T15:29:002021-01-11T11:40:002020-12-21 115211354 Brandon, Donald M. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521709115217092020-12-22T10:26:002021-07-272020-12-22T10:26:002021-06-14T15:06:002020-12-222021-07-27 115211354 Brandon, Donald M. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521710115217102020-12-22T11:28:002021-07-142020-12-22T11:28:002021-06-11T10:44:002020-12-222021-07-14 115211354 Brandon, Donald M. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521711115217112020-12-22T12:05:002021-07-062020-12-22T12:05:002021-01-12T14:00:002020-12-222021-07-06 115211354 Brandon, Donald M. (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521712115217122020-12-22T16:04:002021-07-282020-12-22T16:04:002021-06-16T14:31:002020-12-222021-07-28 115211354 Brandon, Donald M. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521713115217132020-12-23T14:33:002021-07-062020-12-23T14:33:002021-01-12T15:41:002020-12-232021-07-06 115211354 Brandon, Donald M. (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521714115217142020-12-23T15:18:002021-07-122020-12-23T15:18:002021-06-14T14:52:002020-12-232021-07-12 115211354 Brandon, Donald M. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521715115217152020-12-23T16:10:002021-07-062020-12-23T16:10:002021-01-11T15:52:002020-12-232021-07-06 115211354 Brandon, Donald M. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521716115217162020-12-28T16:27:002021-07-202020-12-28T16:27:002021-01-18T11:02:002020-12-282021-07-20 115211354 Brandon, Donald M. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521717115217172020-12-28T16:59:002021-07-082020-12-28T16:59:002021-06-07T15:48:002020-12-282021-07-08 115211354 Brandon, Donald M. (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521718115217182020-12-29T11:20:002021-07-152020-12-29T11:20:002021-01-21T15:25:002020-12-292021-07-15 115211354 Brandon, Donald M. (b)(6)AğYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521719115217192020-12-29T12:06:002021-07-062020-12-29T12:06:002021-06-07T10:25:002020-12-292021-07-06 115211354 Brandon, Donald M. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521720115217202020-12-29T15:42:002021-07-192020-12-29T15:42:002021-06-09T15:38:002020-12-292021-07-19 115211354 Brandon, Donald M. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521721115217212020-12-29T15:49:002021-07-282020-12-29T15:49:002021-01-19T15:56:002020-12-292021-07-28 115211354 Brandon, Donald M. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521722115217222020-12-30T12:25:002021-08-312020-12-30T12:25:002021-01-21T15:41:002020-12-302021-08-31 115211354 Brandon, Donald M. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521723115217232020-12-30T15:11:002021-07-162020-12-30T15:11:002021-06-18T11:36:002020-12-302021-07-16 115211354 Brandon, Donald M. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521724115217242020-12-30T16:52:002021-07-132020-12-30T16:52:002021-01-18T12:13:002020-12-302021-07-13 115211354 Brandon, Donald M. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521725115217252020-12-30T16:40:002021-07-142020-12-30T16:40:002021-06-16T10:17:002020-12-302021-07-14 115211354 Brandon, Donald M. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521726115217262020-12-30T17:44:002021-06-152020-12-30T17:44:002021-01-18T16:05:002020-12-302021-06-15 115211354 Brandon, Donald M. (b)(6)AÀYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521727115217272021-01-04T10:54:002021-07-192021-01-04T10:54:002021-01-25T09:26:002021-01-042021-07-19 115211354 Brandon, Donald M. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521728115217282021-01-04T11:09:002021-07-232021-01-04T11:09:002021-01-25T08:52:002021-01-042021-07-23 115211354 Brandon, Donald M. (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521729115217292021-01-04T11:56:002021-07-122021-01-04T11:56:002021-06-14T14:23:002021-01-042021-07-12 115211354 Brandon, Donald M. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521730115217302021-01-04T15:36:002021-07-292021-01-04T15:36:002021-01-27T15:26:002021-01-042021-07-29 115211354 Brandon, Donald M. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521731115217312021-01-04T17:03:002021-05-102021-01-04T17:03:002021-04-12T13:53:002021-01-042021-05-10 115211354 Brandon, Donald M. (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521732115217322021-01-05T10:21:002021-07-212021-01-05T10:21:002021-01-27T11:22:002021-01-052021-07-21 115211354 Brandon, Donald M. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521733115217332021-01-05T16:16:002021-07-092021-01-05T16:16:002021-06-11T16:29:002021-01-052021-07-09 115211354 Brandon, Donald M. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521734115217342021-01-05T17:29:002021-07-282021-01-05T17:29:002021-01-27T16:38:002021-01-052021-07-28 115211354 Brandon, Donald M. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521735115217352021-01-05T17:34:002021-08-232021-01-05T17:34:002021-08-23T08:41:002021-01-052021-08-23 115211354 Brandon, Donald M. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521736115217362021-01-05T17:41:002021-07-192021-01-05T17:41:002021-01-25T13:38:002021-01-052021-07-19 115211354 Brandon, Donald M. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521737115217372021-01-06T11:29:002021-08-032021-01-06T11:29:002021-01-25T08:07:002021-01-062021-08-03 115211354 Brandon, Donald M. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521738115217382021-01-06T15:41:002021-08-162021-01-06T15:41:002021-07-19T16:01:002021-01-062021-08-16 115211354 Brandon, Donald M. (b)(6)AğYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521739115217392021-01-07T15:42:002021-07-092021-01-07T15:42:002021-06-11T15:52:002021-01-072021-07-09 115211354 Brandon, Donald M. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521740115217402021-01-07T16:43:002021-07-122021-01-07T16:43:002021-06-14T11:40:002021-01-072021-07-12 115211354 Brandon, Donald M. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521741115217412021-01-07T17:19:002021-07-122021-01-07T17:19:002021-06-14T11:47:002021-01-072021-07-12 115211354 Brandon, Donald M. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521742115217422021-01-08T08:56:002021-07-222021-01-08T08:56:002021-01-28T09:00:002021-01-082021-07-22 115211354 Brandon, Donald M. (b)(6)AĞYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521743115217432021-01-08T09:35:002021-07-212021-01-08T09:35:002021-01-27T11:53:002021-01-082021-07-21 115211354 Brandon, Donald M. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521744115217442021-01-08T09:41:002021-07-212021-01-08T09:41:002021-01-27T11:59:002021-01-082021-07-21 115211354 Brandon, Donald M. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521745115217452021-01-08T15:30:002021-08-062021-01-08T15:30:002021-01-28T14:29:002021-01-082021-08-06 115211354 Brandon, Donald M. (b)(6)AàYEARSMASIAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521746115217462021-01-08T15:36:002021-08-262021-01-08T15:36:002021-08-26T13:38:002021-01-08 115211354 Brandon, Donald M. (b)(6)AÀYEARSFASIAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521747115217472021-01-08T16:51:002021-07-262021-01-08T16:51:002021-05-20T15:56:002021-01-082021-07-26 115211354 Brandon, Donald M. (b)(6)AàYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521748115217482021-01-08T16:59:002021-07-212021-01-08T16:59:002021-01-27T13:21:002021-01-082021-07-21 115211354 Brandon, Donald M. (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521749115217492021-01-08T18:12:002021-07-222021-01-08T18:12:002021-01-28T15:35:002021-01-082021-07-22 115211354 Brandon, Donald M. (b)(6)AĞYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521750115217502021-01-08T19:05:002021-07-122021-01-08T19:05:002021-06-14T12:06:002021-01-082021-07-12 115211354 Brandon, Donald M. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521751115217512021-01-11T08:52:002021-05-182021-01-11T08:52:002021-02-02T09:04:002021-01-112021-05-18 115211354 Brandon, Donald M. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521752115217522021-01-11T09:45:002021-07-192021-01-11T09:45:002021-06-14T08:38:002021-01-112021-07-19 115211354 Brandon, Donald M. (b)(6)AğYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521753115217532021-01-11T09:56:002021-07-272021-01-11T09:56:002021-02-02T08:47:002021-01-112021-07-27 115211354 Brandon, Donald M. (b)(6)AĞYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521754115217542021-01-11T16:46:002021-05-212021-01-11T16:46:002021-02-01T16:12:002021-01-112021-05-21 115211354 Brandon, Donald M. (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1152 11521755115217552021-01-11T16:37:002021-08-092021-01-11T16:37:002021-02-01T15:44:002021-01-112021-08-09 115211354 Brandon, Donald M. (b)(6)AğYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521756115217562021-01-11T18:24:002021-08-032021-01-11T18:24:002021-02-01T17:32:002021-01-112021-08-03 115211354 Brandon, Donald M. (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1152 11521757115217572021-01-11T18:31:002021-07-072021-01-11T18:31:002021-06-09T09:08:002021-01-112021-07-07 115211354 Brandon, Donald M. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561243115612432020-10-15T15:57:002021-05-212020-10-15T15:57:002020-11-03T12:21:002020-10-152021-05-21 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561244115612442020-10-15T14:04:002021-07-132020-10-15T14:04:002021-06-15T12:31:002020-10-152021-07-13 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561245115612452020-10-15T14:07:002021-05-212020-10-15T14:07:002020-11-03T12:27:002020-10-152021-05-21 1156427723 Rodriguez, Hector A (b)(6)AğYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561246115612462020-10-22T14:51:002021-07-082020-10-22T14:51:002021-06-11T16:44:002020-10-152021-07-08 1156427723 Rodriguez, Hector A (b)(6)AàYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561247115612472020-10-16T10:29:002021-07-292020-10-16T10:29:002021-06-25T14:48:002020-10-162021-07-29 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSMNOT REPORTED NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561248115612482020-10-16T12:27:002021-08-192020-10-16T12:27:002021-06-01T11:09:002020-10-162021-08-19 1156427723 Rodriguez, Hector A (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561249115612492020-10-16T13:13:002021-06-032020-10-16T13:13:002020-11-04T13:07:002020-10-162021-06-03 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561250115612502020-10-16T15:41:002021-05-192020-10-16T15:41:002020-11-04T14:17:002020-10-16 1156427723 Rodriguez, Hector A (b)(6)AğYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561253115612532020-10-19T12:11:002021-08-022020-10-19T12:11:002021-06-28T11:41:002020-10-192021-08-02 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561254115612542020-10-19T16:03:002021-08-102020-10-19T16:03:002021-07-09T13:31:002020-10-192021-08-10 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561255115612552020-10-20T11:44:002021-07-062020-10-20T11:44:002021-06-07T11:55:002020-10-202021-07-06 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561256115612562020-10-20T11:47:002021-05-172020-10-20T11:47:002020-11-10T11:48:002020-10-202021-05-17 1156427723 Rodriguez, Hector A (b)(6)AğYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561257115612572020-10-20T11:52:002021-05-202020-10-20T11:52:002020-11-12T14:44:002020-10-202021-05-20 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561259115612592020-10-20T17:14:002021-06-232020-10-20T17:14:002020-11-10T11:53:002020-10-202021-06-23 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561260115612602020-10-21T11:46:002021-05-172020-10-21T11:46:002021-04-15T11:14:002020-10-212021-05-17 1156427723 Rodriguez, Hector A (b)(6)AğYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561262115612622020-10-21T13:59:002021-05-182020-10-21T13:59:002020-11-11T12:39:002020-10-212021-05-18 1156427723 Rodriguez, Hector A (b)(6)AàYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561263115612632020-10-21T15:17:002021-07-122020-10-21T15:17:002021-06-14T11:29:002020-10-212021-07-12 1156427723 Rodriguez, Hector A (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561264115612642020-10-22T11:51:002021-05-182020-10-22T11:51:002020-11-10T12:59:002020-10-22 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561265115612652020-10-22T14:41:002021-07-122020-10-22T14:41:002021-06-11T16:46:002020-10-222021-07-12 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561303115613032020-11-30T13:24:002021-06-222020-11-30T13:24:002020-12-22T11:51:002020-11-302021-06-22 1156427723 Rodriguez, Hector A (b)(6)AğYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561304115613042020-11-30T14:59:002021-08-202020-11-30T14:59:002020-12-21T11:02:002020-11-302021-08-20 1156427723 Rodriguez, Hector A (b)(6)AàYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561305115613052020-11-30T15:03:002021-08-232020-11-30T15:03:002021-07-19T13:58:002020-11-302021-08-23 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561306115613062020-12-01T11:10:002021-06-222020-12-01T11:10:002020-12-22T11:51:002020-12-012021-06-22 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561307115613072020-12-01T12:37:002021-08-162020-12-01T12:37:002021-07-15T13:43:002020-12-012021-08-16 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561308115613082020-12-01T12:39:002021-06-252020-12-01T12:39:002020-12-21T10:53:002020-12-012021-06-25 1156427723 Rodriguez, Hector A (b)(6)AàYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561309115613092020-12-01T12:43:002021-08-132020-12-01T12:43:002021-07-15T13:44:002020-12-012021-08-13 1156427723 Rodriguez, Hector A (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561310115613102020-12-01T16:39:002021-07-022020-12-01T16:39:002021-01-07T10:36:002020-12-012021-07-02 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSFBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561311115613112020-12-02T10:29:002021-07-292020-12-02T10:29:002021-01-05T13:57:002020-12-02 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561312115613122020-12-02T11:36:002021-08-092020-12-02T11:36:002021-07-06T11:29:002020-12-022021-08-09 1156427723 Rodriguez, Hector A (b)(6)AğYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561313115613132020-12-02T15:25:002021-06-242020-12-02T15:25:002020-12-21T13:10:002020-12-022021-06-24 1156427723 Rodriguez, Hector A (b)(6)AàYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561314115613142020-12-03T11:15:002021-06-162020-12-03T11:15:002020-12-23T10:52:002020-12-032021-06-16 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561316115613162020-12-03T12:21:002021-05-062020-12-03T12:21:002020-12-28T14:39:002020-12-032021-05-06 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561317115613172020-12-03T15:37:002021-06-282020-12-03T15:37:002020-12-28T15:49:002020-12-032021-06-28 1156427723 Rodriguez, Hector A (b)(6)AàYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561318115613182020-12-04T12:48:002021-07-132020-12-04T12:48:002021-01-05T11:37:002020-12-042021-07-13 1156427723 Rodriguez, Hector A (b)(6)AğYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561319115613192020-12-04T14:12:002021-08-192020-12-04T14:12:002021-07-22T12:56:002020-12-042021-08-19 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561320115613202020-12-04T15:48:002021-01-252020-12-04T15:48:002020-12-23T12:04:002020-12-042021-01-25 1156427723 Rodriguez, Hector A (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561321115613212020-12-07T12:41:002021-06-282020-12-07T12:41:002020-12-28T12:11:002020-12-072021-06-28 1156427723 Rodriguez, Hector A (b)(6)AàYEARSFBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561322115613222020-12-07T13:53:002021-07-062020-12-07T13:53:002021-06-07T11:31:002020-12-072021-07-06 1156427723 Rodriguez, Hector A (b)(6)AàYEARSFBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561323115613232020-12-07T13:56:002021-07-122020-12-07T13:56:002021-06-07T12:00:002020-12-072021-07-12 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSMBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561324115613242020-12-07T13:59:002021-06-252020-12-07T13:59:002020-12-30T14:03:002020-12-072021-06-25 1156427723 Rodriguez, Hector A (b)(6)AàYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561325115613252020-12-08T16:21:002021-07-022020-12-08T16:21:002020-12-28T10:36:002020-12-082021-07-02 1156427723 Rodriguez, Hector A (b)(6)AğYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561327115613272020-12-10T16:34:002021-07-012020-12-10T16:34:002021-06-03T11:02:002020-12-102021-07-01 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561328115613282020-12-14T11:42:002021-08-182020-12-14T11:42:002021-01-04T16:09:002020-12-142021-08-18 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561330115613302020-12-15T16:07:002021-06-302020-12-15T16:07:002021-06-02T15:25:002020-12-152021-06-30 1156427723 Rodriguez, Hector A (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561331115613312020-12-17T15:50:002021-06-302020-12-17T15:50:002021-01-05T16:13:002020-12-172021-06-30 1156427723 Rodriguez, Hector A (b)(6)AàYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561332115613322020-12-17T16:05:002021-08-192020-12-17T16:05:002021-07-22T11:19:002020-12-172021-08-19 1156427723 Rodriguez, Hector A (b)(6)AğYEARSMBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561333115613332020-12-18T13:43:002021-07-062020-12-18T13:43:002021-06-04T15:29:002020-12-182021-07-06 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561334115613342020-12-18T14:51:002021-07-122020-12-18T14:51:002021-01-08T10:17:002020-12-182021-07-12 1156427723 Rodriguez, Hector A (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561335115613352020-12-21T11:13:002021-08-162020-12-21T11:13:002021-08-16T13:42:002020-12-21 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561336115613362020-12-22T12:31:002021-06-082020-12-22T12:31:002021-01-11T11:51:002020-12-222021-06-08 1156427723 Rodriguez, Hector A (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561337115613372020-12-22T16:54:002021-07-082020-12-22T16:54:002021-01-11T16:04:002020-12-222021-07-08 1156427723 Rodriguez, Hector A (b)(6)AàYEARSFBLACK OR AFRICAN AMERICAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561338115613382020-12-23T12:08:002021-07-092020-12-23T12:08:002021-01-11T16:21:002020-12-232021-07-09 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561339115613392020-12-28T12:23:002021-07-062020-12-28T12:23:002021-01-19T16:43:002020-12-282021-07-06 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSFBLACK OR AFRICAN AMERICAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561340115613402020-12-28T13:03:002021-07-142020-12-28T13:03:002021-01-19T14:16:002020-12-282021-07-14 1156427723 Rodriguez, Hector A (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561341115613412020-12-29T13:49:002021-07-062020-12-29T13:49:002021-06-04T11:55:002020-12-292021-07-06 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561342115613422020-12-29T13:52:002021-07-152020-12-29T13:52:002021-01-19T16:51:002020-12-292021-07-15 1156427723 Rodriguez, Hector A (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561343115613432021-01-04T12:12:002021-07-062021-01-04T12:12:002021-06-07T15:21:002021-01-042021-07-06 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561344115613442021-01-04T16:22:002021-08-032021-01-04T16:22:002021-01-25T14:48:002021-01-04 1156427723 Rodriguez, Hector A (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561345115613452021-01-05T11:35:002021-07-302021-01-05T11:35:002021-07-02T16:15:002021-01-052021-07-30 1156427723 Rodriguez, Hector A (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561346115613462021-01-06T11:40:002021-07-222021-01-06T11:40:002021-01-28T11:08:002021-01-062021-07-22 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561347115613472021-01-06T13:41:002021-07-262021-01-06T13:41:002021-01-27T10:47:002021-01-062021-07-26 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561348115613482021-01-06T17:04:002021-07-122021-01-06T17:04:002021-06-14T15:35:002021-01-062021-07-12 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561349115613492021-01-06T16:58:002021-08-022021-01-06T16:58:002021-01-26T16:37:002021-01-062021-08-02 1156427723 Rodriguez, Hector A (b)(6)AğYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561351115613512021-01-07T10:36:002021-07-122021-01-07T10:36:002021-06-14T11:25:002021-01-072021-07-12 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561352115613522021-01-07T14:07:002021-07-292021-01-07T14:07:002021-01-28T14:26:002021-01-072021-07-29 1156427723 Rodriguez, Hector A (b)(6)AàYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561353115613532021-01-07T15:54:002021-07-092021-01-07T15:54:002021-05-17T17:18:002021-01-072021-07-09 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561354115613542021-01-07T15:58:002021-08-192021-01-07T15:58:002021-01-27T16:11:002021-01-072021-08-19 1156427723 Rodriguez, Hector A (b)(6)AàYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561355115613552021-01-07T16:02:002021-08-132021-01-07T16:02:002021-08-13T13:36:002021-01-07 1156427723 Rodriguez, Hector A (b)(6)AàYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561356115613562021-01-07T16:06:002021-08-062021-01-07T16:06:002021-01-29T16:33:002021-01-072021-08-06 1156427723 Rodriguez, Hector A (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561357115613572021-01-07T17:03:002021-07-062021-01-07T17:03:002021-06-07T10:59:002021-01-072021-07-06 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561358115613582021-01-07T17:07:002021-08-062021-01-07T17:07:002021-01-29T16:13:002021-01-072021-08-06 1156427723 Rodriguez, Hector A (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561359115613592021-01-08T10:59:002021-06-302021-01-08T10:59:002021-05-14T12:29:002021-01-082021-06-30 1156427723 Rodriguez, Hector A (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561360115613602021-01-08T12:29:002021-09-012021-01-08T12:29:002021-01-27T10:44:002021-01-082021-09-01 1156427723 Rodriguez, Hector A (b)(6)AàYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561361115613612021-01-08T13:28:002021-08-052021-01-08T13:28:002021-01-28T14:04:002021-01-082021-08-05 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561362115613622021-01-08T14:11:002021-08-182021-01-08T14:11:002021-08-18T14:21:002021-01-08 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561363115613632021-01-08T15:43:002021-08-202021-01-08T15:43:002021-08-20T15:16:002021-01-08 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561364115613642021-01-08T17:05:002021-08-032021-01-08T17:05:002021-01-29T16:39:002021-01-082021-08-03 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561365115613652021-01-11T11:40:002021-08-092021-01-11T11:40:002021-02-01T10:42:002021-01-112021-08-09 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561366115613662021-01-11T11:38:002021-08-092021-01-11T11:38:002021-02-01T10:45:002021-01-112021-08-09 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561367115613672021-01-11T14:41:002021-06-302021-01-11T14:41:002021-06-02T13:59:002021-01-112021-06-30 1156427723 Rodriguez, Hector A (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561368115613682021-01-11T15:42:002021-07-282021-01-11T15:42:002021-02-01T10:32:002021-01-112021-07-28 1156427723 Rodriguez, Hector A (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561369115613692021-01-11T15:46:002021-06-302021-01-11T15:46:002021-06-02T12:19:002021-01-112021-06-30 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561370115613702021-01-11T16:46:002021-08-182021-01-11T16:46:002021-02-01T16:01:002021-01-112021-08-18 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSFASIAN HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561371115613712021-01-12T11:45:002021-05-032021-01-12T11:45:002021-04-05T11:02:002021-01-122021-05-03 1156427723 Rodriguez, Hector A (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561372115613722021-01-12T11:43:002021-07-292021-01-12T11:43:002021-02-04T11:03:002021-01-122021-07-29 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561373115613732021-01-12T12:30:002021-07-072021-01-12T12:30:002021-06-03T11:06:002021-01-122021-07-07 1156427723 Rodriguez, Hector A (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1156 11561374115613742021-01-12T16:10:002021-07-272021-01-12T16:10:002021-02-02T12:37:002021-01-122021-07-27 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1156 11561375115613752021-01-12T16:36:002021-05-192021-01-12T16:36:002021-02-02T16:51:002021-01-122021-05-19 1156427723 Rodriguez, Hector A (b)(6)AÀYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1223 12231267122312672021-01-07T16:07:002021-07-232021-01-07T16:07:002021-01-27T15:39:002021-01-072021-07-23 1223349998 Ogbuagu, Onyema E. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231268122312682021-01-07T16:11:002021-07-092021-01-07T16:11:002021-06-10T13:41:002021-01-07 1223349998 Ogbuagu, Onyema E. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1223 12231269122312692021-01-07T17:34:002021-07-092021-01-07T17:34:002021-06-08T12:49:002021-01-072021-07-09 1223349998 Ogbuagu, Onyema E. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1223 12231270122312702021-01-07T17:34:002021-08-252021-01-07T17:34:002021-01-29T15:58:002021-01-072021-08-25 1223349998 Ogbuagu, Onyema E. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231271122312712021-01-08T16:00:002021-08-092021-01-08T16:00:002021-01-29T12:34:002021-01-082021-08-09 1223349998 Ogbuagu, Onyema E. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231272122312722021-01-09T10:29:002021-07-092021-01-09T10:29:002021-06-10T10:02:002021-01-092021-07-09 1223349998 Ogbuagu, Onyema E. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1223 12231273122312732021-01-09T10:25:002021-07-092021-01-09T10:25:002021-06-10T09:58:002021-01-092021-07-09 1223349998 Ogbuagu, Onyema E. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1223 12231274122312742021-01-09T10:35:002021-08-242021-01-09T10:35:002021-01-29T14:57:002021-01-092021-08-24 1223349998 Ogbuagu, Onyema E. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231275122312752021-01-09T11:03:002021-08-042021-01-09T11:03:002021-02-02T14:59:002021-01-092021-08-04 1223349998 Ogbuagu, Onyema E. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231276122312762021-01-09T11:11:002021-07-082021-01-09T11:11:002021-06-08T15:27:002021-01-092021-07-08 1223349998 Ogbuagu, Onyema E. (b)(6)AÀYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1223 12231277122312772021-01-09T11:07:002021-07-142021-01-09T11:07:002021-06-14T12:11:002021-01-092021-07-14 1223349998 Ogbuagu, Onyema E. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1223 12231278122312782021-01-09T11:53:002021-08-192021-01-09T11:53:002021-02-02T17:45:002021-01-092021-08-19 1223349998 Ogbuagu, Onyema E. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231279122312792021-01-09T11:57:002021-07-142021-01-09T11:57:002021-06-11T11:09:002021-01-092021-07-14 1223349998 Ogbuagu, Onyema E. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1223 12231280122312802021-01-09T12:27:002021-08-302021-01-09T12:27:002021-01-28T14:51:002021-01-092021-08-30 1223349998 Ogbuagu, Onyema E. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231281122312812021-01-09T12:56:002021-08-102021-01-09T12:56:002021-02-02T18:20:002021-01-09 1223349998 Ogbuagu, Onyema E. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231283122312832021-01-09T13:29:002021-08-102021-01-09T13:29:002021-06-09T10:06:002021-01-092021-08-10 1223349998 Ogbuagu, Onyema E. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1223 12231284122312842021-01-12T15:43:002021-08-302021-01-12T15:43:002021-02-02T15:17:002021-01-122021-08-30 1223349998 Ogbuagu, Onyema E. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231285122312852021-01-12T15:39:002021-08-302021-01-12T15:39:002021-02-02T15:21:002021-01-122021-08-30 1223349998 Ogbuagu, Onyema E. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1223 12231286122312862021-01-12T16:26:002021-07-122021-01-12T16:26:002021-06-11T10:02:002021-01-122021-07-12 1223349998 Ogbuagu, Onyema E. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351232123512322020-11-30T10:33:002021-07-142020-11-30T10:33:002021-06-15T11:28:002020-11-302021-07-14 1235240230 Vanchiere, John A. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351233123512332020-11-30T10:40:002021-06-152020-11-30T10:40:002020-12-21T09:11:002020-11-302021-06-15 1235240230 Vanchiere, John A. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1235 12351234123512342020-11-30T12:53:002021-06-182020-11-30T12:53:002020-12-22T11:26:002020-11-302021-06-18 1235240230 Vanchiere, John A. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1235 12351235123512352020-11-30T14:06:002021-07-062020-11-30T14:06:002021-06-07T10:25:002020-11-302021-07-06 1235240230 Vanchiere, John A. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351236123512362020-12-02T14:14:002021-08-272020-12-02T14:14:002021-06-07T14:40:002020-12-022021-08-27 1235240230 Vanchiere, John A. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351238123512382020-12-07T10:29:002021-08-052020-12-07T10:29:002020-12-28T10:35:002020-12-072021-08-05 1235240230 Vanchiere, John A. (b)(6)AğYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1235 12351239123512392020-12-07T11:28:002021-07-072020-12-07T11:28:002021-06-07T14:23:002020-12-072021-07-07 1235240230 Vanchiere, John A. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351242123512422020-12-08T10:43:002021-06-212020-12-08T10:43:002020-12-28T08:37:002020-12-082021-06-21 1235240230 Vanchiere, John A. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1235 12351243123512432020-12-08T12:48:002021-07-152020-12-08T12:48:002020-12-30T11:12:002020-12-082021-07-15 1235240230 Vanchiere, John A. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351244123512442020-12-08T12:52:002021-07-152020-12-08T12:52:002020-12-30T11:02:002020-12-082021-07-15 1235240230 Vanchiere, John A. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351245123512452020-12-08T14:10:002021-06-232020-12-08T14:10:002020-12-30T09:43:002020-12-082021-06-23 1235240230 Vanchiere, John A. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1235 12351246123512462020-12-15T09:40:002021-07-092020-12-15T09:40:002021-01-05T09:50:002020-12-152021-07-09 1235240230 Vanchiere, John A. (b)(6)AğYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1235 12351247123512472020-12-15T09:42:002021-07-092020-12-15T09:42:002021-01-05T09:53:002020-12-152021-07-09 1235240230 Vanchiere, John A. (b)(6)AğYEARSMASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1235 12351248123512482020-12-15T11:00:002021-07-122020-12-15T11:00:002021-06-08T10:33:002020-12-152021-07-12 1235240230 Vanchiere, John A. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351249123512492020-12-15T13:17:002021-07-122020-12-15T13:17:002021-06-08T10:35:002020-12-152021-07-12 1235240230 Vanchiere, John A. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351250123512502020-12-15T14:21:002021-06-302020-12-15T14:21:002021-01-05T13:42:002020-12-152021-06-30 1235240230 Vanchiere, John A. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1235 12351251123512512020-12-18T10:00:002021-07-092020-12-18T10:00:002021-06-04T08:33:002020-12-182021-07-09 1235240230 Vanchiere, John A. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351252123512522020-12-21T14:20:002021-07-062020-12-21T14:20:002021-06-08T10:01:002020-12-212021-07-06 1235240230 Vanchiere, John A. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1235 12351253123512532021-01-08T15:50:002021-07-222021-01-08T15:50:002021-01-28T11:36:002021-01-082021-07-22 1235240230 Vanchiere, John A. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1235 12351254123512542021-01-08T15:53:002021-07-222021-01-08T15:53:002021-01-28T11:38:002021-01-08 1235240230 Vanchiere, John A. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701173127011732020-11-30T11:50:002021-06-292020-11-30T11:50:002021-06-01T11:43:002020-11-302021-06-29 1270280164 Klein, Nicola P. (b)(6)AğYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701174127011742020-11-30T11:50:002021-06-292020-11-30T11:50:002021-06-01T11:43:002020-11-302021-06-29 1270280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701177127011772020-12-01T14:13:002021-06-232020-12-01T14:13:002020-12-21T15:51:002020-12-012021-06-23 1270280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701180127011802020-12-02T13:23:002021-08-312020-12-02T13:23:002020-12-22T13:24:002020-12-022021-08-31 1270280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701181127011812020-12-02T13:23:002021-05-042020-12-02T13:23:002021-04-06T13:50:002020-12-022021-05-04 1270280164 Klein, Nicola P. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701184127011842020-12-02T15:51:002021-06-222020-12-02T15:51:002020-12-23T12:15:002020-12-02 1270280164 Klein, Nicola P. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701187127011872020-12-03T08:33:002021-06-152020-12-03T08:33:002020-12-22T09:00:002020-12-032021-06-15 1270280164 Klein, Nicola P. (b)(6)AğYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701188127011882020-12-03T08:35:002021-07-142020-12-03T08:35:002021-06-14T10:22:002020-12-032021-07-14 1270280164 Klein, Nicola P. (b)(6)AĞYEARSMASIAN HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701189127011892020-12-03T15:19:002021-06-212020-12-03T15:19:002020-12-22T14:47:002020-12-032021-06-21 1270280164 Klein, Nicola P. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701191127011912020-12-03T16:49:002021-08-092020-12-03T16:49:002020-12-23T16:30:002020-12-032021-08-09 1270280164 Klein, Nicola P. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701192127011922020-12-04T11:00:002021-07-072020-12-04T11:00:002021-06-07T10:50:002020-12-042021-07-07 1270280164 Klein, Nicola P. (b)(6)AĞYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701194127011942020-12-04T13:37:002021-07-142020-12-04T13:37:002021-06-16T11:58:002020-12-042021-07-14 1270280164 Klein, Nicola P. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701198127011982020-12-07T12:12:002021-07-022020-12-07T12:12:002020-12-30T12:03:002020-12-072021-07-02 1270280164 Klein, Nicola P. (b)(6)AàYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701199127011992020-12-08T15:11:002021-07-082020-12-08T15:11:002021-06-07T08:42:002020-12-082021-07-08 1270280164 Klein, Nicola P. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701200127012002020-12-10T16:12:002021-07-012020-12-10T16:12:002020-12-29T15:59:002020-12-10 1270280164 Klein, Nicola P. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701201127012012020-12-11T10:08:002021-08-022020-12-11T10:08:002021-05-05T08:49:002020-12-11 1270280164 Klein, Nicola P. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701202127012022020-12-11T14:01:002021-06-242020-12-11T14:01:002020-12-31T16:25:002020-12-11 1270280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701203127012032020-12-11T13:55:002021-07-212020-12-11T13:55:002020-12-30T10:56:002020-12-112021-07-21 1270280164 Klein, Nicola P. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701204127012042020-12-15T08:58:002021-07-122020-12-15T08:58:002021-06-07T14:20:002020-12-152021-07-12 1270280164 Klein, Nicola P. (b)(6)AÀYEARSMNOT REPORTED NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701205127012052020-12-15T14:22:002021-07-132020-12-15T14:22:002021-06-14T09:37:002020-12-152021-07-13 1270280164 Klein, Nicola P. (b)(6)AĞYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701206127012062020-12-15T15:04:002021-07-212020-12-15T15:04:002021-06-16T15:36:002020-12-152021-07-21 1270280164 Klein, Nicola P. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701207127012072020-12-16T09:08:002021-06-292020-12-16T09:08:002021-01-05T13:53:002020-12-162021-06-29 1270280164 Klein, Nicola P. (b)(6)AàYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701208127012082020-12-16T12:46:002021-07-192020-12-16T12:46:002021-06-14T15:31:002020-12-162021-07-19 1270280164 Klein, Nicola P. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701209127012092020-12-16T14:53:002021-07-012020-12-16T14:53:002021-01-04T11:49:002020-12-162021-07-01 1270280164 Klein, Nicola P. (b)(6)AğYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701210127012102020-12-16T15:53:002021-07-092020-12-16T15:53:002021-01-04T15:19:002020-12-162021-07-09 1270280164 Klein, Nicola P. (b)(6)AğYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701211127012112020-12-16T15:53:002021-07-092020-12-16T15:53:002021-01-04T15:19:002020-12-162021-07-09 1270280164 Klein, Nicola P. (b)(6)AàYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701212127012122020-12-16T16:28:002021-05-102020-12-16T16:28:002021-04-09T14:52:002020-12-162021-05-10 1270280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701213127012132020-12-17T09:10:002021-07-192020-12-17T09:10:002021-06-14T11:30:002020-12-172021-07-19 1270280164 Klein, Nicola P. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701214127012142020-12-17T11:13:002021-07-082020-12-17T11:13:002021-01-08T15:33:002020-12-172021-07-08 1270280164 Klein, Nicola P. (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701215127012152020-12-17T12:51:002021-07-092020-12-17T12:51:002021-01-14T13:44:002020-12-172021-07-09 1270280164 Klein, Nicola P. (b)(6)AÀYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701216127012162020-12-17T13:48:002021-08-272020-12-17T13:48:002021-06-07T11:25:002020-12-172021-08-27 1270280164 Klein, Nicola P. (b)(6)AÀYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701217127012172020-12-17T15:13:002021-07-142020-12-17T15:13:002021-06-16T11:58:002020-12-172021-07-14 1270280164 Klein, Nicola P. (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701218127012182020-12-17T16:24:002021-07-132020-12-17T16:24:002021-06-15T13:31:002020-12-17 1270280164 Klein, Nicola P. (b)(6)AàYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701219127012192020-12-18T11:01:002021-07-072020-12-18T11:01:002021-01-08T11:43:002020-12-182021-07-07 1270280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701220127012202020-12-18T11:03:002021-08-112020-12-18T11:03:002021-01-08T11:45:002020-12-182021-08-11 1270280164 Klein, Nicola P. (b)(6)AĞYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701221127012212020-12-18T12:51:002021-07-122020-12-18T12:51:002021-06-14T15:08:002020-12-182021-07-12 1270280164 Klein, Nicola P. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701222127012222020-12-18T16:30:002021-08-062020-12-18T16:30:002021-01-08T14:18:002020-12-182021-08-06 1270280164 Klein, Nicola P. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701223127012232020-12-18T16:34:002021-08-232020-12-18T16:34:002021-06-15T09:41:002020-12-182021-08-23 1270280164 Klein, Nicola P. (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701224127012242020-12-21T13:05:002021-07-122020-12-21T13:05:002021-01-12T16:05:002020-12-21 1270280164 Klein, Nicola P. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701225127012252020-12-29T10:51:002021-07-212020-12-29T10:51:002021-06-15T10:18:002020-12-292021-07-21 1270280164 Klein, Nicola P. (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701226127012262021-01-04T16:07:002021-07-262021-01-04T16:07:002021-01-25T08:52:002021-01-042021-07-26 1270280164 Klein, Nicola P. (b)(6)AàYEARSFASIAN NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701227127012272021-01-05T09:06:002021-07-072021-01-05T09:06:002021-06-08T08:08:002021-01-052021-07-07 1270280164 Klein, Nicola P. (b)(6)AĞYEARSMASIAN NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701228127012282021-01-05T10:50:002021-07-262021-01-05T10:50:002021-06-03T13:33:002021-01-052021-07-26 1270280164 Klein, Nicola P. (b)(6)AÀYEARSFWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701229127012292021-01-05T12:08:002021-07-202021-01-05T12:08:002021-01-26T11:46:002021-01-052021-07-20 1270280164 Klein, Nicola P. (b)(6)AĞYEARSFWHITE HISPANIC OR LATINO B2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701230127012302021-01-05T13:27:002021-05-242021-01-05T13:27:002021-04-26T15:05:002021-01-052021-05-24 1270280164 Klein, Nicola P. (b)(6)AğYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701231127012312021-01-05T13:27:002021-07-082021-01-05T13:27:002021-06-08T13:51:002021-01-052021-07-08 1270280164 Klein, Nicola P. (b)(6)AĞYEARSFMULTIPLE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701232127012322021-01-05T15:31:002021-07-212021-01-05T15:31:002021-01-27T15:40:002021-01-052021-07-21 1270280164 Klein, Nicola P. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701233127012332021-01-05T16:07:002021-08-232021-01-05T16:07:002021-01-26T15:40:002021-01-052021-08-23 1270280164 Klein, Nicola P. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701234127012342021-01-06T09:12:002021-08-032021-01-06T09:12:002021-01-28T08:52:002021-01-062021-08-03 1270280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701235127012352021-01-06T10:25:002021-08-032021-01-06T10:25:002021-01-28T08:58:002021-01-062021-08-03 1270280164 Klein, Nicola P. (b)(6)AÀYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701236127012362021-01-06T15:18:002021-07-072021-01-06T15:18:002021-06-07T14:22:002021-01-06 1270280164 Klein, Nicola P. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701237127012372021-01-07T09:43:002021-07-132021-01-07T09:43:002021-05-19T09:55:002021-01-072021-07-13 1270280164 Klein, Nicola P. (b)(6)AĞYEARSFAMERICAN INDIAN OR ALASKA NATIVE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701238127012382021-01-07T12:04:002021-07-072021-01-07T12:04:002021-06-07T15:13:002021-01-072021-07-07 1270280164 Klein, Nicola P. (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701239127012392021-01-07T12:52:002021-07-262021-01-07T12:52:002021-01-28T13:31:002021-01-072021-07-26 1270280164 Klein, Nicola P. (b)(6)AĞYEARSFWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701240127012402021-01-07T15:10:002021-08-252021-01-07T15:10:002021-01-28T14:35:002021-01-072021-08-25 1270280164 Klein, Nicola P. (b)(6)AğYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701241127012412021-01-07T15:50:002021-07-212021-01-07T15:50:002021-06-14T14:54:002021-01-072021-07-21 1270280164 Klein, Nicola P. (b)(6)AĞYEARSMWHITE HISPANIC OR LATINO PLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701242127012422021-01-08T12:59:002021-07-022021-01-08T12:59:002021-06-04T13:58:002021-01-082021-07-02 1270280164 Klein, Nicola P. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USAC4591001DMC4591001 1270 12701243127012432021-01-11T16:18:002021-07-302021-01-11T16:18:002021-02-02T13:47:002021-01-112021-07-30 1270280164 Klein, Nicola P. (b)(6)AÀYEARSMWHITE NOT HISPANIC OR LATINOB2_P23_30BNT162b2 Phase 2/3 (30 mcg) B2_P23_30BNT162b2 Phase 2/3 (30 mcg)USAC4591001DMC4591001 1270 12701244127012442021-01-11T16:18:002021-07-192021-01-11T16:18:002021-06-07T16:02:002021-01-112021-07-19 1270280164 Klein, Nicola P. (b)(6)AàYEARSFWHITE NOT HISPANIC OR LATINOPLACEBO Placebo PLACEBO Placebo USA